{
    "questions": [
        {
            "body": "What is the alternative lengthening of telomeres?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28741530",
                "http://www.ncbi.nlm.nih.gov/pubmed/27829156",
                "http://www.ncbi.nlm.nih.gov/pubmed/25471051",
                "http://www.ncbi.nlm.nih.gov/pubmed/10913111",
                "http://www.ncbi.nlm.nih.gov/pubmed/22989712",
                "http://www.ncbi.nlm.nih.gov/pubmed/21574432",
                "http://www.ncbi.nlm.nih.gov/pubmed/18418389",
                "http://www.ncbi.nlm.nih.gov/pubmed/27314101",
                "http://www.ncbi.nlm.nih.gov/pubmed/11196173",
                "http://www.ncbi.nlm.nih.gov/pubmed/23429284"
            ],
            "id": "5ab908d4fcf456587200001a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28741530",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Alternative lengthening of telomeres (ALT) is an enigmatic process that allows certain cancers to maintain telomeres in the absence of telomerase."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27829156",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "Proteomic Profiling Reveals a Specific Role for Translesion DNA Polymerase \u03b7 in the Alternative Lengthening of Telomeres."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25471051",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25471051",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 514,
                    "text": "The astrocytic subgroup was found to have frequent mutations in ATRX, TP53 and displays alternative lengthening of telomeres."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10913111",
                    "endSection": "title",
                    "offsetInBeginSection": 125,
                    "offsetInEndSection": 185,
                    "text": "Implication of NBS1 in alternative lengthening of telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25471051",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1271,
                    "offsetInEndSection": 1550,
                    "text": "The JHH-273 model is characteristic of anaplastic astrocytoma and represents a valuable tool for investigating the pathogenesis of this distinct molecular subset of gliomas and for preclinical testing of compounds targeting IDH1 mutations or alternative lengthening of telomeres."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22989712",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "The roles of WRN and BLM RecQ helicases in the Alternative Lengthening of Telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25471051",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1081,
                    "offsetInEndSection": 1270,
                    "text": "The model has a similar phenotype and histopathology as the original patient tumor, expresses the IDH1 (R132H) mutant protein and exhibits an alternative lengthening of telomeres phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10913111",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1010,
                    "offsetInEndSection": 1140,
                    "text": "These results suggest that NBS1 may be involved in alternative lengthening of telomeres in telomerase-negative immortalized cells."
                }
            ]
        },
        {
            "body": "Which organ express and secretes the hormone FGF21?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                "http://www.ncbi.nlm.nih.gov/pubmed/9139448",
                "http://www.ncbi.nlm.nih.gov/pubmed/18045786",
                "http://www.ncbi.nlm.nih.gov/pubmed/25871519",
                "http://www.ncbi.nlm.nih.gov/pubmed/26915669",
                "http://www.ncbi.nlm.nih.gov/pubmed/20675007",
                "http://www.ncbi.nlm.nih.gov/pubmed/24697521",
                "http://www.ncbi.nlm.nih.gov/pubmed/23066506",
                "http://www.ncbi.nlm.nih.gov/pubmed/26441837"
            ],
            "id": "5ad3aa47133db5eb78000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 90,
                    "offsetInEndSection": 198,
                    "text": "The placenta actively synthesizes and secretes many hormones, but it is unknown whether this includes FGF21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Adipose tissue is a metabolically responsive endocrine organ that secretes a myriad of adipokines."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 790,
                    "offsetInEndSection": 998,
                    "text": "Of the 379 genes robustly regulated by two structurally distinct PPARgamma agonists in the epididymal white adipose tissue (EWAT) of db/db mice, 33 encoded for known secreted proteins, one of which was FGF21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9139448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 435,
                    "offsetInEndSection": 535,
                    "text": "Heart secretes in blood the peptide compound natriuretic hormone which regulates the sodium balance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1561,
                    "offsetInEndSection": 1710,
                    "text": "The absence of FGF21 in fetal cord blood suggests that neither placental FGF21 nor maternal circulating FGF21 is secreted into the fetal circulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 627,
                    "text": "One possible mechanism involves the alteration in adipokine secretion, in particular the up-regulation of secreted factors that increase whole-body insulin sensitivity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 789,
                    "text": "Here, we report the use of transcriptional profiling to identify genes encoding for secreted proteins the expression of which is regulated by PPARgamma agonists."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18045786",
                    "endSection": "abstract",
                    "offsetInBeginSection": 347,
                    "offsetInEndSection": 543,
                    "text": "An elementary communication is displayed as a causal link from a cell that secretes a particular hormone to those cells which express the corresponding hormone receptor and respond to the hormone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1711,
                    "offsetInEndSection": 1770,
                    "text": "Placental FGF21 may be a regulator of placental metabolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9139448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 256,
                    "offsetInEndSection": 434,
                    "text": "Further, it has been shown that certain brain structures, hypothalamus in particular, are also endocrine organs which secrete in blood a large number of various peptide hormones."
                }
            ]
        },
        {
            "body": "What is the biological role of Neddylation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                "http://www.ncbi.nlm.nih.gov/pubmed/27593482",
                "http://www.ncbi.nlm.nih.gov/pubmed/28096463",
                "http://www.ncbi.nlm.nih.gov/pubmed/24821572",
                "http://www.ncbi.nlm.nih.gov/pubmed/28034751",
                "http://www.ncbi.nlm.nih.gov/pubmed/18826954",
                "http://www.ncbi.nlm.nih.gov/pubmed/26895833",
                "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                "http://www.ncbi.nlm.nih.gov/pubmed/25349211",
                "http://www.ncbi.nlm.nih.gov/pubmed/25531226"
            ],
            "id": "5ace3e3f0340b9f058000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "The neddylation conjugation pathway has a pivotal role in mediating ubiquitination of proteins and regulation of numerous biological processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 518,
                    "offsetInEndSection": 727,
                    "text": "Neddylation, a process mediated by the protein NEDD8, is required for conformational changes of cullins, a scaffolding protein situated in the core of cullin-RING ligases, and regulation of E3 ligase activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 728,
                    "offsetInEndSection": 872,
                    "text": "In this review, we present a comprehensive discussion of the recent findings on the neddylation pathway and its importance during tumorigenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 144,
                    "offsetInEndSection": 237,
                    "text": "Dysregulation in the ubiquitination and neddylation pathways is associated with many cancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 873,
                    "offsetInEndSection": 993,
                    "text": "The ramifications regarding the potential therapeutic use of ubiquination and neddylation inhibition are also discussed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27593482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 658,
                    "offsetInEndSection": 739,
                    "text": "However, the role of neddylation in type I interferon expression remains unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28096463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 448,
                    "offsetInEndSection": 588,
                    "text": "Little is known about the role of other deneddylating enzymes besides CSN and the role of neddylation and deneddylation of their substrates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24821572",
                    "endSection": "abstract",
                    "offsetInBeginSection": 664,
                    "offsetInEndSection": 743,
                    "text": "The regulatory role of neddylation is conserved in human Smurf1 and yeast Rsp5."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 40,
                    "text": "Targeting neddylation in cancer therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28034751",
                    "endSection": "abstract",
                    "offsetInBeginSection": 136,
                    "offsetInEndSection": 264,
                    "text": "BRCA1 is one of the key repair factors in the homologous recombination repair and may play a downstream role of the neddylation."
                }
            ]
        },
        {
            "body": "What is break induced replication?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                "http://www.ncbi.nlm.nih.gov/pubmed/16888651",
                "http://www.ncbi.nlm.nih.gov/pubmed/17626884",
                "http://www.ncbi.nlm.nih.gov/pubmed/26055704",
                "http://www.ncbi.nlm.nih.gov/pubmed/17905819",
                "http://www.ncbi.nlm.nih.gov/pubmed/11052944",
                "http://www.ncbi.nlm.nih.gov/pubmed/17280685",
                "http://www.ncbi.nlm.nih.gov/pubmed/26957021"
            ],
            "id": "5ab9050bfcf4565872000019",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "Break induced replication in eukaryotes: mechanisms, functions, and consequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Broken replication forks result in DNA breaks that are normally repaired via homologous recombination or break induced replication (BIR)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                    "endSection": "abstract",
                    "offsetInBeginSection": 603,
                    "offsetInEndSection": 819,
                    "text": "The Mec1-Rad53 induced phosphorylation of Pif1, previously found necessary for inhibition of telomerase at double strand breaks, was also important for the role of Pif1 in BIR and telomere elongation in cdc9-1 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 467,
                    "text": "When DNA double-strand breaks are induced at specific sites in the chromosome, Tn7 transposition is stimulated and insertions are directed proximal to the induced break."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                    "endSection": "abstract",
                    "offsetInBeginSection": 125,
                    "offsetInEndSection": 219,
                    "text": "This type of DSB break typically arises at collapsed replication forks or at eroded telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                    "endSection": "abstract",
                    "offsetInBeginSection": 138,
                    "offsetInEndSection": 411,
                    "text": "Mild insufficiency in the replicative ligase Cdc9 in budding yeast Saccharomyces cerevisiae resulted in a population of cells with persistent DNA damage, most likely due to broken replication forks, constitutive activation of the DNA damage checkpoint and longer telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                    "endSection": "abstract",
                    "offsetInBeginSection": 991,
                    "offsetInEndSection": 1124,
                    "text": "We propose a model whereby the passage of BIR forks through telomeres promotes telomerase activity and leads to telomere lengthening."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                    "endSection": "abstract",
                    "offsetInBeginSection": 377,
                    "offsetInEndSection": 590,
                    "text": "This synthesis is drastically different from S-phase replication in that instead of a replication fork, BIR proceeds via a migrating bubble and is associated with conservative inheritance of newly synthesized DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "Break-induced replication (BIR) is an important pathway specializing in repair of one-ended double-strand DNA breaks (DSBs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16888651",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 232,
                    "text": "Molecular studies on double-strand break (DSB) repair in mitosis are usually performed with enzymatically induced DSBs, but spontaneous DSBs might arise because of replication failures, for example when replication encounters nicks."
                }
            ]
        },
        {
            "body": "What is a fibrocyte?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18427397",
                "http://www.ncbi.nlm.nih.gov/pubmed/22022512",
                "http://www.ncbi.nlm.nih.gov/pubmed/25713803",
                "http://www.ncbi.nlm.nih.gov/pubmed/22796709",
                "http://www.ncbi.nlm.nih.gov/pubmed/19937928",
                "http://www.ncbi.nlm.nih.gov/pubmed/27773739",
                "http://www.ncbi.nlm.nih.gov/pubmed/25429068",
                "http://www.ncbi.nlm.nih.gov/pubmed/22043022",
                "http://www.ncbi.nlm.nih.gov/pubmed/24507087",
                "http://www.ncbi.nlm.nih.gov/pubmed/10851555"
            ],
            "id": "5ad247720340b9f058000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18427397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1360,
                    "offsetInEndSection": 1689,
                    "text": "With fibrocytes being a monocyte derived cell, we suggest that monocytes may play a more crucial role in the clinical outcome of atherosclerosis than previously realized as they not only contribute directly to plaque instability (through foam cell formation), but also promote plaque stability by transformation into a fibrocyte."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18427397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 518,
                    "offsetInEndSection": 760,
                    "text": "METHODS\nWe examined human carotid endarterectomy specimens for the presence of fibrocytes by immunohistochemistry staining for CD34/procollagen I and leukocyte specific protein-1/procollagen I) and examined fibrocyte differentiation in vitro."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1196,
                    "offsetInEndSection": 1356,
                    "text": "The fibrocyte differentiation-inhibiting factor serum amyloid P (SAP) inhibits HMWHA-induced fibrocyte differentiation and potentiates LMWHA-induced inhibition."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25713803",
                    "endSection": "abstract",
                    "offsetInBeginSection": 999,
                    "offsetInEndSection": 1510,
                    "text": "Therefore, the fibrocyte function(s) still remain(s) lack of understanding, mostly due to (I) the lack of mouse models that can provide complimentary in vivo real-time and cell fate mapping studies of the dynamic differentiation of fibrocytes and their progeny into collagen type I producing cells (and/or possibly, other cell types of the hematopoietic system); (II) the complexity of hematopoietic cell differentiation pathways in response to various stimuli; (III) the high plasticity of hematopoietic cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 385,
                    "offsetInEndSection": 556,
                    "text": "METHODS AND FINDINGS\nIn this report, we show that HMWHA potentiates the differentiation of human monocytes into fibrocytes, while LMWHA inhibits fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1357,
                    "offsetInEndSection": 1491,
                    "text": "Conversely, LMWHA inhibits the ability of HMWHA, interleukin-4 (IL-4), or interleukin-13 (IL-13) to promote fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22796709",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1208,
                    "offsetInEndSection": 1476,
                    "text": "Moreover, the fibrocyte subsets expressing the chemokine markers CXCR4 (P\u200a<\u200a0.0001), CCR2 (P\u200a<\u200a0.0001), CCR7 (P\u200a<\u200a0.0001) and coexpression of both CXCR4 and CCR2 (P\u200a<\u200a0.0001) were significantly elevated in patients with hypertensive heart disease compared to controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19937928",
                    "endSection": "abstract",
                    "offsetInBeginSection": 145,
                    "offsetInEndSection": 531,
                    "text": "To determine if Omniscan can affect the differentiation of monocytes into fibroblast-like cells called fibrocytes that are found in the fibrotic lesions of NSF, peripheral blood mononuclear cells (PBMCs) from NSF patients, hemodialysis patients without NSF, and healthy, renally sufficient controls were exposed to Omniscan in a standardized in vitro fibrocyte differentiation protocol."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1013,
                    "offsetInEndSection": 1195,
                    "text": "The addition of anti-CD44 antibodies potentiates fibrocyte differentiation, suggesting that CD44 mediates at least some of the effect of hyaluronic acid on fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 692,
                    "offsetInEndSection": 872,
                    "text": "Monocytes internalize HMWHA and LMWHA equally well, suggesting that the opposing effects on fibrocyte differentiation are not due to differential internalization of HMWHA or LMWHA."
                }
            ]
        },
        {
            "body": "Which cellular functions are affected by lncRNA H19 in the heart?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                "http://www.ncbi.nlm.nih.gov/pubmed/24926466",
                "http://www.ncbi.nlm.nih.gov/pubmed/26722426",
                "http://www.ncbi.nlm.nih.gov/pubmed/28165553",
                "http://www.ncbi.nlm.nih.gov/pubmed/27059301",
                "http://www.ncbi.nlm.nih.gov/pubmed/24671855",
                "http://www.ncbi.nlm.nih.gov/pubmed/26482621",
                "http://www.ncbi.nlm.nih.gov/pubmed/24466011",
                "http://www.ncbi.nlm.nih.gov/pubmed/28881833",
                "http://www.ncbi.nlm.nih.gov/pubmed/25866221"
            ],
            "id": "5ac7185f0340b9f058000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "OBJECTIVE\nThe long non-coding RNA (lncRNA) gene, H19, has been involving in multiple biological functions, which also plays a vital role in colorectal cancer carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24926466",
                    "endSection": "abstract",
                    "offsetInBeginSection": 408,
                    "offsetInEndSection": 826,
                    "text": "Here, we highlight recent progresses that have identified a myriad of molecular functions on tumorigenesis for several lncRNAs including metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), prostate cancer associated non-coding RNA 1 (PRNCR1), prostate cancer gene expression marker 1 (PCGEM1), H19, and homeobox transcript antisense intergenic RNA (HOTAIR), and several new lncRNAs for glioma development."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26722426",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 203,
                    "text": "To verify c-Myc can regulate the expression of lncRNA H19 directly in non-small cell lung cancer (NSCLC) and clarify the molecular mechanism on how lncRNA H19 promote the cell cycle progression of NSCLC."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28165553",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027436",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1072,
                    "offsetInEndSection": 1211,
                    "text": "Additionally, bioinformatic analysis showed that rs2839698 may change the crucial folding structures and alter the target microRNAs of H19."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24926466",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 293,
                    "text": "Those transcripts also include tens of thousands of long non-coding RNAs (lncRNAs) which are emerging as key elements of cellular homeostasis, essentially tumorigenesis steps."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27059301",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "LncRNA H19 functions as a competing endogenous RNA to regulate AQP3 expression by sponging miR-874 in the intestinal barrier."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28165553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1060,
                    "offsetInEndSection": 1195,
                    "text": "CONCLUSIONS\nLncRNA H19 was highly expressed in atherosclerosis, which could be used as a potential target for treating atherosclerosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24671855",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1470,
                    "offsetInEndSection": 1755,
                    "text": "In conclusion, our study demonstrates that the altered expression of lncRNA H19, which is induced by c-Myc, is involved in the development and progression of GC by regulating cell proliferation and shows that H19 may be a potential diagnostic and prognostic target in patients with GC."
                }
            ]
        },
        {
            "body": "Dinutuximab is used for treatment of which disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                "http://www.ncbi.nlm.nih.gov/pubmed/28061552",
                "http://www.ncbi.nlm.nih.gov/pubmed/27456981",
                "http://www.ncbi.nlm.nih.gov/pubmed/28154831",
                "http://www.ncbi.nlm.nih.gov/pubmed/27756784",
                "http://www.ncbi.nlm.nih.gov/pubmed/25851859",
                "http://www.ncbi.nlm.nih.gov/pubmed/27485082"
            ],
            "id": "589a247078275d0c4a000035",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Dinutuximab is a monoclonal antibody targeted at disialoganglioside (GD2), a tumor-associated antigen widely expressed in human neuroblastoma cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 939,
                    "offsetInEndSection": 1343,
                    "text": "Dinutuximab is a chimeric, human-murine, anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [IL-2]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "Dinutuximab: An Anti-GD2 Monoclonal Antibody for High-Risk Neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1596,
                    "offsetInEndSection": 1877,
                    "text": "CONCLUSIONS\nDinutuximab is the first anti-GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 309,
                    "offsetInEndSection": 504,
                    "text": "Dinutuximab has shown to be effective in prolonging survival for patients receiving standard multimodal treatment regimens and has now become standard of care during the final phase of treatment."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "Dinutuximab for the treatment of pediatric patients with neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 149,
                    "offsetInEndSection": 308,
                    "text": "The incorporation of dinutuximab into standard treatment regimens for patients with high-risk neuroblastoma has changed the landscape of neuroblastoma therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1878,
                    "offsetInEndSection": 2054,
                    "text": "Ongoing research will determine if dinutuximab could be used earlier in treatment, in nonresponders to initial therapies, in combination with chemotherapy, or in other cancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "OBJECTIVE\nTo review the pharmacology, pharmacokinetics, efficacy, safety, dosage and administration, and formulary considerations for dinutuximab."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1344,
                    "offsetInEndSection": 1471,
                    "text": "In phase III trials, dinutuximab increased 2-year event-free survival and overall survival when compared to standard treatment."
                }
            ]
        },
        {
            "body": "What is the ChIP-exo method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                "http://www.ncbi.nlm.nih.gov/pubmed/25612620",
                "http://www.ncbi.nlm.nih.gov/pubmed/26038153",
                "http://www.ncbi.nlm.nih.gov/pubmed/25249628",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                "http://www.ncbi.nlm.nih.gov/pubmed/27814676",
                "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                "http://www.ncbi.nlm.nih.gov/pubmed/26518661"
            ],
            "id": "5ac24c9495d0062724000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 324,
                    "text": "We describe an Illumina-based ChIP-exo method which provides a global improvement of the data quality of estrogen receptor (ER) ChIP and insights into the motif structure for key ER-associated factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "ChIP-exonuclease (ChIP-exo) is a modified ChIP-seq approach for high resolution mapping of transcription factor DNA sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 432,
                    "offsetInEndSection": 544,
                    "text": "The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1138,
                    "text": "Here, we describe the ChIP-exo method that we have optimized and streamlined for mammalian systems and next-generation sequencing-by-synthesis platform."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 545,
                    "offsetInEndSection": 775,
                    "text": "The key distinction of the ChIP-exo methodology is the incorporation of lambda exonuclease digestion in the library preparation workflow to effectively footprint the left and right 5' DNA borders of the protein-DNA crosslink site."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "The ChIP-exo Method: Identifying Protein-DNA Interactions with Near Base Pair Precision."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 468,
                    "text": "ChIP-exo of the ER pioneer factor FoxA1 identifies protected DNA with a predictable 8\u00a0bp overhang from the Forkhead motif, which we term mesas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 567,
                    "offsetInEndSection": 666,
                    "text": "Our Illumina-based ChIP-exo provides high resolution mapping of transcription factor binding sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 297,
                    "text": "To identify sequences responsible for recruitment of this transcription factor (TF) to individual loci, we turned to the high-resolution ChIP-exo approach."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 776,
                    "offsetInEndSection": 848,
                    "text": "The ChIP-exo libraries are then subjected to high throughput sequencing."
                }
            ]
        },
        {
            "body": "Where do mitochondrial DNA deletion breakpoints tend to occur?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                "http://www.ncbi.nlm.nih.gov/pubmed/9344670",
                "http://www.ncbi.nlm.nih.gov/pubmed/22661583",
                "http://www.ncbi.nlm.nih.gov/pubmed/26530670",
                "http://www.ncbi.nlm.nih.gov/pubmed/16432145",
                "http://www.ncbi.nlm.nih.gov/pubmed/22677107",
                "http://www.ncbi.nlm.nih.gov/pubmed/27084947",
                "http://www.ncbi.nlm.nih.gov/pubmed/23472757",
                "http://www.ncbi.nlm.nih.gov/pubmed/2215526",
                "http://www.ncbi.nlm.nih.gov/pubmed/24958239"
            ],
            "id": "5abc9ecffcf4565872000021",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 348,
                    "offsetInEndSection": 635,
                    "text": "In this work, we performed a computational analysis of the human mitochondrial genome using the \"Pattern Finder\" G-quadruplex (G4) predictor algorithm to assess whether G4-forming sequences reside in close proximity (within 20 base pairs) to known mitochondrial DNA deletion breakpoints."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 217,
                    "text": "DNA sequences proximal to human mitochondrial DNA deletion breakpoints prevalent in human disease form G-quadruplexes, a class of DNA structures inefficiently unwound by the mitochondrial replicative Twinkle helicase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9344670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 624,
                    "offsetInEndSection": 811,
                    "text": "On the other hand, in the proximal part of the gene, deletion breakpoints do not preferentially occur in a few introns, but are spread over a large DNA segment containing introns 2 to 42."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 823,
                    "offsetInEndSection": 1002,
                    "text": "Circular dichroism and UV spectral analysis demonstrated that mitochondrial G-rich sequences near deletion breakpoints prevalent in human disease form G-quadruplex DNA structures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1003,
                    "offsetInEndSection": 1403,
                    "text": "A biochemical analysis of purified recombinant human Twinkle protein (gene product of c10orf2) showed that the mitochondrial replicative helicase inefficiently unwinds well characterized intermolecular and intramolecular G-quadruplex DNA substrates, as well as a unimolecular G4 substrate derived from a mitochondrial sequence that nests a deletion breakpoint described in human renal cell carcinoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9344670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 394,
                    "offsetInEndSection": 623,
                    "text": "Within the central high-frequency deletion region, the small, 6.6-kb, intron 49 shows a much higher density of deletion breakpoints than intron 44, which was previously believed to coincide with the most mutable zone of the gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22661583",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 848,
                    "text": "Furthermore, we discover that the most frequent deletion breakpoints occur within or near predicted structures, a result that is supported by data from transgenic mice with mitochondrial disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9344670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 240,
                    "offsetInEndSection": 393,
                    "text": "Our results, compared with data on the distribution of deletion breakpoints by intron, elucidate the topography of the intragenic deletion-prone regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26530670",
                    "endSection": "abstract",
                    "offsetInBeginSection": 182,
                    "offsetInEndSection": 425,
                    "text": "The high-throughput sequence data generated allow the detection of mitochondrial DNA (mtDNA) point mutations and deletions with the ability to accurately quantify the mtDNA point mutation heteroplasmy and to determine the deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16432145",
                    "endSection": "abstract",
                    "offsetInBeginSection": 598,
                    "offsetInEndSection": 718,
                    "text": "The deletion breakpoints cluster in a few regions that are similar to what is found in human mtDNA deletions in general."
                }
            ]
        },
        {
            "body": "Name 4 circular RNA molecules associated with carcinogenesis.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                "http://www.ncbi.nlm.nih.gov/pubmed/9154796",
                "http://www.ncbi.nlm.nih.gov/pubmed/29081691",
                "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                "http://www.ncbi.nlm.nih.gov/pubmed/24339831",
                "http://www.ncbi.nlm.nih.gov/pubmed/26485708",
                "http://www.ncbi.nlm.nih.gov/pubmed/18639824",
                "http://www.ncbi.nlm.nih.gov/pubmed/8692851",
                "http://www.ncbi.nlm.nih.gov/pubmed/1092704",
                "http://www.ncbi.nlm.nih.gov/pubmed/7538253"
            ],
            "id": "5ac721230340b9f058000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 768,
                    "offsetInEndSection": 965,
                    "text": "Although, the precise contribution of RNA molecules by themselves and RNA-regulated processes on cancer development is currently unknown, recent data suggest their important role in carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9154796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 813,
                    "offsetInEndSection": 1100,
                    "text": "In rat testis, a similar analysis allowed the detection of a circular RNA molecule composed of exons 6 and 7 of the androgen binding protein (ABP) gene, with the donor splice site of exon 7 joined to the acceptor splice site of exon 6, and of an ABP mRNA which had skipped exons 6 and 7."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9154796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1101,
                    "offsetInEndSection": 1342,
                    "text": "These results apparently substantiate the hypothesis that alternative pre-mRNA splicing has the potential to generate not only mRNAs that lack one or more exons but also circular RNA molecules that are composed of the exons that are skipped."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29081691",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 248,
                    "text": "BACKGROUND\nRecently, identification and functional studies of circular RNAs, a type of non-coding RNAs arising from a ligation of 3' and 5' ends of a linear RNA molecule, were conducted in mammalian cells with the development of RNA-seq technology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 634,
                    "offsetInEndSection": 767,
                    "text": "Moreover, RNA molecules can regulate a variety of cellular functions through interactions with RNA, DNA as well as protein molecules."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Circular RNA participates in the carcinogenesis and the malignant behavior of cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9154796",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "Exon skipping and circular RNA formation in transcripts of the human cytochrome P-450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24339831",
                    "endSection": "abstract",
                    "offsetInBeginSection": 808,
                    "offsetInEndSection": 989,
                    "text": "For the miRNAs associated with individual diseases, we constructed a network of predicted interactions between the miRNAs and protein coding, long non-coding and circular RNA genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26485708",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 221,
                    "text": "Covalently closed circular RNA molecules (circRNAs) have recently emerged as a class of RNA isoforms with widespread and tissue specific expression across animals, oftentimes independent of the corresponding linear mRNAs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9154796",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1535,
                    "offsetInEndSection": 1741,
                    "text": "This observation is interpreted as indicative that at low frequency, numerous circular RNA formation and exon skipping events may occur, allowing the joining of a variety of different combinations of exons."
                }
            ]
        },
        {
            "body": "Which is the enzymatic activity of nardilysin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                "http://www.ncbi.nlm.nih.gov/pubmed/26244291",
                "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                "http://www.ncbi.nlm.nih.gov/pubmed/12054470",
                "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                "http://www.ncbi.nlm.nih.gov/pubmed/27051521",
                "http://www.ncbi.nlm.nih.gov/pubmed/23954170",
                "http://www.ncbi.nlm.nih.gov/pubmed/22294699",
                "http://www.ncbi.nlm.nih.gov/pubmed/23959073",
                "http://www.ncbi.nlm.nih.gov/pubmed/16923819"
            ],
            "id": "5ac138aa95d0062724000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 353,
                    "offsetInEndSection": 499,
                    "text": "Since for those processes its enzymatic activity is not required, it is now evident that nardilysin fulfills at least two distinct functions, i.e."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Nardilysin (NRDc), a metallopeptidase of the M16 family, presents, in vitro, cleavage specificity for basic residues."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Nardilysin, a basic residues specific metallopeptidase that mediates cell migration and proliferation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26244291",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1071,
                    "offsetInEndSection": 1262,
                    "text": "The expression of mature ADAM10, ADAM17, and cleaved Notch 1 proteins in ARPE/EBV cells was downregulated after treatment with sorafenib through the regulatory activity of nardilysin (NRD-1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 221,
                    "text": "Gel filtration chromatography showed that nardilysin activity in a rat testis or rat brain extract exhibited an apparent molecular weight of approximately 300 kDa compared to approximately 187 kDa for the purified enzyme."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12054470",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "The use of proteolysis to study the structure of nardilysin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 202,
                    "offsetInEndSection": 352,
                    "text": "As a new receptor for heparin-binding EGF-like growth factor (HB-EGF), NRDc was recently shown to be involved in cellular migration and proliferation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 562,
                    "text": "The addition of a GST fusion protein containing the acidic domain of nardilysin eliminated the higher molecular weight nardilysin forms, suggesting that oligomerization involves the acidic domain of nardilysin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 818,
                    "offsetInEndSection": 936,
                    "text": "Mitochondrial MDH increased nardilysin activity about 50%, while nardilysin stabilized mMDH towards heat inactivation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1136,
                    "offsetInEndSection": 1286,
                    "text": "Our data are consistent with the notion that the proposed alpha-secretase-enhancing activity of nardilysin might play a role in human brain pathology."
                }
            ]
        },
        {
            "body": "The Mantoux test detects what latent infection/disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21987138",
                "http://www.ncbi.nlm.nih.gov/pubmed/20843417",
                "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                "http://www.ncbi.nlm.nih.gov/pubmed/19442260",
                "http://www.ncbi.nlm.nih.gov/pubmed/17501976",
                "http://www.ncbi.nlm.nih.gov/pubmed/12238571",
                "http://www.ncbi.nlm.nih.gov/pubmed/22086450",
                "http://www.ncbi.nlm.nih.gov/pubmed/21219680",
                "http://www.ncbi.nlm.nih.gov/pubmed/17455134",
                "http://www.ncbi.nlm.nih.gov/pubmed/17515641"
            ],
            "id": "5ab147edfcf4565872000013",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21987138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 555,
                    "offsetInEndSection": 821,
                    "text": "Assays based on the detection of synthesis of gamma interferon in vitro by peripheral monoclonal cells, stimulated by specific antigens (ESAT-6 and CFP-10), seem to offer better accuracy when compared to the Mantoux test in identifying latent tuberculosis infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21987138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 370,
                    "offsetInEndSection": 554,
                    "text": "Investigation of latent tuberculosis infection with tuberculin skin test is ineffective due to its low specificity and the dubious results that it generates in patients with psoriasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20843417",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "BACKGROUND\nThe Mantoux tuberculin skin test (TST) is widely used to diagnose latent infection with Mycobacterium tuberculosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19442260",
                    "endSection": "abstract",
                    "offsetInBeginSection": 111,
                    "offsetInEndSection": 476,
                    "text": "On arrival to the country all asylum seekers are screened with Mantoux test and chest x-ray aimed to identify cases of active tuberculosis and, in the case of latent tuberculosis, to offer follow-up or prophylactic treatment.We assessed a national programme for screening, treatment and follow-up of tuberculosis infection and disease in a cohort of asylum seekers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17501976",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "The performances of the QuantiFERON-TB Gold in Tubes (QFGT), T SPOT-TB (ELISPOT) and the Mantoux test were compared for the diagnosis of latent tuberculosis infection in Finland, a country of low tuberculosis incidence."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 657,
                    "text": "Until recently, the 100-year-old tuberculin skin test (Mantoux) has been the only available diagnostic test for latent tuberculosis infection, despite its many well-known limitations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19442260",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 1166,
                    "text": "Those with a Mantoux test >or= 6 mm or positive x-ray findings were included in a study group for follow-up.Data were collected from public health authorities in the municipality to where the asylum seekers had moved, and from hospital based internists in case they had been referred to specialist care.Individual subjects included in the study group were matched with the Norwegian National Tuberculosis Register which receive reports of everybody diagnosed with active tuberculosis, or who had started treatment for latent tuberculosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1036,
                    "offsetInEndSection": 1305,
                    "text": "They are more sensitive than the tuberculin skin test in detecting people with active tuberculosis, and their results correlate more closely with M. tuberculosis exposure risk factors than the tuberculin skin test in people likely to have latent tuberculosis infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12238571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 288,
                    "text": "In order to determine the prevalence of latent infection due to Mycobacterium tuberculosis in drug users and to provide centres for drug users with a practical tool for tuberculosis screening, 237 drug users were subjected to the Monotest and, for reference purposes, to the Mantoux test."
                }
            ]
        },
        {
            "body": "What is measured with the Proseek panels?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/28694499",
                "http://www.ncbi.nlm.nih.gov/pubmed/28734077",
                "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
                "http://www.ncbi.nlm.nih.gov/pubmed/28948068"
            ],
            "id": "5a9d99ac4e03427e73000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 738,
                    "offsetInEndSection": 948,
                    "text": "The samples were analyzed with a multiplex proximity extension assay in which 92 inflammation-related proteins were measured simultaneously (Proseek Multiplex Inflammation I; Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 362,
                    "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 366,
                    "offsetInEndSection": 542,
                    "text": "To simultaneously measure 92 inflammatory biomarkers, we used the proximity extension assay with the Proseek Multiplex Inflammation I panel (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28694499",
                    "endSection": "abstract",
                    "offsetInBeginSection": 503,
                    "offsetInEndSection": 814,
                    "text": "Using the Proseek Multiplex Inflammation assay, we measured in patients that had suffered mild TBI (n\u2009=\u200910) or severe TBI (n\u2009=\u200910) with extra-cranial injury or extracranial injury only (EC) (n\u2009=\u200910), 92 inflammation-associated proteins in serum obtained: <1\u2009hr (within 1-hour), 4-12\u2009hr and 48-72\u2009hr post injury."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28734077",
                    "endSection": "abstract",
                    "offsetInBeginSection": 524,
                    "offsetInEndSection": 702,
                    "text": "METHODS AND RESULTS\nPlasma concentrations of MMP12 were measured at baseline in 3394 subjects with high-risk for cardiovascular disease (CVD) using the Olink ProSeek CVD I array."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 750,
                    "offsetInEndSection": 962,
                    "text": "Blood samples were obtained at baseline (0 hour), 6, 24, and 96 hours post PCI, and stored at -80\u00b0C until they were analyzed by PROSEEK Multiplex CVD and PROSEEK Multiplex INF (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 929,
                    "text": "In addition to conventional laboratory tests, 92 inflammatory proteins were analysed with a multiplex system (Proseek Multiplex Inflammation I, Olink Bioscience)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                    "endSection": "abstract",
                    "offsetInBeginSection": 498,
                    "offsetInEndSection": 588,
                    "text": "Samples were analyzed by Mesoscale Discovery, Myriad RBM MAP technology and Olink Proseek."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
                    "endSection": "abstract",
                    "offsetInBeginSection": 160,
                    "offsetInEndSection": 575,
                    "text": "Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek Multiplex, Olink), enhanced serum levels of Adrenomedullin (ADM, Pcorr= .0004), Growth differentiation factor 15 (GDF15, Pcorr= .003), and soluble Major histocompatibility complex class I-related chain A (sMICA, Pcorr= .023), all prosurvival and chemoprotective factors for myeloma cells, were detected in MM comparing to MGUS."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 304,
                    "offsetInEndSection": 449,
                    "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120\u00a0min afterward with the Proseek Multiplex Neurology\u00a0I kit."
                }
            ]
        },
        {
            "body": "Is Enlimomab effective for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                "http://www.ncbi.nlm.nih.gov/pubmed/11692032",
                "http://www.ncbi.nlm.nih.gov/pubmed/19849665",
                "http://www.ncbi.nlm.nih.gov/pubmed/9744839",
                "http://www.ncbi.nlm.nih.gov/pubmed/12365824",
                "http://www.ncbi.nlm.nih.gov/pubmed/9973515",
                "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                "http://www.ncbi.nlm.nih.gov/pubmed/10096530",
                "http://www.ncbi.nlm.nih.gov/pubmed/12777909",
                "http://www.ncbi.nlm.nih.gov/pubmed/12038658"
            ],
            "id": "58ec6eb5eda5a5767200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 282,
                    "text": "Enlimomab, a murine intercellular adhesion molecule-1 (ICAM-1) antibody, reduces leukocyte adhesion and infarct size in experimental stroke studies."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1440,
                    "offsetInEndSection": 1635,
                    "text": "CONCLUSIONS\nThe authors conclude that anti-ICAM therapy with enlimomab is not an effective treatment for ischemic stroke in the model studied and, indeed, may significantly worsen stroke outcome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11692032",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "BACKGROUND AND PURPOSE\nEnlimomab, a murine monoclonal anti-human intercellular adhesion molecule (ICAM)-1 antibody, had a negative outcome in a multicenter acute-stroke trial."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11692032",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 199,
                    "text": "Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 283,
                    "offsetInEndSection": 384,
                    "text": "The purpose of the current clinical trial was to evaluate the use of enlimomab after ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 387,
                    "offsetInEndSection": 546,
                    "text": "METHODS\nA total of 625 patients with ischemic stroke were randomized to receive either enlimomab (n = 317) or placebo (n = 308) within 6 hours of stroke onset."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1037,
                    "offsetInEndSection": 1151,
                    "text": "Fewer patients had symptom-free recovery on enlimomab than placebo (p = 0.004), and more died (22.2 versus 16.2%)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11692032",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1796,
                    "offsetInEndSection": 1973,
                    "text": "These observations provide several possible mechanisms for central nervous system-related clinical deterioration that occurred when Enlimomab was given in acute ischemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 910,
                    "offsetInEndSection": 1036,
                    "text": "RESULTS\nAt day 90, the Modified Rankin Scale score was worse in patients treated with enlimomab than with placebo (p = 0.004)."
                }
            ]
        },
        {
            "body": "Are AAV vectors considered for the treatment of retinal dystrophies?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                "http://www.ncbi.nlm.nih.gov/pubmed/27416076",
                "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                "http://www.ncbi.nlm.nih.gov/pubmed/23150381",
                "http://www.ncbi.nlm.nih.gov/pubmed/24664763",
                "http://www.ncbi.nlm.nih.gov/pubmed/24572793",
                "http://www.ncbi.nlm.nih.gov/pubmed/21344187",
                "http://www.ncbi.nlm.nih.gov/pubmed/19066593",
                "http://www.ncbi.nlm.nih.gov/pubmed/24150896",
                "http://www.ncbi.nlm.nih.gov/pubmed/23593201"
            ],
            "id": "5a74acd80384be9551000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "BACKGROUND\nGene transfer using adeno-associated viral (AAV) vectors has been successfully applied in the retina for the treatment of inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27416076",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Gene therapy using adeno-associated viral (AAV) vectors for the treatment of retinal degenerations has shown safety and efficacy in clinical trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Recombinant adeno-associated viral (AAV) vectors have become powerful gene delivery tools for the treatment of retinal degeneration in a variety of animal models that mimic corresponding human diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27416076",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1153,
                    "offsetInEndSection": 1329,
                    "text": "Capsid mutant AAV vectors transduce human retinal cells and may be particularly suited to treat retinal degenerations in which high levels of transgene expression are required."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 442,
                    "offsetInEndSection": 682,
                    "text": "In the sheltered environment of the retina, AAV vectors are able to maintain high levels of transgene expression in the retinal pigmented epithelium (RPE), photoreceptors, or ganglion cells for long periods of time after a single treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 203,
                    "offsetInEndSection": 441,
                    "text": "AAV vectors possess a number of features that render them ideally suited for retinal gene therapy, including a lack of pathogenicity, minimal immunogenicity, and the ability to transduce postmitotic cells in a stable and efficient manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23150381",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Adeno-associated virus (AAV) vectors are in wide use for in vivo gene transfer for the treatment of inherited retinal disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24664763",
                    "endSection": "abstract",
                    "offsetInBeginSection": 480,
                    "offsetInEndSection": 709,
                    "text": "While the monogenic nature of many of these conditions makes them amenable to treatment with gene therapy, the ABCA4 cDNA is 6.8\u00a0kb and is thus too large for the AAV vectors which have been most successful for other ocular genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24572793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 283,
                    "text": "Gene therapy with adeno-associated viral (AAV) vectors is limited by AAV cargo capacity that prevents their application to the inherited retinal diseases (IRDs), such as Stargardt disease (STGD) or Usher syndrome type IB (USH1B), which are due to mutations in genes larger than 5\u2009kb."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27416076",
                    "endSection": "abstract",
                    "offsetInBeginSection": 426,
                    "offsetInEndSection": 627,
                    "text": "In this study, we assessed two vectors with single capsid mutations, rAAV2/2(Y444F) and rAAV2/8(Y733F) in their ability to transduce retina in the Abca4-/- and rd1 mouse models of retinal degeneration."
                }
            ]
        },
        {
            "body": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                "http://www.ncbi.nlm.nih.gov/pubmed/10582983",
                "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                "http://www.ncbi.nlm.nih.gov/pubmed/9305321",
                "http://www.ncbi.nlm.nih.gov/pubmed/27072975",
                "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                "http://www.ncbi.nlm.nih.gov/pubmed/18637642",
                "http://www.ncbi.nlm.nih.gov/pubmed/12271462",
                "http://www.ncbi.nlm.nih.gov/pubmed/22845688"
            ],
            "id": "58ec709aeda5a5767200000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1908,
                    "offsetInEndSection": 2059,
                    "text": "INTERPRETATION\nUnder the circumstances of the ICTUS trial, citicoline is not efficacious in the treatment of moderate-to-severe acute ischaemic stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "BACKGROUND\nCiticoline is approved in some countries for the treatment of acute ischaemic stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10582983",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "A randomized efficacy trial of citicoline in patients with acute ischemic stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Efficacy of citicoline as an acute stroke treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 378,
                    "text": "OBJECTIVE\nTo determine the safety and efficacy of citicoline treatment in acute stroke patients."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9305321",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "A randomized dose-response trial of citicoline in acute ischemic stroke patients."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27072975",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Early application of citicoline in the treatment of acute stroke: A meta-analysis of randomized controlled trials."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials."
                }
            ]
        },
        {
            "body": "Is human lysyl oxidase-like 2 a glycoprotein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                "http://www.ncbi.nlm.nih.gov/pubmed/11386757",
                "http://www.ncbi.nlm.nih.gov/pubmed/23319596",
                "http://www.ncbi.nlm.nih.gov/pubmed/26612622",
                "http://www.ncbi.nlm.nih.gov/pubmed/14551188",
                "http://www.ncbi.nlm.nih.gov/pubmed/11691588",
                "http://www.ncbi.nlm.nih.gov/pubmed/27063404"
            ],
            "id": "5ad240f70340b9f058000015",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "A general protease digestion procedure for optimal protein sequence coverage and post-translational modifications analysis of recombinant glycoproteins: application to the characterization of human lysyl oxidase-like 2 glycosylation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1382,
                    "offsetInEndSection": 1478,
                    "text": "This method was successfully applied to a novel recombinant protein, human lysyl oxidase-like 2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "The lysyl oxidase-like 2 (LOXL2) protein is a human paralogue of lysyl oxidase (LOX) that functions as an amine oxidase for formation of lysine-derived cross-links found in collagen and elastin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "A tissue-specific variant of the human lysyl oxidase-like protein 3 (LOXL3) functions as an amine oxidase with substrate specificity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 153,
                    "text": "The human lysyl oxidase-like 3 (LOXL3) encodes a member of the emerging family of lysyl oxidase (LOX) that functions as a copper-dependent amine oxidase."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11386757",
                    "endSection": "abstract",
                    "offsetInBeginSection": 730,
                    "offsetInEndSection": 928,
                    "text": "The gene encoding this new cDNA, which we have referred to as human lysyl oxidase-like 3 (humanLOXL3), has been mapped to chromosome 2p13.3, overlapping at its 3' end the HtrA2 serine protease gene."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23319596",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "Post-translational modifications of recombinant human lysyl oxidase-like 2 (rhLOXL2) secreted from Drosophila S2 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Human lysyl oxidase-like 3\u00a0(LOXL3) functions as a copper-dependent amine oxidase toward collagen and elastin."
                }
            ]
        },
        {
            "body": "Can GDF15 be a biomarker for metformin treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                "http://www.ncbi.nlm.nih.gov/pubmed/27510384",
                "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                "http://www.ncbi.nlm.nih.gov/pubmed/28880265",
                "http://www.ncbi.nlm.nih.gov/pubmed/26497212",
                "http://www.ncbi.nlm.nih.gov/pubmed/24179558",
                "http://www.ncbi.nlm.nih.gov/pubmed/28801589",
                "http://www.ncbi.nlm.nih.gov/pubmed/25880686",
                "http://www.ncbi.nlm.nih.gov/pubmed/28855167",
                "http://www.ncbi.nlm.nih.gov/pubmed/25446397"
            ],
            "id": "5ad3013d0340b9f058000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 863,
                    "offsetInEndSection": 1010,
                    "text": "CONCLUSIONS\nGDF15 levels are a biomarker for the use of metformin in people with dysglycemia, and its concentration reflects the dose of metformin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27510384",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1216,
                    "offsetInEndSection": 1346,
                    "text": "This suggests that the level of GDF15 may be a useful predictive biomarker of cardiovascular risk in newly diagnosed T2D patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1610,
                    "offsetInEndSection": 1683,
                    "text": "GDF15 may be a novel biomarker for detecting IFG in nondiabetic patients."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "GDF15 Is a Novel Biomarker for Impaired Fasting Glucose."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 447,
                    "offsetInEndSection": 698,
                    "text": "RESULTS\nGrowth differentiation factor 15 (GDF15) was strongly linked to metformin, such that the odds of metformin use per SD increase in level varied from 3.73 (95% CI 3.40, 4.09) to 3.94 (95% CI 3.59, 4.33) depending on the other included variables."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28880265",
                    "endSection": "abstract",
                    "offsetInBeginSection": 801,
                    "offsetInEndSection": 1075,
                    "text": "Together, our findings demonstrate that CDP138 positively modulates the TGF-\u03b2/Smad signaling pathway via GDF15 to promote radioresistance and metastasis, suggesting CDP138 as a potential oncogenic biomarker and a promising therapeutic target in the treatment of lung cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 774,
                    "offsetInEndSection": 860,
                    "text": "A 1.64 ng/mL higher GDF15 level predicted a 188-mg higher metformin dose (P < 0.0001)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27510384",
                    "endSection": "abstract",
                    "offsetInBeginSection": 453,
                    "offsetInEndSection": 529,
                    "text": "Serum GDF15 levels were measured using an enzyme-linked immunosorbent assay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1296,
                    "offsetInEndSection": 1456,
                    "text": "As a biomarker for IFG based on the receiver operating characteristic curve analysis, the cutoff value of GDF15 was 510 pg/mL in males and 400 pg/mL in females."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27510384",
                    "endSection": "abstract",
                    "offsetInBeginSection": 647,
                    "offsetInEndSection": 746,
                    "text": "The mean serum GDF15 level was elevated in the T2D group compared to the control group (P < 0.001)."
                }
            ]
        },
        {
            "body": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23717903",
                "http://www.ncbi.nlm.nih.gov/pubmed/20462915",
                "http://www.ncbi.nlm.nih.gov/pubmed/18783837",
                "http://www.ncbi.nlm.nih.gov/pubmed/16937453",
                "http://www.ncbi.nlm.nih.gov/pubmed/25546674",
                "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                "http://www.ncbi.nlm.nih.gov/pubmed/28533306",
                "http://www.ncbi.nlm.nih.gov/pubmed/21386778",
                "http://www.ncbi.nlm.nih.gov/pubmed/19308659",
                "http://www.ncbi.nlm.nih.gov/pubmed/24853856"
            ],
            "id": "5aa395fcd6d6b54f79000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23717903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 550,
                    "text": "This review describes some dysimmune neuromuscular disorders and their recent management: syndrome of peripheral nerve hyperexcitability (treatment of cramps, immunosuppressors); Guillain-Barr\u00e9 syndrome (new mechanisms and consensus treatment); chronic inflammatory demyelinating polyradiculoneuropathy (new indication for the use of pulse dexamethasone, new scores of activity); importance of subcutaneous immunoglobulin in multifocal motor neuropathy and of infusions of rituximab in myasthenia gravis; new entities in myositis and their treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20462915",
                    "endSection": "abstract",
                    "offsetInBeginSection": 993,
                    "offsetInEndSection": 1167,
                    "text": "Rituximab treatment was followed by an improvement in muscle strength, allowing successful weaning from mechanical ventilation, diminution in myokymia and improved cognition."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18783837",
                    "endSection": "abstract",
                    "offsetInBeginSection": 171,
                    "offsetInEndSection": 337,
                    "text": "Rituximab, a chimeric anti-human CD20 antibody, is the only anti-B cell biological agent presently under study for the treatment of autoimmune neuromuscular diseases."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18783837",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 78,
                    "text": "B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16937453",
                    "endSection": "abstract",
                    "offsetInBeginSection": 184,
                    "offsetInEndSection": 316,
                    "text": "The patient developed acute hepatitis C with symptoms of general fatigues, jaundice, and ascites 4 wk after the needle-stick injury."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25546674",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1396,
                    "offsetInEndSection": 1604,
                    "text": "On the other hand, 1 of the 5 patients in the treatment discontinuation group developed relapse during the observation period after the first four rituximab infusions, and the rituximab treatment was resumed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18783837",
                    "endSection": "abstract",
                    "offsetInBeginSection": 338,
                    "offsetInEndSection": 595,
                    "text": "Isolated case histories and series, pilot and retrospective studies report on the experimental administration of rituximab as treatment of a variety of immune-mediated neuropathy syndromes, treatment-refractory myasthenia gravis and inflammatory myopathies."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20462915",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20462915",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1268,
                    "offsetInEndSection": 1416,
                    "text": "This case suggests that rituximab may be useful in the treatment of autoimmune neurological disease refractory to other immunosuppressant therapies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20462915",
                    "endSection": "abstract",
                    "offsetInBeginSection": 725,
                    "offsetInEndSection": 886,
                    "text": "Treatment with intravenous immunoglobulin, plasma exchange and high-dose steroids were ineffective, and the patient remained dependent on mechanical ventilation."
                }
            ]
        },
        {
            "body": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                "http://www.ncbi.nlm.nih.gov/pubmed/25959964",
                "http://www.ncbi.nlm.nih.gov/pubmed/18323444",
                "http://www.ncbi.nlm.nih.gov/pubmed/26616915",
                "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                "http://www.ncbi.nlm.nih.gov/pubmed/28073589",
                "http://www.ncbi.nlm.nih.gov/pubmed/23479741",
                "http://www.ncbi.nlm.nih.gov/pubmed/22465609"
            ],
            "id": "5ab9032afcf4565872000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 489,
                    "offsetInEndSection": 846,
                    "text": "Instead, the mutation patterns of the tumour suppressor TP53 (which encodes p53), ataxia telangiectasia mutated (ATM) and cyclin-dependent kinase inhibitor 2A (CDKN2A; which encodes p16INK4A and p14ARF) support the oncogene-induced DNA replication stress model, which attributes genomic instability and TP53 and ATM mutations to oncogene-induced DNA damage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Oncogene-induced DNA replication stress is thought to drive genomic instability in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1063,
                    "offsetInEndSection": 1278,
                    "text": "We propose that single-stranded DNA generated in response to oncogene-induced replication stress compromises the repair of deaminated cytosines and other damaged bases, leading to the observed SNS mutator phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1641,
                    "offsetInEndSection": 1756,
                    "text": "Our results demonstrate how oncogene-induced replication stress contributes to genomic instability in human cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18323444",
                    "endSection": "abstract",
                    "offsetInBeginSection": 861,
                    "offsetInEndSection": 995,
                    "text": "Thus, oncogene-induced DNA damage may explain two key features of cancer: genomic instability and the high frequency of p53 mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26616915",
                    "endSection": "abstract",
                    "offsetInBeginSection": 475,
                    "offsetInEndSection": 736,
                    "text": "In this review, we explore the mechanisms by which sustained proliferation can lead to replication stress and genome instability, and discuss how the pattern of mutations observed in human cancers is supportive of this oncogene-induced replication stress model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 931,
                    "offsetInEndSection": 1148,
                    "text": "Consequently, we reveal that increased transcription can be a mechanism of oncogene-induced DNA damage, providing a molecular link between upregulation of the transcription machinery and genomic instability in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 552,
                    "offsetInEndSection": 754,
                    "text": "Loss of WRN affects cell cycle progression and results in enhanced accumulation of double-strand breaks and instability at common fragile sites in cells experiencing oncogene-induced replication stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22410776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1218,
                    "text": "Overall, our findings give insights into the mechanisms protecting replication forks in cells experiencing oncogene-induced replication stress, and identify factors that, when mutated or dysfunctional, may enhance genome instability in precancerous cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28073589",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 51,
                    "text": "Mechanisms of oncogene-induced genomic instability."
                }
            ]
        },
        {
            "body": "Is the petrous bone used in ancient DNA sampling?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                "http://www.ncbi.nlm.nih.gov/pubmed/28526291",
                "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                "http://www.ncbi.nlm.nih.gov/pubmed/26595274",
                "http://www.ncbi.nlm.nih.gov/pubmed/24288018",
                "http://www.ncbi.nlm.nih.gov/pubmed/19043689",
                "http://www.ncbi.nlm.nih.gov/pubmed/19018271",
                "http://www.ncbi.nlm.nih.gov/pubmed/17148352",
                "http://www.ncbi.nlm.nih.gov/pubmed/17901335"
            ],
            "id": "5abd3707fcf456587200002d",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Optimal Ancient DNA Yields from the Inner Ear Part of the Human Petrous Bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 890,
                    "text": "In this study we investigate whether (a) different parts of the petrous bone of archaeological human specimens give different percentages of endogenous DNA yields, (b) there are significant differences in average DNA read lengths, damage patterns and total DNA concentration, and (c) it is possible to obtain endogenous ancient DNA from petrous bones from hot environments."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Comparing Ancient DNA Preservation in Petrous Bone and Tooth Cementum."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1341,
                    "offsetInEndSection": 1462,
                    "text": "Lastly, we show that petrous bones from ancient cremated individuals contain no measurable levels of authentic human DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28526291",
                    "endSection": "abstract",
                    "offsetInBeginSection": 605,
                    "offsetInEndSection": 708,
                    "text": "The petrous part yielded more endogenous ancient DNA molecules than the squamous part of the same bone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "A minimally-invasive method for sampling human petrous bones from the cranial base for ancient DNA analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26595274",
                    "endSection": "abstract",
                    "offsetInBeginSection": 375,
                    "offsetInEndSection": 648,
                    "text": "The new samples include, to our knowledge, the first genome-wide ancient DNA from Anatolian Neolithic farmers, whose genetic material we obtained by extracting from petrous bones, and who we show were members of the population that was the source of Europe's first farmers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1092,
                    "offsetInEndSection": 1359,
                    "text": "We obtained shotgun DNA sequences from three distinct areas within the petrous: a spongy part of trabecular bone (part A), the dense part of cortical bone encircling the osseous inner ear, or otic capsule (part B), and the dense part within the otic capsule (part C)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1360,
                    "offsetInEndSection": 1714,
                    "text": "Our results confirm that dense bone parts of the petrous bone can provide high endogenous aDNA yields and indicate that endogenous DNA fractions for part C can exceed those obtained for part B by up to 65-fold and those from part A by up to 177-fold, while total endogenous DNA concentrations are up to 126-fold and 109-fold higher for these comparisons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "abstract",
                    "offsetInBeginSection": 341,
                    "offsetInEndSection": 516,
                    "text": "The only skeletal element for which a systematically higher endogenous DNA content compared to other skeletal elements has been shown is the petrous part of the temporal bone."
                }
            ]
        },
        {
            "body": "Is recursive splicing more common in short introns?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970246",
                "http://www.ncbi.nlm.nih.gov/pubmed/11269499",
                "http://www.ncbi.nlm.nih.gov/pubmed/19924226",
                "http://www.ncbi.nlm.nih.gov/pubmed/16260721",
                "http://www.ncbi.nlm.nih.gov/pubmed/7838730",
                "http://www.ncbi.nlm.nih.gov/pubmed/12134150",
                "http://www.ncbi.nlm.nih.gov/pubmed/16314266"
            ],
            "id": "5abc974bfcf456587200001f",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 167,
                    "offsetInEndSection": 364,
                    "text": "We present bioinformatic, phylogenetic, and experimental evidence in Drosophila for a mechanism that subdivides many large introns by recursive splicing at nonexonic elements and alternative exons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 971,
                    "offsetInEndSection": 1253,
                    "text": "Experimental analyses of in vivo processing intermediates and lariat products from four large introns in the unrelated genes kuzbanian, outspread, and Ultrabithorax confirmed that these introns are removed by a series of recursive splicing steps using the predicted nonexonic sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1254,
                    "offsetInEndSection": 1427,
                    "text": "Mutation of nonexonic site RP3 within Ultrabithorax also confirmed that recursive splicing is the predominant processing pathway even with a shortened version of the intron."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                    "endSection": "abstract",
                    "offsetInBeginSection": 844,
                    "offsetInEndSection": 1029,
                    "text": "This process, called \"recursive splicing,\" often involves non-canonical splicing elements positioned deep within introns, and different mechanisms for its deployment have been proposed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 839,
                    "offsetInEndSection": 970,
                    "text": "These patterns of enrichment and conservation indicate that recursive splice sites are advantageous in the context of long introns."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 69,
                    "text": "Cutting a Long Intron Short: Recursive Splicing and Its Implications."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 365,
                    "offsetInEndSection": 646,
                    "text": "Recursive splice sites predicted with highly stringent criteria are found at much higher frequency than expected in the sense strands of introns >20 kb, but they are found only at the expected frequency on the antisense strands, and they are underrepresented within introns <10 kb."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1428,
                    "offsetInEndSection": 1498,
                    "text": "We discuss currently known and potential roles for recursive splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1038,
                    "offsetInEndSection": 1226,
                    "text": "Together, these results indicate that recursive splicing is commonly used in Drosophila, occurs in humans, and provides insight into the mechanisms by which some large introns are removed."
                }
            ]
        },
        {
            "body": "Is Lysyl oxidase crosslinking collagen?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21215756",
                "http://www.ncbi.nlm.nih.gov/pubmed/23928381",
                "http://www.ncbi.nlm.nih.gov/pubmed/7546771",
                "http://www.ncbi.nlm.nih.gov/pubmed/9402968",
                "http://www.ncbi.nlm.nih.gov/pubmed/20460108",
                "http://www.ncbi.nlm.nih.gov/pubmed/8096378",
                "http://www.ncbi.nlm.nih.gov/pubmed/25238333",
                "http://www.ncbi.nlm.nih.gov/pubmed/2890532",
                "http://www.ncbi.nlm.nih.gov/pubmed/26893379",
                "http://www.ncbi.nlm.nih.gov/pubmed/906929"
            ],
            "id": "5ac07b67dd95b2cd42000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21215756",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21215756",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1434,
                    "offsetInEndSection": 1599,
                    "text": "Left atrial myocardium of patients with atrial fibrillation is characterized by increased lysyl oxidase and fibronectin expression as well as collagen cross-linking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23928381",
                    "endSection": "abstract",
                    "offsetInBeginSection": 545,
                    "offsetInEndSection": 942,
                    "text": "Herein we show that physical compaction (the process in which cells gather and pack together and cause associated changes in cell shape and size) of human glioblastoma cell lines U87MG, U251, and LN229 induces expression of collagen types IV and VI and the collagen crosslinking enzyme lysyl oxidase and up-regulates in vitro expression of the angiogenic factor vascular endothelial growth factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7546771",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Lysyl oxidase, a copper-dependent metalloenzyme, plays a central role in crosslinking of collagen and elastin in the extracellular matrix."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23928381",
                    "endSection": "abstract",
                    "offsetInBeginSection": 943,
                    "offsetInEndSection": 1140,
                    "text": "The lysyl oxidase inhibitor \u03b2-aminopropionitrile disrupts collagen structure in the tumor and inhibits tumor angiogenesis and glioblastoma multiforme growth in a mouse orthotopic brain tumor model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9402968",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 176,
                    "text": "The lysyl oxidase-like (LOXL) gene is a new member of the lysyl oxidase family, a copper-dependent enzyme that is implicated in the crosslinking of collagen and elastin fibers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20460108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "LOX, the principal enzyme involved in crosslinking of collagen, was the first of several lysyl oxidase isotypes to be characterized."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8096378",
                    "endSection": "abstract",
                    "offsetInBeginSection": 185,
                    "offsetInEndSection": 348,
                    "text": "A decrease in the functional activity of lysyl oxidase, a cuproenzyme, is thought in part to be responsible for the decreased crosslinking of collagen and elastin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25238333",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 230,
                    "text": "P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell MDA-MB-231 contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2890532",
                    "endSection": "abstract",
                    "offsetInBeginSection": 979,
                    "offsetInEndSection": 1290,
                    "text": "The results suggest that lysyl oxidase and collagen crosslinking play a vital role in primary mesenchyme migration, gastrulation, and morphogenesis during sea urchin development and indicate that BAPN may be very useful in studying the extracellular matrix-cell interactions at the cellular and molecular level."
                }
            ]
        },
        {
            "body": "Is sternotomy closure done using either a sternal ZipFix\u2122 implant  or conventional steel wire following cardiac surgery?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19592548",
                "http://www.ncbi.nlm.nih.gov/pubmed/18167574",
                "http://www.ncbi.nlm.nih.gov/pubmed/22611181",
                "http://www.ncbi.nlm.nih.gov/pubmed/2794943",
                "http://www.ncbi.nlm.nih.gov/pubmed/17073957",
                "http://www.ncbi.nlm.nih.gov/pubmed/27909272",
                "http://www.ncbi.nlm.nih.gov/pubmed/26346231",
                "http://www.ncbi.nlm.nih.gov/pubmed/20026533",
                "http://www.ncbi.nlm.nih.gov/pubmed/11698940",
                "http://www.ncbi.nlm.nih.gov/pubmed/18504234"
            ],
            "id": "5ab2cdc5fcf4565872000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19592548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 694,
                    "text": "Between 2000 and 2007, 200 patients undergoing median sternotomy for cardiac surgery, with one or more risk factors including New York Heart Association functional class III/IV, chronic obstructive pulmonary disease, osteoporosis, obesity, and off-midline sternotomy, were randomly assigned to group A (sternal weave closure, 100 patients) or group B (routine sternal wire closure, 100 patients)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18167574",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Steel wire sternum fixation in patients who underwent median sternotomy for cardiac surgery, is a routine procedure in our clinical practice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22611181",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 307,
                    "text": "METHODS\nBetween September 2007 and February 2011, 2672 patients underwent a standard peri-sternal wire closure following a median sternotomy for a first-time cardiac surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2794943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "Following sternotomy for open heart surgery, a 57-year-old man had the sternum closed in the usual manner with six No.22 gauge stainless steel wire sutures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17073957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 410,
                    "offsetInEndSection": 672,
                    "text": "METHODS\nThree hundred sixty-six patients undergoing elective cardiac surgery with full median sternotomy and having body surface area (BSA) less than 1.5 m(2) were randomly assigned to receive PDS (n = 181) or stainless steel (SS, n = 185) sternal approximation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27909272",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "During cardiac surgery through midline sternotomy, sternum closure metal wires are usually used for."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26346231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 274,
                    "offsetInEndSection": 522,
                    "text": "METHODS\nAll patients with BMI \u226530 undergoing cardiac surgery via median sternotomy between February 2008 and February 2013 in our institution were divided into two groups depending on sternal closure technique-sternal wires or thermoreactive clips."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18167574",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "[Titanium transverse plate fixation system after sternum dehiscence in cardiac surgery]."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2794943",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Death due to disruption of sternal fixation wire--a rare complication after open heart surgery through sternotomy: report of a case."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20026533",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Sternal dehiscence is a rare but devastating complication following median sternotomy for cardiac surgery."
                }
            ]
        },
        {
            "body": "Is transcription of eRNA bidirectional?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23273978",
                "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                "http://www.ncbi.nlm.nih.gov/pubmed/26308897",
                "http://www.ncbi.nlm.nih.gov/pubmed/21572438",
                "http://www.ncbi.nlm.nih.gov/pubmed/23636943",
                "http://www.ncbi.nlm.nih.gov/pubmed/28225006",
                "http://www.ncbi.nlm.nih.gov/pubmed/27932455",
                "http://www.ncbi.nlm.nih.gov/pubmed/24953189",
                "http://www.ncbi.nlm.nih.gov/pubmed/25404134",
                "http://www.ncbi.nlm.nih.gov/pubmed/27084101"
            ],
            "id": "5ac24f7595d0062724000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23273978",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1029,
                    "offsetInEndSection": 1124,
                    "text": "Moreover, eRNA production from p53BERs is required for efficient p53 transcription enhancement."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 322,
                    "text": "Here, by using genome-wide binding profiling, we show extensive occupancy of transcription factors of myogenesis (MyoD and Myogenin) at extragenic enhancer regions coinciding with RNA synthesis (i.e., eRNA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26308897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 808,
                    "offsetInEndSection": 967,
                    "text": "Global nuclear run-on and RNAPII profiling reveals a role for Integrator in 3'-end cleavage of eRNA primary transcripts leading to transcriptional termination."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21572438",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23636943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1035,
                    "offsetInEndSection": 1289,
                    "text": "We find that flavopiridol, a CDK9 inhibitor that blocks transcription elongation, inhibits eRNA production but does not affect other molecular indicators of enhancer activity, suggesting that eRNA production occurs after the assembly of active enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 323,
                    "offsetInEndSection": 509,
                    "text": "In particular, multiple regions were transcribed to eRNA within the regulatory region of MYOD1, including previously characterized distal regulatory regions (DRR) and core enhancer (CE)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28225006",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1199,
                    "offsetInEndSection": 1414,
                    "text": "Thus, our data support the view that eRNA dysregulation in HD striatum is a key mechanism leading to altered transcription of striatal neuron identity genes, through reduced recruitment of RNAPII at super-enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21572438",
                    "endSection": "abstract",
                    "offsetInBeginSection": 797,
                    "offsetInEndSection": 1098,
                    "text": "These enhancers are functional, as evidenced by the production of enhancer-templated non-coding RNA (eRNA) based on global nuclear run-on sequencing (GRO-seq) analysis, with a unique class apparently requiring no nucleosome remodelling to induce specific enhancer-promoter looping and gene activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27932455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1131,
                    "offsetInEndSection": 1362,
                    "text": "Lastly, basal eRNA transcription at enhancers, but not E2-induced transcription, is maintained upon depletion of MLL1 and ER\u03b1, suggesting some degree of chromatin accessibility prior to signal-dependent activation of transcription."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24953189",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "A TEAD1/p65 complex regulates the eutherian-conserved MnSOD intronic enhancer, eRNA transcription and the innate immune response."
                }
            ]
        },
        {
            "body": "Is the protein pelota a ribosomal rescue factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                "http://www.ncbi.nlm.nih.gov/pubmed/25132172",
                "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                "http://www.ncbi.nlm.nih.gov/pubmed/22358840",
                "http://www.ncbi.nlm.nih.gov/pubmed/16280348",
                "http://www.ncbi.nlm.nih.gov/pubmed/28213379",
                "http://www.ncbi.nlm.nih.gov/pubmed/12438745",
                "http://www.ncbi.nlm.nih.gov/pubmed/17889667",
                "http://www.ncbi.nlm.nih.gov/pubmed/27164299"
            ],
            "id": "5ad35933133db5eb78000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                    "endSection": "abstract",
                    "offsetInBeginSection": 308,
                    "offsetInEndSection": 571,
                    "text": "Here, we discover that loss of GTPBP2, a novel binding partner of the ribosome recycling protein Pelota, in mice with a mutation in a tRNA gene that is specifically expressed in the central nervous system causes ribosome stalling and widespread neurodegeneration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                    "endSection": "abstract",
                    "offsetInBeginSection": 677,
                    "offsetInEndSection": 788,
                    "text": "A Drosophila homolog of Dom34p, pelota, is required for the proper coordination of meiosis and spermatogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                    "endSection": "abstract",
                    "offsetInBeginSection": 789,
                    "offsetInEndSection": 979,
                    "text": "Heterologous expression of pelota in dom34delata mutants restores wild-type growth and differentiation, suggesting conservation of function between the eukaryotic members of the gene family."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25132172",
                    "endSection": "abstract",
                    "offsetInBeginSection": 411,
                    "offsetInEndSection": 549,
                    "text": "We find that the primary role of the ribosome splitting factors Hbs1, Pelota, and ABCE1 is to permit Listerin access to the nascent chain."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "An archaebacterial homolog of pelota, a meiotic cell division protein in eukaryotes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 277,
                    "text": "An open reading frame (pelA) specifying a homolog of pelota and DOM34, proteins required for meiotic cell division in Drosophila melanogaster and Saccharomyces cerevisiae, respectively, has been cloned, sequenced and identified from the archaebacterium Sulfolobus solfataricus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22358840",
                    "endSection": "abstract",
                    "offsetInBeginSection": 430,
                    "offsetInEndSection": 604,
                    "text": "Here we present cryo-electron microscopy reconstructions of eukaryotic and archaeal ribosome recycling complexes containing ABCE1 and the termination factor paralogue Pelota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22358840",
                    "endSection": "abstract",
                    "offsetInBeginSection": 711,
                    "offsetInEndSection": 969,
                    "text": "Moreover, the iron-sulphur cluster domain of ABCE1 interacts with and stabilizes Pelota in a conformation that reaches towards the peptidyl transferase centre, thus explaining how ABCE1 may stimulate peptide-release activity of canonical termination factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8900058",
                    "endSection": "abstract",
                    "offsetInBeginSection": 415,
                    "offsetInEndSection": 620,
                    "text": "The presence of a pelota homolog in archaebacteria implies that the meiotic functions of the eukaryotic protein were co-opted from, or added to, other functions existing before the emergence of eukaryotes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16280348",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Pelota controls self-renewal of germline stem cells by repressing a Bam-independent differentiation pathway."
                }
            ]
        },
        {
            "body": "Is CXCL7 a chemokine?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27052313",
                "http://www.ncbi.nlm.nih.gov/pubmed/28245630",
                "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                "http://www.ncbi.nlm.nih.gov/pubmed/19450895",
                "http://www.ncbi.nlm.nih.gov/pubmed/20022386",
                "http://www.ncbi.nlm.nih.gov/pubmed/20652876",
                "http://www.ncbi.nlm.nih.gov/pubmed/21084802",
                "http://www.ncbi.nlm.nih.gov/pubmed/20652010",
                "http://www.ncbi.nlm.nih.gov/pubmed/24678812",
                "http://www.ncbi.nlm.nih.gov/pubmed/15720439"
            ],
            "id": "5a9db99ffd02ddc336000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27052313",
                    "endSection": "abstract",
                    "offsetInBeginSection": 481,
                    "offsetInEndSection": 658,
                    "text": "Antibody arrays and ELISA assays confirmed that NK cells secrete RANTES (CCL5) and revealed that human NK cells secrete NAP-2 (CXCL7), a chemokine that can induce MSC migration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28245630",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "CXCL7, a chemokine highly expressed in platelets, orchestrates neutrophil recruitment during thrombosis and related pathophysiological processes by interacting with CXCR2 receptor and sulfated glycosaminoglycans (GAG)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 313,
                    "text": "CXCL7 exerts its function by activating the CXC chemokine receptor 2 (CXCR2) receptor and binding sulfated glycosaminoglycans (GAGs) that regulate receptor activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19450895",
                    "endSection": "abstract",
                    "offsetInBeginSection": 159,
                    "offsetInEndSection": 436,
                    "text": "Using the recently developed chemokine protein arrays, we analyzed 38 chemokines associated with monocyte-derived DC (MoDC), including the CC family (CCL2, CCL3, CCL4, CCL17, CCL18, CCL22, CCL23, CCL24, CCL27) and the CXC family (CXCL3, CXCL5, CXCL7, CXCL8, CXCL16) chemokines."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28245630",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan Heparin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20022386",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Many cells, including leucocytes and stromal cells, express CXCL7, a member of the CXC chemokine family, also known as platelet basic protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28245630",
                    "endSection": "abstract",
                    "offsetInBeginSection": 219,
                    "offsetInEndSection": 372,
                    "text": "CXCL7 exists as monomers and dimers, and dimerization (~50 \u03bcM) and CXCR2 binding (~10 nM) constants indicate that CXCL7 is a potent agonist as a monomer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27052313",
                    "endSection": "abstract",
                    "offsetInBeginSection": 659,
                    "offsetInEndSection": 783,
                    "text": "Inhibition with specific antagonists of CXCR2, a receptor that recognizes NAP-2, abolished NK cell-mediated MSC recruitment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28245630",
                    "endSection": "abstract",
                    "offsetInBeginSection": 495,
                    "offsetInEndSection": 704,
                    "text": "Using solution nuclear magnetic resonance (NMR) spectroscopy, we characterized the binding of CXCL7 monomer to the CXCR2 N-terminal domain (CXCR2Nd) that constitutes a critical docking site and to GAG heparin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 147,
                    "text": "Platelet-derived chemokine CXCL7 (also known as NAP-2) plays a crucial role in orchestrating neutrophil recruitment in response to vascular injury."
                }
            ]
        },
        {
            "body": "The TRPM2 gene is associated with development of spontaneous thromboembolism?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                "http://www.ncbi.nlm.nih.gov/pubmed/27868415",
                "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                "http://www.ncbi.nlm.nih.gov/pubmed/16252251",
                "http://www.ncbi.nlm.nih.gov/pubmed/20515676",
                "http://www.ncbi.nlm.nih.gov/pubmed/19004782",
                "http://www.ncbi.nlm.nih.gov/pubmed/19133961",
                "http://www.ncbi.nlm.nih.gov/pubmed/28199210",
                "http://www.ncbi.nlm.nih.gov/pubmed/23277130",
                "http://www.ncbi.nlm.nih.gov/pubmed/21587268"
            ],
            "id": "5ab144fefcf4565872000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 868,
                    "offsetInEndSection": 1032,
                    "text": "Genetic variants of the TRPM2 gene confer a risk of developing Western Pacific amyotropic lateral sclerosis and parkinsonism-dementia complex and bipolar disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27868415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "Objective: To investigate the association between single nucleotide polymorphism (SNP) in the 11th exon of transient receptor potential melastatin 2 (TRPM2) gene with the susceptibility and outcome of sepsis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 581,
                    "offsetInEndSection": 785,
                    "text": "Considering that TRPM2 is activated by oxidative stress, mediated cell death and inflammation, and is highly expressed in brain, the channel has been investigated in the context of central nervous system."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27868415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1005,
                    "offsetInEndSection": 1152,
                    "text": "Conclusion: The TRPM2 SNP rs1556314 does not have significant association with sepsis, but this result need to be confirmed by large scale studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 786,
                    "offsetInEndSection": 867,
                    "text": "TRPM2 plays a role in H(2)O(2) and amyloid \u03b2-peptide induced striatal cell death."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27868415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 820,
                    "offsetInEndSection": 1004,
                    "text": "And no significant difference in genotype frequencies and allelic frequencies of TRPM2 SNP rs1556314 was observed between the survivors and fatal cases of septic patients (all P>0.05)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 289,
                    "offsetInEndSection": 580,
                    "text": "Since the mechanisms that lead to TRPM2 gating in response to ADPR and H(2)O(2) are not understood in neuronal cells, I summarized previous findings and important recent advances in the understanding of Ca(2+) influx via TRPM2 channels in different neuronal cell types and disease processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 288,
                    "text": "The Na+ and Ca(2+)-permeable melastatin related transient receptor potential 2 (TRPM2) channels can be gated either by ADP-ribose (ADPR) in concert with Ca(2+) or by hydrogen peroxide (H(2)O(2)), an experimental model for oxidative stress, binding to the channel's enzymatic Nudix domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21140288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1033,
                    "offsetInEndSection": 1150,
                    "text": "TRPM2 also contributes to traumatic brain injury processes such as oxidative stress, inflammation and neuronal death."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "TRPM2 SNP genotype previously associated with susceptibility to Rhodococcus equi pneumonia in Quarter Horse foals displays differential gene expression identified using RNA-Seq."
                }
            ]
        },
        {
            "body": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                "http://www.ncbi.nlm.nih.gov/pubmed/28198446",
                "http://www.ncbi.nlm.nih.gov/pubmed/27366760",
                "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                "http://www.ncbi.nlm.nih.gov/pubmed/29022864",
                "http://www.ncbi.nlm.nih.gov/pubmed/29044149",
                "http://www.ncbi.nlm.nih.gov/pubmed/27179424",
                "http://www.ncbi.nlm.nih.gov/pubmed/27787521",
                "http://www.ncbi.nlm.nih.gov/pubmed/27492477",
                "http://www.ncbi.nlm.nih.gov/pubmed/26865554"
            ],
            "id": "5ac0aee419833b0d7b000004",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "A single mutation in the prM protein of Zika virus contributes to fetal microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 558,
                    "text": "Here we show that a single serine-to-asparagine substitution [Ser139\u2192Asn139 (S139N)] in the viral polyprotein substantially increased ZIKV infectivity in both human and mouse neural progenitor cells (NPCs) and led to more severe microcephaly in the mouse fetus, as well as higher mortality rates in neonatal mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 743,
                    "offsetInEndSection": 894,
                    "text": "This functional adaption makes ZIKV more virulent to human NPCs, thus contributing to the increased incidence of microcephaly in recent ZIKV epidemics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Zika virus (ZIKV) has evolved into a global health threat because of its unexpected causal link to microcephaly."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28198446",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "A Mutation Identified in Neonatal Microcephaly Destabilizes Zika Virus NS1 Assembly in Vitro."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27366760",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "Zika virus (ZIKV) infection is a new emerging threat around the globe which might be responsible for microcephaly and Guillain-Barre syndrome in the infants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Zika virus (ZIKV), a mosquito-transmitted flavivirus, responsible for sporadic outbreaks of mild and febrile illness in Africa and Asia, re-emerged in the last decade causing serious human diseases including microcephaly, congenital malformations, and Guillain-Barr\u00e9 syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29022864",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "Zika virus (ZIKV, genus Flavivirus) has emerged as a major mosquito-transmitted human pathogen, with recent outbreaks associated with an increased incidence of neurological complications, particularly microcephaly and the Guillain-Barr\u00e9 syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28198446",
                    "endSection": "abstract",
                    "offsetInBeginSection": 98,
                    "offsetInEndSection": 299,
                    "text": "ZIKV infection was recently confirmed by CDC (the Centers for Disease Control and Prevention) to cause neonatal microcephaly, which posed a significant public health emergency of international concern."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29044149",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "The recent outbreak of Zika virus (ZIKV) disease caused an enormous number of infections in Central and South America, and the unusual increase in the number of infants born with microcephaly associated with ZIKV infection aroused global concern."
                }
            ]
        },
        {
            "body": "What is the aim of the PhenCode database?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22069583",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                "http://www.ncbi.nlm.nih.gov/pubmed/20674843",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822110",
                "http://www.ncbi.nlm.nih.gov/pubmed/10909009",
                "http://www.ncbi.nlm.nih.gov/pubmed/16971749",
                "http://www.ncbi.nlm.nih.gov/pubmed/27499284",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822120",
                "http://www.ncbi.nlm.nih.gov/pubmed/27843347",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822083"
            ],
            "id": "5ad4f4f5133db5eb7800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22069583",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 329,
                    "text": "The aim of this article is to present what type of information users can access from each database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 237,
                    "text": "AIM\nThe aim of this study is to set up a database in order to monitor the detection rates and false-positive rates of first-trimester screening for chromosomal abnormalities and prenatal detection rates of fetal malformations in Denmark."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 847,
                    "offsetInEndSection": 939,
                    "text": "Furthermore, results of all pre- and postnatal chromosome analyses are sent to the database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 240,
                    "offsetInEndSection": 397,
                    "text": "STUDY POPULATION\nPregnant women with a first or second trimester ultrasound scan performed at all public hospitals in Denmark are registered in the database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1190,
                    "offsetInEndSection": 1342,
                    "text": "The database is valuable to assess the performance at a regional level and to compare Danish performance with international results at a national level."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20674843",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "OBJECTIVE\nThe aim of the present report is to provide an overview of the first database on clinical research in veterinary homeopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822110",
                    "endSection": "abstract",
                    "offsetInBeginSection": 97,
                    "offsetInEndSection": 223,
                    "text": "The aim of this database was to collect data on nonmelanoma skin cancer (NMSC) treatment and improve its treatment in Denmark."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10909009",
                    "endSection": "abstract",
                    "offsetInBeginSection": 383,
                    "offsetInEndSection": 499,
                    "text": "Since this is a new technique, the clinical findings and surgical outcome are prospectively collected in a database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22069583",
                    "endSection": "abstract",
                    "offsetInBeginSection": 98,
                    "offsetInEndSection": 229,
                    "text": "To be useful to the scientific community, this knowledge has been stored, annotated and made easy to retrieve by several databases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 615,
                    "text": "MAIN VARIABLES/DESCRIPTIVE DATA\nData on maternal characteristics, ultrasonic, and biochemical variables are continuously sent from the fetal medicine units' Astraia databases to the central database via web service."
                }
            ]
        },
        {
            "body": "What is the basis of the Sp3 procedure used in proteomics?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                "http://www.ncbi.nlm.nih.gov/pubmed/11432740",
                "http://www.ncbi.nlm.nih.gov/pubmed/27668303",
                "http://www.ncbi.nlm.nih.gov/pubmed/27639109",
                "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                "http://www.ncbi.nlm.nih.gov/pubmed/12676787",
                "http://www.ncbi.nlm.nih.gov/pubmed/24451589",
                "http://www.ncbi.nlm.nih.gov/pubmed/18474540",
                "http://www.ncbi.nlm.nih.gov/pubmed/10698168"
            ],
            "id": "5ac28c0c95d006272400000a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Molecular basis for keratoconus: lack of TrkA expression and its transcriptional repression by Sp3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11432740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1040,
                    "offsetInEndSection": 1265,
                    "text": "Our demonstration that activation of the lamin A proximal promoter is mediated by Sp3 and AP-1 transcription factors affords a basis for further studies on the regulation of this important gene during development and disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                    "endSection": "abstract",
                    "offsetInBeginSection": 758,
                    "offsetInEndSection": 884,
                    "text": "Sp3 is a bifunctional transcription factor that has been reported to stimulate or repress the transcription of numerous genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                    "endSection": "abstract",
                    "offsetInBeginSection": 599,
                    "offsetInEndSection": 757,
                    "text": "The absence of TrkA(NGFR) expression was associated with a strong increase in the Sp3 repressor short isoform(s) and a lack of the Sp3 activator long isoform."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11432740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 577,
                    "offsetInEndSection": 780,
                    "text": "Activation by expression of Sp3 is more pronounced than that by Sp1 although both proteins can bind to the GC box in vitro; activation clearly depends on an intact GC box as deduced from mutant analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                    "endSection": "abstract",
                    "offsetInBeginSection": 885,
                    "offsetInEndSection": 1013,
                    "text": "Indeed, we found that Sp3 short isoform(s) overexpression in cell culture results in a down-regulation of TrkA(NGFR) expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27668303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 197,
                    "offsetInEndSection": 511,
                    "text": "In this study, we examined the effect of TFF2 on gastric cancer cell lines in\u00a0vitro and characterized the interaction between TFF2 and Sp3, including the mechanisms that mediate this interaction, using genomics and proteomics approaches, as well as genetics techniques, such as RNA interference and gene knockdown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11432740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 111,
                    "offsetInEndSection": 353,
                    "text": "We have analysed previously the putative promoter sequences of the gene and shown that the rat lamin A proximal promoter contains two essential motifs, a GC box that can bind to Sp1 and Sp3, and an AP-1 motif that can bind to c-Jun and c-Fos."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11432740",
                    "endSection": "abstract",
                    "offsetInBeginSection": 354,
                    "offsetInEndSection": 448,
                    "text": "In this study we have investigated the role of Sp1 and Sp3 in transactivation of the promoter."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11432740",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "SP3 and AP-1 mediate transcriptional activation of the lamin A proximal promoter."
                }
            ]
        },
        {
            "body": "What is \"enhancer hijacking\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                "http://www.ncbi.nlm.nih.gov/pubmed/26229090",
                "http://www.ncbi.nlm.nih.gov/pubmed/26065614",
                "http://www.ncbi.nlm.nih.gov/pubmed/27490482",
                "http://www.ncbi.nlm.nih.gov/pubmed/28029156",
                "http://www.ncbi.nlm.nih.gov/pubmed/27856734",
                "http://www.ncbi.nlm.nih.gov/pubmed/25414315",
                "http://www.ncbi.nlm.nih.gov/pubmed/14998483",
                "http://www.ncbi.nlm.nih.gov/pubmed/12112711"
            ],
            "id": "5abc9157fcf456587200001e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 235,
                    "offsetInEndSection": 476,
                    "text": "Here we present a framework for inferring cancer-related gene overexpression resulting from CRE reorganization (e.g., enhancer hijacking) by integrating SCNAs, gene expression data and information on topologically associating domains (TADs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 751,
                    "offsetInEndSection": 880,
                    "text": "We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1131,
                    "text": "Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229090",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1313,
                    "offsetInEndSection": 1504,
                    "text": "We identify novel mechanisms of enhancer-driven regulation of the oncogenes MYC and BCL6, and show that the BCL6 locus can serve as an enhancer donor in an \"enhancer hijacking\" translocation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "abstract",
                    "offsetInBeginSection": 737,
                    "offsetInEndSection": 902,
                    "text": "Somatic structural variants juxtapose GFI1 or GFI1B coding sequences proximal to active enhancer elements, including super-enhancers, instigating oncogenic activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 881,
                    "offsetInEndSection": 1088,
                    "text": "Recurrent tandem duplications intersecting with a TAD boundary mediate de novo formation of a 3D contact domain comprising IGF2 and a lineage-specific super-enhancer, resulting in high-level gene activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 234,
                    "text": "Extensive prior research focused on somatic copy-number alterations (SCNAs) affecting cancer genes, yet the extent to which recurrent SCNAs exert their influence through rearrangement of cis-regulatory elements (CREs) remains unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229090",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 595,
                    "text": "This method detects rearrangements involving known cancer genes, including CCND1, BCL2, MYC, PDCD1LG2, NOTCH1, CIITA, and SGK1, as well as novel enhancer duplication events of likely oncogenic significance."
                }
            ]
        },
        {
            "body": "What disease is tinea ?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12040364",
                "http://www.ncbi.nlm.nih.gov/pubmed/23439970",
                "http://www.ncbi.nlm.nih.gov/pubmed/12894115",
                "http://www.ncbi.nlm.nih.gov/pubmed/25396139",
                "http://www.ncbi.nlm.nih.gov/pubmed/12913810",
                "http://www.ncbi.nlm.nih.gov/pubmed/10354029",
                "http://www.ncbi.nlm.nih.gov/pubmed/14996619",
                "http://www.ncbi.nlm.nih.gov/pubmed/10948816",
                "http://www.ncbi.nlm.nih.gov/pubmed/24134312",
                "http://www.ncbi.nlm.nih.gov/pubmed/63655"
            ],
            "id": "5aa67b4fd6d6b54f7900000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12040364",
                    "endSection": "abstract",
                    "offsetInBeginSection": 866,
                    "offsetInEndSection": 1118,
                    "text": "Relapse of the disease was observed in 4 of 51 patients at 1 year after treatment, 4 of 25 at 2 years, and 2 of 9 at 3 years in the plantar type, and in 4 of 30 at 1 year, 0 of 14 at 2 years, and 0 of 6 at 3 years in the interdigital tinea pedis group."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12040364",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Tinea pedis responds well to topical antifungal therapy, however, relapse of the disease is not uncommon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23439970",
                    "endSection": "abstract",
                    "offsetInBeginSection": 683,
                    "offsetInEndSection": 785,
                    "text": "DISCUSSION\nTinea capitis is a disease of prepubertal children with common in age group of 5- 15 years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12894115",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Tinea capitis is generally thought to be a common disease in children but not in adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25396139",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Tinea capitis is generally thought to be a common disease in children but not in adults."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12913810",
                    "endSection": "abstract",
                    "offsetInBeginSection": 473,
                    "offsetInEndSection": 668,
                    "text": "We believe these cases to have been infected in Myanmar, and suggest the possibility that tinea caused by M. ferrugineum may become a re-emergent infection or an imported fungal disease in Japan."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10354029",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1187,
                    "offsetInEndSection": 1335,
                    "text": "These data confirm that tinea pedis, a potentially transmissible disease, is common in Australian schoolchildren, including those in primary school."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14996619",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 64,
                    "text": "Tinea capitis is primarily a disease of pre-adolescent children."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10948816",
                    "endSection": "abstract",
                    "offsetInBeginSection": 535,
                    "offsetInEndSection": 687,
                    "text": "Tinea pedis may be a risk factor for streptococcal infections such as erysipelas, mainly in tropical countries, where tinea pedis is a frequent disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24134312",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Tinea capitis is a common disease of childhood that typically follows one of several clinical patterns."
                }
            ]
        },
        {
            "body": "How are deletion breakpoints defined?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8314578",
                "http://www.ncbi.nlm.nih.gov/pubmed/21103668",
                "http://www.ncbi.nlm.nih.gov/pubmed/8307327",
                "http://www.ncbi.nlm.nih.gov/pubmed/11001932",
                "http://www.ncbi.nlm.nih.gov/pubmed/16512914",
                "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                "http://www.ncbi.nlm.nih.gov/pubmed/28501396",
                "http://www.ncbi.nlm.nih.gov/pubmed/7868119",
                "http://www.ncbi.nlm.nih.gov/pubmed/15732063",
                "http://www.ncbi.nlm.nih.gov/pubmed/11336982"
            ],
            "id": "5abc9c1efcf4565872000020",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8314578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1059,
                    "offsetInEndSection": 1256,
                    "text": "One YAC in the centromeric contig contains an insert encompassing the minimum interval for GK deficiency defined by patient deletion breakpoints, and this clone includes all or part of the GK gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21103668",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 162,
                    "text": "Large deletions are found in approximately 5% of patients with severe haemophilia A, but only a few deletion breakpoints have been characterised precisely so far."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8307327",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1177,
                    "offsetInEndSection": 1359,
                    "text": "The mapping of these loci to specific genetic intervals defined by deletion breakpoints suggests a number of positional-cloning strategies for the molecular isolation of these genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11001932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 372,
                    "text": "By sequence-tagged site (STS) content mapping, we roughly defined deletion breakpoints in two unrelated, azoospermic men with AZFa deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8314578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 605,
                    "offsetInEndSection": 770,
                    "text": "Patient deletion breakpoints in the region of the two YAC contigs define at least eight intervals, and seven deletion breakpoints are contained within these contigs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21103668",
                    "endSection": "abstract",
                    "offsetInBeginSection": 163,
                    "offsetInEndSection": 403,
                    "text": "In this study we characterised the deletion breakpoints of two patients with severe haemophilia A, large deletions and factor VIII (FVIII) inhibitors, and subsequently established deletion-specific assays for the identification of carriers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21103668",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1263,
                    "offsetInEndSection": 1436,
                    "text": "The exact identification of the deletion breakpoints provides a reliable diagnostic tool for carrier identification in affected families by means of a deletion-specific PCR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16512914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1092,
                    "offsetInEndSection": 1257,
                    "text": "CONCLUSION\nThis Alu sequence like SSBR is commonly in the proximity of all known deletion breakpoints of 22q11 region and also in the low copy repeat regions (LCRs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 499,
                    "text": "Subsequently, the deletion of exon 2 of the copper metabolism domain containing 1 (COMMD1) gene (formerly MURR1) was shown to be the major cause of copper toxicosis, although the deletion breakpoints were not defined."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28501396",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1511,
                    "offsetInEndSection": 1842,
                    "text": "The analysis of Gene Ontology (GO) terms revealed that a cluster with the highest enrichment score among genes with many deletion breakpoints was represented by GO terms related to ion transport, whereas the GO term cluster mostly enriched among the genes with many duplication breakpoints was related to binding of macromolecules."
                }
            ]
        },
        {
            "body": "How is the nuclear localization of lncRNA mediated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                "http://www.ncbi.nlm.nih.gov/pubmed/23828888",
                "http://www.ncbi.nlm.nih.gov/pubmed/27250657",
                "http://www.ncbi.nlm.nih.gov/pubmed/25690653",
                "http://www.ncbi.nlm.nih.gov/pubmed/25843628",
                "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                "http://www.ncbi.nlm.nih.gov/pubmed/25417700",
                "http://www.ncbi.nlm.nih.gov/pubmed/25555588",
                "http://www.ncbi.nlm.nih.gov/pubmed/23723417"
            ],
            "id": "5ab8fb5bfcf4565872000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 788,
                    "offsetInEndSection": 1067,
                    "text": "To address whether localization of the lncRNA influences susceptibility to degradation by either ASOs or RNAi, nuclear lncRNAs (MALAT1 and NEAT1), cytoplasmic lncRNAs (DANCR and OIP5-AS1) and dual-localized lncRNAs (TUG1, CasC7 and HOTAIR) were compared for knockdown efficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 150,
                    "offsetInEndSection": 427,
                    "text": "As many lncRNAs regulate nuclear events and thus must localize to nuclei, we analyzed the sequence requirements for nuclear localization in an intergenic lncRNA named BORG (BMP2-OP1-responsive gene), which is both spliced and polyadenylated but is strictly localized in nuclei."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1068,
                    "offsetInEndSection": 1269,
                    "text": "We found that nuclear lncRNAs were more effectively suppressed using ASOs, cytoplasmic lncRNAs were more effectively suppressed using RNAi and dual-localized lncRNAs were suppressed using both methods."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1270,
                    "offsetInEndSection": 1448,
                    "text": "A mixed-modality approach combining ASOs and RNAi reagents improved knockdown efficacy, particularly for those lncRNAs that localize to both nuclear and cytoplasmic compartments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 250,
                    "offsetInEndSection": 411,
                    "text": "Complicating their study, lncRNAs have widely varying subcellular distributions: some reside predominantly in the nucleus, the cytoplasm or in both compartments."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 186,
                    "offsetInEndSection": 249,
                    "text": "However, most lncRNAs have not been functionally characterized."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Thousands of long non-coding RNAs (lncRNAs) have been identified in mammalian cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23828888",
                    "endSection": "abstract",
                    "offsetInBeginSection": 136,
                    "offsetInEndSection": 290,
                    "text": "We investigated the localization mechanisms of the Xist lncRNA during X-chromosome inactivation (XCI), a paradigm of lncRNA-mediated chromatin regulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27250657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 906,
                    "offsetInEndSection": 1204,
                    "text": "Further, lncRNA SPRY4-IT1 can directly increase the transcription, expression, and nuclear localization of Snail, one key transcription factor during the EMT processes of cancer cells, while siRNA-mediated specific knockdown of Snail can significantly attenuate SPRY4-IT1-induced EMT of ESCC cells."
                }
            ]
        },
        {
            "body": "What is ATAC-seq?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29296732",
                "http://www.ncbi.nlm.nih.gov/pubmed/28625481",
                "http://www.ncbi.nlm.nih.gov/pubmed/26683334",
                "http://www.ncbi.nlm.nih.gov/pubmed/27482699",
                "http://www.ncbi.nlm.nih.gov/pubmed/27443938",
                "http://www.ncbi.nlm.nih.gov/pubmed/26251845",
                "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                "http://www.ncbi.nlm.nih.gov/pubmed/24097267",
                "http://www.ncbi.nlm.nih.gov/pubmed/26607380",
                "http://www.ncbi.nlm.nih.gov/pubmed/28754907"
            ],
            "id": "5abd31e0fcf456587200002c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29296732",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "ATAC-seq provides genome-wide chromatin state in 3 cell types of hematopoietic stem/progenitor cells.Transcription factor cohorts are associated with dynamic changes of open chromatin during the differentiation of LT/ST-HSCs to MPPs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625481",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Here, we define the landscape and dynamics of active regulatory DNA in cutaneous T\u00a0cell lymphoma (CTCL) by ATAC-seq."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26683334",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "A novel ATAC-seq approach reveals lineage-specific reinforcement of the open chromatin landscape via cooperation between BAF and p63."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27482699",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1091,
                    "offsetInEndSection": 1253,
                    "text": "HDAC5 knockdown followed by ATAC-seq assay in SSc ECs identified key HDAC5-regulated genes involved in angiogenesis and fibrosis, such as CYR61, PVRL2, and FSTL1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27482699",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1588,
                    "offsetInEndSection": 1719,
                    "text": "CONCLUSION\nSeveral novel HDAC5-regulated target genes associated with impaired angiogenesis were identified in SSc ECs by ATAC-seq."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27482699",
                    "endSection": "abstract",
                    "offsetInBeginSection": 724,
                    "offsetInEndSection": 905,
                    "text": "An assay for transposase-accessible chromatin using sequencing (ATAC-seq) was performed to assess and localize the genome-wide effects of HDAC5 knockdown on chromatin accessibility."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27443938",
                    "endSection": "abstract",
                    "offsetInBeginSection": 893,
                    "offsetInEndSection": 1168,
                    "text": "ATAC-seq is a very efficient technique that, using a very low number of cells as starting material, allows the identification of active chromatin regions genome wide, whereas 4C-seq detects the subset of sequences that interact specifically with the promoter of a given gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26251845",
                    "endSection": "abstract",
                    "offsetInBeginSection": 571,
                    "offsetInEndSection": 785,
                    "text": "ATAC-seq revealed previously undescribed elements that escape X chromosome inactivation and predicted gender-specific gene regulatory networks across autosomes, which coordinately affect genes with immune function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 631,
                    "offsetInEndSection": 1000,
                    "text": "ATAC-seq is a robust and sensitive alternative to DNase I hypersensitivity analysis coupled with next-generation sequencing (DNase-seq) and formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) for genome-wide analysis of chromatin accessibility and to the sequencing of micrococcal nuclease-sensitive sites (MNase-seq) to determine nucleosome positioning."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Mapping Genome-wide Accessible Chromatin in Primary Human T Lymphocytes by ATAC-Seq."
                }
            ]
        },
        {
            "body": "What is the TALE-iD method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                "http://www.ncbi.nlm.nih.gov/pubmed/24228087",
                "http://www.ncbi.nlm.nih.gov/pubmed/28674932",
                "http://www.ncbi.nlm.nih.gov/pubmed/28074901",
                "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                "http://www.ncbi.nlm.nih.gov/pubmed/23672257",
                "http://www.ncbi.nlm.nih.gov/pubmed/23821439",
                "http://www.ncbi.nlm.nih.gov/pubmed/25866970",
                "http://www.ncbi.nlm.nih.gov/pubmed/23840477",
                "http://www.ncbi.nlm.nih.gov/pubmed/27604899"
            ],
            "id": "5a8d8f39fcd1d6a10c000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 450,
                    "offsetInEndSection": 590,
                    "text": "This platform is fully compatible with the Golden Gate TALEN and TAL Effector Kit 2.0, a widely used and efficient method for TALE assembly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24228087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 920,
                    "offsetInEndSection": 1157,
                    "text": "The feature of both ease-of-operation and high efficiency of ULtiMATE system makes it not only an ideal method for biologic labs, but also an approach well suited for large-scale assembly of TALENs and any other TALE-based constructions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 956,
                    "offsetInEndSection": 1168,
                    "text": "Together, our results suggest that this multicolor TALE-KRAB vector platform is a promising and versatile tool for knockdown of multiple gene targets and could greatly facilitate dissection of molecular pathways."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 114,
                    "offsetInEndSection": 293,
                    "text": "Because it allows sequence-specific DNA binding, transcription activator-like effector (TALE) offers a new genetic perturbation technique that allows for gene-specific repression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Stable and efficient knockdown of multiple gene targets is highly desirable for dissection of molecular pathways."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24228087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 127,
                    "offsetInEndSection": 285,
                    "text": "Although many methods have been reported, it remains a challenge for the assembly of designer-based TALE repeats in a fast, precise and cost-effective manner."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24228087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 436,
                    "offsetInEndSection": 607,
                    "text": "This method takes advantage of uracil-specific excision reagent (USER) to create multiple distinct sticky ends between any neighboring DNA fragments for specific ligation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28674932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 72,
                    "offsetInEndSection": 306,
                    "text": "The use of transcription activator-like effectors (TALEs) is a powerful genome-engineering tool, which can facilitate genome editing and transcriptional modulation, and has been used for genetic modification in a variety of organisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24228087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Engineered TAL-effector nucleases (TALENs) and TALE-based constructs have become powerful tools for eukaryotic genome editing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28074901",
                    "endSection": "abstract",
                    "offsetInBeginSection": 480,
                    "offsetInEndSection": 730,
                    "text": "Here, combining bimolecular fluorescence complementation (BiFC) and transcription activator-like effector (TALE) technologies, we developed a novel method for labeling genomic loci (BiFC-TALE), which largely reduces the background fluorescence level."
                }
            ]
        },
        {
            "body": "What is Paget's Disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19181600",
                "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                "http://www.ncbi.nlm.nih.gov/pubmed/11705325",
                "http://www.ncbi.nlm.nih.gov/pubmed/23918905",
                "http://www.ncbi.nlm.nih.gov/pubmed/22747870",
                "http://www.ncbi.nlm.nih.gov/pubmed/16429324",
                "http://www.ncbi.nlm.nih.gov/pubmed/18638386",
                "http://www.ncbi.nlm.nih.gov/pubmed/678749",
                "http://www.ncbi.nlm.nih.gov/pubmed/19899400",
                "http://www.ncbi.nlm.nih.gov/pubmed/8209869"
            ],
            "id": "5aa67b6ad6d6b54f79000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19181600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 46,
                    "text": "Paget's disease in the Far East is quite rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 129,
                    "offsetInEndSection": 186,
                    "text": "Paget's disease is primarily a disease of the osteoclast."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Paget's disease of bone is a chronic focal skeletal disorder that affects up to 2-3% of the population over the age of 60 years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11705325",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Paget's disease is a chronic focal disease of the skeleton that affects up to 2-3% of the population over the age of 60 years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19181600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 569,
                    "offsetInEndSection": 817,
                    "text": "The first patient, who may be the first documented case of Paget's disease in the lumbar spine with progressive neurologic deficiency in an Asian population, received decompressive laminectomy due to marked spinal stenosis with neurologic deficits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23918905",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "INTRODUCTION\nPaget's disease of the vulva is a rare malignancy primarily affecting Caucasian women in their seventh to eighth decades."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 524,
                    "offsetInEndSection": 598,
                    "text": "Paget's disease is an autosomal dominant trait with genetic heterogeneity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11705325",
                    "endSection": "abstract",
                    "offsetInBeginSection": 127,
                    "offsetInEndSection": 247,
                    "text": "There is a genetic predisposition for Paget's disease, with one predisposition locus identified on chromosome 18q-21-22."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22747870",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Paget's disease of bone is a common metabolic bone disease in most of the European countries."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16429324",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Paget's disease of bone is a chronic focal skeletal disorder characterized by increased bone resorption by the osteoclasts."
                }
            ]
        },
        {
            "body": "What is the function of penicillinase, also known as beta lactamase?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                "http://www.ncbi.nlm.nih.gov/pubmed/6972858",
                "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                "http://www.ncbi.nlm.nih.gov/pubmed/3541135",
                "http://www.ncbi.nlm.nih.gov/pubmed/9158767",
                "http://www.ncbi.nlm.nih.gov/pubmed/9624479",
                "http://www.ncbi.nlm.nih.gov/pubmed/8248237",
                "http://www.ncbi.nlm.nih.gov/pubmed/4990588",
                "http://www.ncbi.nlm.nih.gov/pubmed/8494361",
                "http://www.ncbi.nlm.nih.gov/pubmed/7759391"
            ],
            "id": "5aae651ffcf456587200000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 501,
                    "text": "In both cases, we have shown the simultaneous biosynthesis of two enzymes: an inducible and chromosome cephalosporinase frequently found in this germ, and a constitutive beta lactamase, with a penicillinase activity which has been identified with the extrachromosomic beta lactamase R-TEM."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "[Identification of the beta lactamase R-TEM of Pseudomonas aeruginosa]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 502,
                    "offsetInEndSection": 766,
                    "text": "These two enzymes have been separated by affinity chromatography, characterized by their kinetic constants given by computerized microacidimetry, and their isoelectric points which are respectively 9.2 for the cephalosporinase and 5.40 for the penicillinase R-TEM."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 78,
                    "offsetInEndSection": 160,
                    "text": "aeruginosa resistant to classical beta lactam antibiotics including carbenicillin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "This paper is dealing with the enzymatic problem raised by two strains of Ps."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 161,
                    "offsetInEndSection": 211,
                    "text": "These two strains hydrolyse all these antibiotics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6972858",
                    "endSection": "abstract",
                    "offsetInBeginSection": 648,
                    "offsetInEndSection": 793,
                    "text": "Ro 13-9904 was seen to be a potent inhibitor of several cephalosporinases, but had little or no affinity for penicillinases or the TEM lactamase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 836,
                    "text": "Isoelectric focussing also shows the separation of these two enzymes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6972858",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 74,
                    "text": "Properties of Ro 13-99041 as a substrate and inhibitor of beta-lactamases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6972858",
                    "endSection": "abstract",
                    "offsetInBeginSection": 80,
                    "offsetInEndSection": 152,
                    "text": "Its stability against hydrolysis by several beta-lactamases was studied."
                }
            ]
        },
        {
            "body": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22154254",
                "http://www.ncbi.nlm.nih.gov/pubmed/12969463",
                "http://www.ncbi.nlm.nih.gov/pubmed/26577206",
                "http://www.ncbi.nlm.nih.gov/pubmed/24807184",
                "http://www.ncbi.nlm.nih.gov/pubmed/15482056",
                "http://www.ncbi.nlm.nih.gov/pubmed/551363",
                "http://www.ncbi.nlm.nih.gov/pubmed/28196774",
                "http://www.ncbi.nlm.nih.gov/pubmed/27135263",
                "http://www.ncbi.nlm.nih.gov/pubmed/23327159",
                "http://www.ncbi.nlm.nih.gov/pubmed/8759144"
            ],
            "id": "5ab1483bfcf4565872000014",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22154254",
                    "endSection": "abstract",
                    "offsetInBeginSection": 741,
                    "offsetInEndSection": 954,
                    "text": "in Asiatic lion, Bengal tiger, Indian leopard and domestic cat was Hepatozoon felis (98-99% similarity) and in the Indian wild and domestic dog the phylogenetic neighbour was Hepatozoon canis (97-100% similarity)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12969463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 536,
                    "offsetInEndSection": 794,
                    "text": "Genetic variability was significantly partitioned among taxonomic groups (FST = 0.11; RST = 0.41; P < 0.001) and sampling locations (FST = 0.07; RST = 0.06; P < 0.001), suggesting that wild and domestic cats are subdivided into distinct gene pools in Europe."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26577206",
                    "endSection": "abstract",
                    "offsetInBeginSection": 217,
                    "offsetInEndSection": 466,
                    "text": "Although the cat lungworm Aelurostrongylus abstrusus is considered as enzootic in domestic cats (Felis silvestris catus) living in some areas of continental Greece, conversely, Troglostrongylus brevior, has only been reported in the island of Crete."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22154254",
                    "endSection": "abstract",
                    "offsetInBeginSection": 197,
                    "offsetInEndSection": 350,
                    "text": "in Asiatic lion, Indian tiger, Indian leopard, Indian wild dog, Indian domestic dog and cat based on partial 18S rRNA gene sequences from Hepatozoon spp."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12969463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 295,
                    "offsetInEndSection": 535,
                    "text": "Cats were identified as European wildcats (Felis silvestris silvestris), Sardinian wildcats (F. s. libyca) and domestic cats (F. s. catus), according to phenotypic traits, geographical locations and independently of any genetic information."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24807184",
                    "endSection": "abstract",
                    "offsetInBeginSection": 422,
                    "offsetInEndSection": 617,
                    "text": "SLAM of the domestic dog (Canis lupus familiaris) were similar to those of other members of the suborder Caniformia, indicating that the animals in this group have similar sensitivity to dog CDV."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15482056",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "Perceptual and acoustic evidence for species-level differences in meow vocalizations by domestic cats (Felis catus) and African wild cats (Felis silvestris lybica)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15482056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 231,
                    "text": "To test for possible anthropogenic selection effects on meows in domestic felids, vocalizations by domestic cats (Felis catus) were compared with cries by their closest wild relative, the African wild cat (Felis silvestris lybica)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15482056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 427,
                    "offsetInEndSection": 696,
                    "text": "Both the acoustic and perceptual comparisons revealed clear species-level differences: The domestic cat meows were significantly shorter in mean duration than the wild cat meows, showed higher mean formant frequencies, and exhibited higher mean fundamental frequencies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22154254",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Hepatozoon species are parasites that infect a wide variety of domestic and wild animals."
                }
            ]
        },
        {
            "body": "What is caused by the ectopic expression of CTCF?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                "http://www.ncbi.nlm.nih.gov/pubmed/15941718",
                "http://www.ncbi.nlm.nih.gov/pubmed/19369356",
                "http://www.ncbi.nlm.nih.gov/pubmed/28161276",
                "http://www.ncbi.nlm.nih.gov/pubmed/9591631",
                "http://www.ncbi.nlm.nih.gov/pubmed/26268681",
                "http://www.ncbi.nlm.nih.gov/pubmed/17071074",
                "http://www.ncbi.nlm.nih.gov/pubmed/14980504"
            ],
            "id": "5abcf6b9fcf4565872000027",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1228,
                    "text": "Depletion of CTCF resulted in reduced motility and invasiveness in HCC cells that could be reversed by ectopic expression of FOXM1, suggesting that FOXM1 is one of the important downstream effectors of CTCF in HCC."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 655,
                    "text": "Here we show that ectopic expression of CTCF in many cell types inhibits cell clonogenicity by causing profound growth retardation without apoptosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                    "endSection": "abstract",
                    "offsetInBeginSection": 120,
                    "offsetInEndSection": 310,
                    "text": "Ectopic expression of CTCF in various normal and tumoral human cell lines inhibits cell division and clonogenicity, with the consequence to consider CTCF a potential tumor-suppressor factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15941718",
                    "endSection": "abstract",
                    "offsetInBeginSection": 585,
                    "offsetInEndSection": 1087,
                    "text": "By using these model systems we demonstrated that: (i) ectopic expression of CTCF in K562 cells led to growth retardation and promotion of differentiation into the erythroid lineage; (ii) CTCF knock-down significantly inhibited differentiation of K562 cells into erythroid lineage; (iii) differentiation of K562 into the megakaryocytic lineage was not significantly affected; and (iv) down-regulation of MYC has been identified as one of the mechanisms by which CTCF promotes erythroid differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                    "endSection": "abstract",
                    "offsetInBeginSection": 547,
                    "offsetInEndSection": 896,
                    "text": "Short hairpin RNA (shRNA)-mediated suppression of CTCF inhibited cell proliferation, motility and invasiveness in HCC cell lines; these effects were correlated with prominent reductions in the expression of telomerase reverse transcriptase (TERT), the shelterin complex member telomerase repeat-binding factor 1, and forkhead box protein M1 (FOXM1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19369356",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1173,
                    "offsetInEndSection": 1405,
                    "text": "Ectopic expression of Rad21 repressed CTCF-regulated transcription of KSHV lytic genes, and a Rad21-CTCF chimeric protein converted CTCF into an efficient transcriptional repressor of KSHV genes normally activated in the G(2) phase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28161276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1056,
                    "text": "The role of GATA-1 in interaction between CTCF sites was revealed by its ectopic expression in 293 cells and by deletion of a GATA-1 site in the LCR HS2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                    "endSection": "abstract",
                    "offsetInBeginSection": 897,
                    "offsetInEndSection": 1013,
                    "text": "In contrast, upregulation of CTCF was positively correlated with FOXM1 and TERT expression in clinical HCC biopsies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                    "endSection": "abstract",
                    "offsetInBeginSection": 311,
                    "offsetInEndSection": 569,
                    "text": "In this review article, we focused on the molecular mechanisms engaged by CTCF to modulate the expression of several key-regulators of differentiation, cellular senescence, cell cycle control and progression, whose expression is frequently altered in tumors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9591631",
                    "endSection": "abstract",
                    "offsetInBeginSection": 852,
                    "offsetInEndSection": 920,
                    "text": "Enforced ectopic expression of CTCF inhibits cell growth in culture."
                }
            ]
        },
        {
            "body": "What is the dardarin protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16175160",
                "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                "http://www.ncbi.nlm.nih.gov/pubmed/16026116",
                "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                "http://www.ncbi.nlm.nih.gov/pubmed/16280683",
                "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                "http://www.ncbi.nlm.nih.gov/pubmed/16991141",
                "http://www.ncbi.nlm.nih.gov/pubmed/22988875"
            ],
            "id": "5ac0fccf19833b0d7b000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16175160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 818,
                    "offsetInEndSection": 1189,
                    "text": "Last, mutations in 2 of these genes turned out to be frequent enough to have relevance in clinical practice: parkin mutations are common in early-onset familial and sporadic PD; moreover, emerging data delineate mutations in the LRRK2 gene (encoding the dardarin protein) as a frequent cause of the familial late onset PD forms, and even of few late-onset sporadic cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "BACKGROUND\nRecently, mutations in LRRK2 encoding the protein dardarin have been linked to an autosomal dominant form of parkinsonism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 858,
                    "offsetInEndSection": 1000,
                    "text": "We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16026116",
                    "endSection": "abstract",
                    "offsetInBeginSection": 117,
                    "offsetInEndSection": 296,
                    "text": "It is now known that there are two autosomal dominant disease genes, alpha-synuclein and dardarin, and three genes responsible for autosomal recessive PD, parkin, DJ-1 and PINK-1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 204,
                    "text": "Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Mutations in the leucine-rich repeat kinase 2 (LRRK 2), encoding dardarin protein, have been demonstrated to be linked to autosomal dominant Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 393,
                    "offsetInEndSection": 480,
                    "text": "First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16280683",
                    "endSection": "abstract",
                    "offsetInBeginSection": 971,
                    "offsetInEndSection": 1049,
                    "text": "The protein product was named dardarin and contains GTPase and kinase domains."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases."
                }
            ]
        },
        {
            "body": "In which syndrome is the RPS19 gene most frequently mutated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19898770",
                "http://www.ncbi.nlm.nih.gov/pubmed/18768533",
                "http://www.ncbi.nlm.nih.gov/pubmed/17053056",
                "http://www.ncbi.nlm.nih.gov/pubmed/17376718",
                "http://www.ncbi.nlm.nih.gov/pubmed/29222326",
                "http://www.ncbi.nlm.nih.gov/pubmed/27550323",
                "http://www.ncbi.nlm.nih.gov/pubmed/20054847",
                "http://www.ncbi.nlm.nih.gov/pubmed/12750732",
                "http://www.ncbi.nlm.nih.gov/pubmed/16458028",
                "http://www.ncbi.nlm.nih.gov/pubmed/26447946"
            ],
            "id": "5a896c26fcd1d6a10c000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19898770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Diamond-Blackfan anemia is a bone marrow failure syndrome associated with heterozygous mutations in the ribosomal protein S19 (RPS19) gene in a subgroup of patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768533",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 240,
                    "text": "BACKGROUND\nMutations in the ribosomal protein S19 gene (RPS19) have been found in 25% of patients with Diamond-Blackfan anemia, a rare syndrome of congenital bone marrow failure characterized by erythroblastopenia and various malformations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17053056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "The gene encoding the ribosomal protein S19 (RPS19) is frequently mutated in Diamond-Blackfan anemia (DBA), a congenital erythroblastopenia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17376718",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "The gene encoding the small subunit ribosomal protein 19 (RPS19) is mutated in about 25% of cases of the bone marrow failure syndrome Diamond Blackfan Anemia (DBA), a childhood disease characterized by failure of red cell production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29222326",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 262,
                    "text": "A mutation in the gene encoding the small subunit-associated ribosomal protein RPS19, leading to RPS19 haploinsufficiency, is one of the ribosomal protein gene defects responsible for the rare inherited bone marrow failure syndrome Diamond Blackfan anemia (DBA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27550323",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 267,
                    "text": "Diamond blackfan anemia (DBA) is a well-known inherited bone marrow failure syndrome mostly caused by mutations in ribosomal protein (RP) genes but also rarely in the hematopoietic transcription factor gene, GATA1, or TSR2, a ribosomal protein (Rps26) chaperone gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20054847",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "Mutations in the RPS19 gene have been identified in 25% of individuals affected by Diamond-Blackfan anemia (DBA), a congenital erythroblastopenia characterized by an aregenerative anemia and a variety of malformations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19898770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 846,
                    "offsetInEndSection": 1053,
                    "text": "Our findings suggest that combined Rps19 insufficiency and Pim-1 deficiency promote murine myeloid cell growth through a deregulation of c-Myc and a simultaneous up-regulation of anti-apoptotic Bcl proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12750732",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 180,
                    "text": "INTRODUCTION\nA total of 25% of patients presenting with Diamond-Blackfan anemia (DBA) carry mutations in the rps19 gene, which encodes protein RPS19 of the small ribosomal subunit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19898770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 166,
                    "offsetInEndSection": 241,
                    "text": "One of the interacting partners with RPS19 is the oncoprotein PIM-1 kinase."
                }
            ]
        },
        {
            "body": "What type of sequences do enhancers evolve from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                "http://www.ncbi.nlm.nih.gov/pubmed/25635462",
                "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                "http://www.ncbi.nlm.nih.gov/pubmed/19913403",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151964",
                "http://www.ncbi.nlm.nih.gov/pubmed/26253316",
                "http://www.ncbi.nlm.nih.gov/pubmed/18986212",
                "http://www.ncbi.nlm.nih.gov/pubmed/28760812",
                "http://www.ncbi.nlm.nih.gov/pubmed/22102826"
            ],
            "id": "5ac37afc0340b9f058000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1283,
                    "offsetInEndSection": 1474,
                    "text": "We suggest that the novel optic lobe enhancer evolved by exploiting the cryptic activity of extant regulatory sequences, and this may reflect a general mechanism whereby new enhancers evolve."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 90,
                    "offsetInEndSection": 242,
                    "text": "However, the evolutionary origins of novel expression patterns, and the transcriptional control elements (\"enhancers\") that govern them, remain unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 332,
                    "text": "Here, we sought to explore the molecular genetic mechanisms by which new enhancers arise."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Enhancers of RNA polymerase I transcription in higher eukaryotes are repetitive elements within the intergenic spacers of rRNA genes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 338,
                    "text": "In Xenopus and mouse, enhancers and the gene promoter bind the activator protein, upstream binding factor, and in Xenopus, enhancers also share sequence similarity with an upstream domain of the promoter."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Ribosomal gene promoter domains can function as artificial enhancers of RNA polymerase I transcription, supporting a promoter origin for natural enhancers in Xenopus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 664,
                    "offsetInEndSection": 881,
                    "text": "These data demonstrate functional relatedness between the promoter and enhancers, supporting the hypothesis that enhancers could have evolved from duplicated promoter domains that bind essential transcription factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25635462",
                    "endSection": "abstract",
                    "offsetInBeginSection": 696,
                    "offsetInEndSection": 907,
                    "text": "Our data further reveal that recently evolved enhancers can be associated with genes under positive selection, demonstrating the power of this approach for annotating regulatory adaptations in genomic sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25635462",
                    "endSection": "abstract",
                    "offsetInBeginSection": 465,
                    "offsetInEndSection": 600,
                    "text": "Most of the recently evolved enhancers arise from ancestral DNA exaptation, rather than lineage-specific expansions of repeat elements."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8290549",
                    "endSection": "abstract",
                    "offsetInBeginSection": 882,
                    "offsetInEndSection": 1048,
                    "text": "The ability of upstream binding factor to bind enhancers inactivated by mutation suggests that upstream binding factor binding alone cannot explain enhancer function."
                }
            ]
        },
        {
            "body": "What nerve is involved in carpal tunnel syndrome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7594983",
                "http://www.ncbi.nlm.nih.gov/pubmed/18683528",
                "http://www.ncbi.nlm.nih.gov/pubmed/3492109",
                "http://www.ncbi.nlm.nih.gov/pubmed/20067212",
                "http://www.ncbi.nlm.nih.gov/pubmed/12124876",
                "http://www.ncbi.nlm.nih.gov/pubmed/27894853",
                "http://www.ncbi.nlm.nih.gov/pubmed/15451351",
                "http://www.ncbi.nlm.nih.gov/pubmed/26014322",
                "http://www.ncbi.nlm.nih.gov/pubmed/26589645",
                "http://www.ncbi.nlm.nih.gov/pubmed/6642296"
            ],
            "id": "5abcf010fcf4565872000023",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7594983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 619,
                    "text": "In contrast, the wrists of patients with carpal tunnel syndrome had significantly less sliding (0.37 +/- 0.34 mm; P = 0.0001), which indicates that physiological motion of the nerve is restricted."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7594983",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 64,
                    "text": "Restricted motion of the median nerve in carpal tunnel syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7594983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 620,
                    "offsetInEndSection": 724,
                    "text": "This decrease in nerve mobility may be of significance in the pathophysiology of carpal tunnel syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7594983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "Motion of the median nerve was compared on an axial ultrasonographic image in the mid-carpal tunnel in 30 wrists of 15 women with bilateral idiopathic carpal tunnel syndrome and 30 wrists of 15 healthy women."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18683528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 117,
                    "offsetInEndSection": 287,
                    "text": "As nerve entrapment induces impairment of somatic fibres followed by clinical symptoms and signs of the syndrome, one can assume that sympathetic fibres are involved too."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3492109",
                    "endSection": "abstract",
                    "offsetInBeginSection": 906,
                    "offsetInEndSection": 1127,
                    "text": "Preliminary observations in 10 wrists of patients with carpal tunnel syndrome include segmental and diffuse swelling of the median nerve in six, distortion of the nerve in one, and thickening of the tendon sheaths in one."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18683528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Carpal tunnel syndrome is a complex of symptoms as a result of compression of the median nerve in the carpal tunnel."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20067212",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "BACKGROUND\nCarpal tunnel syndrome, involving the median nerve, is the most frequent compressive neuropathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7594983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 422,
                    "text": "During passive flexion and extension of the index finger, the control wrists had transverse sliding of the nerve beneath the flexor retinaculum (1.75 +/- 0.49 mm), which was regarded as a physiological phenomenon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18683528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 624,
                    "offsetInEndSection": 747,
                    "text": "Eight papers presenting the results of sympathetic skin response from median nerve in carpal tunnel syndrome were analysed."
                }
            ]
        },
        {
            "body": "What is the function of LOX proteins in the ECM?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                "http://www.ncbi.nlm.nih.gov/pubmed/28668305",
                "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                "http://www.ncbi.nlm.nih.gov/pubmed/28453968",
                "http://www.ncbi.nlm.nih.gov/pubmed/26646068",
                "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                "http://www.ncbi.nlm.nih.gov/pubmed/18765548",
                "http://www.ncbi.nlm.nih.gov/pubmed/25875748",
                "http://www.ncbi.nlm.nih.gov/pubmed/28550176"
            ],
            "id": "5ad243e30340b9f058000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25146937",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 285,
                    "text": "LOXL2 is proposed to function similarly to LOX in the extracellular matrix (ECM) by promoting crosslinking of collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 404,
                    "offsetInEndSection": 645,
                    "text": "While the catalytic function of LOX is essential for cross-linking of ECM proteins, we also reported that LOX induced invasive and metastatic properties in breast tumour epithelial cells through hydrogen peroxide-mediated FAK/Src activation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 175,
                    "offsetInEndSection": 430,
                    "text": "In this study, we assess the progression of cardiovascular remodeling from the compensatory to decompensatory phase, with a focus on the change in LOX expression and activity as it relates to alterations in ECM composition and changes in cardiac function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                    "endSection": "abstract",
                    "offsetInBeginSection": 897,
                    "offsetInEndSection": 1268,
                    "text": "Considering the current knowledge on the function of mammalian LOX isoforms in ECM remodeling, we propose that LOXL2/L3/L4 members might have preferentially been involved in making cross-linked collagen IV-based basement membrane, whereas the diversification of LOX/L1/L5 forms contributed to chordate/vertebrate-specific ECM innovations, such as elastin and fibronectin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28453968",
                    "endSection": "abstract",
                    "offsetInBeginSection": 136,
                    "offsetInEndSection": 286,
                    "text": "Alterations in collagen content and LOX protein expression in the ECM of degenerative mitral valve may enhance leaflet expansion and disease severity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                    "endSection": "abstract",
                    "offsetInBeginSection": 111,
                    "offsetInEndSection": 311,
                    "text": "The best-studied role of LOX enzymes is the remodeling of the extracellular matrix (ECM) in animals by cross-linking collagens and elastin, although intracellular functions have been reported as well."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28453968",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1587,
                    "offsetInEndSection": 1797,
                    "text": "Observed changes in Type I and III collagen densities in Degenerative Mitral Valve Disease may be secondary to alterations in LOX protein expression, contributing to disorganization of ECM and disease severity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26646068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 300,
                    "text": "Endothelial dysfunction involves deregulation of the key extracellular matrix (ECM) enzyme lysyl oxidase (LOX) and the vasoconstrictor protein, endothelin-1 (ET-1), whose gene expression can be modulated by the transcriptional activators nuclear factor kappa B (NF-\u03baB) and activator protein-1 (AP-1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1018,
                    "offsetInEndSection": 1109,
                    "text": "Therefore, LOX expression level in the ECM may function as an independent predictor of Pca."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 174,
                    "text": "A key feature of heart failure is adverse extracellular matrix (ECM) remodeling, which is associated with increases in the collagen cross-linking enzyme, lysyl oxidase (LOX)."
                }
            ]
        },
        {
            "body": "Please list 3 diseases treated with Valtrex(valacyclovir)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24885821",
                "http://www.ncbi.nlm.nih.gov/pubmed/17630083",
                "http://www.ncbi.nlm.nih.gov/pubmed/19088926",
                "http://www.ncbi.nlm.nih.gov/pubmed/12884680",
                "http://www.ncbi.nlm.nih.gov/pubmed/23940911",
                "http://www.ncbi.nlm.nih.gov/pubmed/20879013",
                "http://www.ncbi.nlm.nih.gov/pubmed/27425241",
                "http://www.ncbi.nlm.nih.gov/pubmed/25362676",
                "http://www.ncbi.nlm.nih.gov/pubmed/20441121",
                "http://www.ncbi.nlm.nih.gov/pubmed/23769085"
            ],
            "id": "5abcf755fcf4565872000028",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24885821",
                    "endSection": "abstract",
                    "offsetInBeginSection": 838,
                    "offsetInEndSection": 951,
                    "text": "RESULTS\nOut of 3,149 patients with stage 3 or 4 CKD, only 16% of patients had CKD documented on the problem list."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24885821",
                    "endSection": "abstract",
                    "offsetInBeginSection": 537,
                    "offsetInEndSection": 835,
                    "text": "We examined the association of problem list documentation with: 1) serum eGFR monitoring test, 2) urine protein or albumin monitoring test, 3) an angiotensin converting enzyme inhibitor or angiotensin receptor blocker (ACE/ARB) prescription, 4) mean systolic blood pressure (BP), and 5) BP control."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17630083",
                    "endSection": "abstract",
                    "offsetInBeginSection": 511,
                    "offsetInEndSection": 599,
                    "text": "and \"Please list the programs that offered you interview invitations before November 1.\""
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19088926",
                    "endSection": "abstract",
                    "offsetInBeginSection": 881,
                    "offsetInEndSection": 1178,
                    "text": "Sixty-one patients were removed from the waiting list: transplanted 41 (65%), death seven (11%), candidate condition deteriorated/too sick to transplant eight (13%), medically unsuitable one (2%), other one (2%), transferred to another center two (3%), and transplanted at another center one (2%)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24885821",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1319,
                    "offsetInEndSection": 1442,
                    "text": "After adjustment, problem list documentation was not associated with ACE/ARB prescription, mean systolic BP, or BP control."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24885821",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 305,
                    "text": "Our objective was to determine whether electronic problem list documentation of CKD is associated with monitoring and treatment."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24885821",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Electronic problem list documentation of chronic kidney disease and quality of care."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24885821",
                    "endSection": "abstract",
                    "offsetInBeginSection": 952,
                    "offsetInEndSection": 1318,
                    "text": "After adjustment for eGFR, gender, and race/ethnicity and after clustering by physician, problem list documentation of CKD was associated with serum eGFR testing (97% with problem list documentation vs. 94% without problem list documentation, p=0.02) and urine protein testing (47% with problem list documentation vs. 40% without problem list documentation, p=0.04)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12884680",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 534,
                    "text": "With linkage, the series was immediately treated as a 15-item ordered list."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24885821",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1698,
                    "offsetInEndSection": 1853,
                    "text": "Interventions aimed at increasing documentation of CKD on the problem list may improve stage-appropriate monitoring, but may not improve clinical outcomes."
                }
            ]
        },
        {
            "body": "Which olfactory gene senses androsterone?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                "http://www.ncbi.nlm.nih.gov/pubmed/8921833",
                "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                "http://www.ncbi.nlm.nih.gov/pubmed/8422755",
                "http://www.ncbi.nlm.nih.gov/pubmed/20440461",
                "http://www.ncbi.nlm.nih.gov/pubmed/3138978",
                "http://www.ncbi.nlm.nih.gov/pubmed/9566734"
            ],
            "id": "5ace17c30340b9f058000009",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 230,
                    "text": "Olfactory sensitivity to two odorants, isoamyl acetate and androsterone, was assessed in 14 obsessive compulsive disorder (OCD) patients, nine major depressive disorder (MDD) patients, and 16 sex- and age-matched healthy controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 236,
                    "text": "The present study examined differences in olfactory sensitivity between 16 naturally cycling (NC) women and 17 women taking monophasic oral contraceptives (OCs) to six odors: lemon, peppermint, rose, musk, androstenone and androsterone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "abstract",
                    "offsetInBeginSection": 395,
                    "offsetInEndSection": 527,
                    "text": "NC women in the periovulatory phase were significantly more sensitive to androstenone, androsterone, and musk than women taking OCs."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Olfactory sensitivity in major depressive disorder and obsessive compulsive disorder."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "abstract",
                    "offsetInBeginSection": 346,
                    "offsetInEndSection": 461,
                    "text": "No difference in olfactory sensitivity, to either odorant, was found between OCD patients and controls at any time."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 623,
                    "offsetInEndSection": 891,
                    "text": "Genomic DNA amplifications with synthetic primers which have nucleotide sequences corresponding to the 5'-region of androsterone UDPGT cDNA, suggested that androsterone UDPGT gene has exon 1 with a length of some 700 bp and that this exon is deleted in LA Wistar rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 892,
                    "offsetInEndSection": 1128,
                    "text": "Based on these lines of evidence, it is concluded that the large portion of androsterone UDPGT gene is deleted in LA Wistar rats, which results in the absence of androsterone UDPGT mRNA and consequently the corresponding enzyme protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "abstract",
                    "offsetInBeginSection": 462,
                    "offsetInEndSection": 613,
                    "text": "In MDD patients, a significant increase in the sensitivity to isoamyl acetate was observed 6 weeks after initiation of treatment, compared to controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "abstract",
                    "offsetInBeginSection": 516,
                    "offsetInEndSection": 769,
                    "text": "Nuclear magnetic resonance spectroscopy demonstrated the direct binding of androsterone to purified human FXR (hFXR) ligand-binding domain (LBD) protein, resulting in the recruitment of steroid receptor coactivator protein-1 (SRC-1) coactivator peptide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 438,
                    "text": "In order to clarify the molecular mechanism of the deficiency, androsterone UDPGT cDNA clone, pGT2 was isolated from rat liver cDNA library and was digested with restriction enzymes to afford three probes for Northern and Southern blot analyses in HA (normal), heterozygous LA and LA Wistar rats."
                }
            ]
        },
        {
            "body": "Where in the body would the navicular bone be found?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                "http://www.ncbi.nlm.nih.gov/pubmed/20525052",
                "http://www.ncbi.nlm.nih.gov/pubmed/10029187",
                "http://www.ncbi.nlm.nih.gov/pubmed/24788547",
                "http://www.ncbi.nlm.nih.gov/pubmed/9776073",
                "http://www.ncbi.nlm.nih.gov/pubmed/24719271",
                "http://www.ncbi.nlm.nih.gov/pubmed/27298914",
                "http://www.ncbi.nlm.nih.gov/pubmed/23697734",
                "http://www.ncbi.nlm.nih.gov/pubmed/2735530"
            ],
            "id": "5abd13e1fcf4565872000029",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 523,
                    "offsetInEndSection": 721,
                    "text": "Both an accessory navicular and the body of the navicular bone may develop osteomyelitis in immunocompromised patients; early diagnosis is important for prescribing effective conservative treatment."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Osteomyelitis of the accessory and body of the navicular bone: a case report."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 254,
                    "text": "He was admitted to our hospital with osteomyelitis of the accessory and body of the navicular bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 72,
                    "offsetInEndSection": 356,
                    "text": "Analysis based on these cases and on 36 patients suffering from identical fractures reported in the literature led to a new mechanical assumption: the axial compression on the foot, as a result of falling from height, causes impaction of the talus into the body of the navicular bone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Fractures of the body of the tarsal navicular bone: case reports and literature review."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052",
                    "endSection": "abstract",
                    "offsetInBeginSection": 962,
                    "offsetInEndSection": 1278,
                    "text": "RESULTS\nThere were significant correlations between the presence of a cystic structure in the distal third of the navicular bone, or a distal border fragment, or increased signal intensity in fat suppressed images at the insertion of the DSIL on the distal phalanx and the histological grade of the body of the DSIL."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1279,
                    "offsetInEndSection": 1854,
                    "text": "There were significant associations between a cystic structure in the distal third of the navicular bone and the presence of either a distal border fragment or entheseous new bone at the insertion of the DSIL, swelling of the DSIL and increased signal intensity in the DSIL in fat suppressed images; between distal elongation of the flexor border of the navicular bone and the presence of one or more distal border fragments and between swelling of the body of the DSIL and irregularity of its palmar border or increased signal intensity in fat suppressed images in the DSIL."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10029187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 303,
                    "offsetInEndSection": 595,
                    "text": "In ponies, navicular bone measurements were smallest for light ponies and regularly increased with body size, but in horses, navicular bone dimensions were smallest for the athletic halfbred, intermediate for draft horse, thoroughbreds and sedentary halfbreds and largest for heavy halfbreds."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 568,
                    "text": "Favorable results are obtained in a vertical two-part fracture, by an open reduction and internal fixation of the tarsal navicular body fracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "Four patients sustaining tarsal navicular body fractures are presented."
                }
            ]
        },
        {
            "body": "Name an lncRNA associated with dilated cardiomyopathy.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                "http://www.ncbi.nlm.nih.gov/pubmed/28115490",
                "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                "http://www.ncbi.nlm.nih.gov/pubmed/23175614",
                "http://www.ncbi.nlm.nih.gov/pubmed/25119045",
                "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                "http://www.ncbi.nlm.nih.gov/pubmed/25707511",
                "http://www.ncbi.nlm.nih.gov/pubmed/28416735",
                "http://www.ncbi.nlm.nih.gov/pubmed/25399422",
                "http://www.ncbi.nlm.nih.gov/pubmed/26481356"
            ],
            "id": "5ac716810340b9f058000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Microarray profiling of long non-coding RNA (lncRNA) associated with hypertrophic cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28115490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 414,
                    "offsetInEndSection": 571,
                    "text": "METHODS AND RESULTS\nWe obtained left ventricular tissue from human patients undergoing cardiac surgery and used RNA sequencing to describe an lncRNA profile."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 258,
                    "text": "Dysregulation of the lncRNA known as myocardial infarction-associated transcript (MIAT) has been associated with myocardial infarction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "abstract",
                    "offsetInBeginSection": 521,
                    "offsetInEndSection": 707,
                    "text": "METHODS\nMyocardial tissues were obtained from 7 HCM patients and 5 healthy individuals, and lncRNA and mRNA expression profiles were analyzed using the Arraystar human lncRNA microarray."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "abstract",
                    "offsetInBeginSection": 708,
                    "offsetInEndSection": 790,
                    "text": "Real-time PCR was conducted to validate the expression pattern of lncRNA and mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1355,
                    "offsetInEndSection": 1471,
                    "text": "CONCLUSION\nLncRNAs are involved in the pathogenesis of HCM through the modulation of multiple pathogenetic pathways."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28115490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 804,
                    "offsetInEndSection": 1094,
                    "text": "Coding genes in close proximity to differentially expressed lncRNAs and coding genes that have coordinated expression with these lncRNAs are enriched in functional categories related to myocardial infarction, including heart function, metabolism, the stress response, and the immune system."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28115490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 302,
                    "text": "In the heart, lncRNAs have been implicated in the regulation of development, ischemic and dilated cardiomyopathy, and myocardial infarction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28115490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1293,
                    "offsetInEndSection": 1395,
                    "text": "As a result, lncRNAs may serve as novel diagnostic and therapeutic targets for ischemic heart disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23175614",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1104,
                    "offsetInEndSection": 1221,
                    "text": "We normalized the disease name and the type of lncRNA dysfunction and provided a detailed description for each entry."
                }
            ]
        },
        {
            "body": "Which gene is responsible for red hair?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                "http://www.ncbi.nlm.nih.gov/pubmed/17147521",
                "http://www.ncbi.nlm.nih.gov/pubmed/19482440",
                "http://www.ncbi.nlm.nih.gov/pubmed/11030758",
                "http://www.ncbi.nlm.nih.gov/pubmed/8783939",
                "http://www.ncbi.nlm.nih.gov/pubmed/23568403",
                "http://www.ncbi.nlm.nih.gov/pubmed/11511307",
                "http://www.ncbi.nlm.nih.gov/pubmed/11549109"
            ],
            "id": "5ace19420340b9f05800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 190,
                    "text": "A specific variant of MC1R gene (R allele) is responsible for the red hair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 677,
                    "offsetInEndSection": 987,
                    "text": "However, comparison of the MSHR genotypes in dizygotic twin pairs discordant for red hair colour indicates that the MSHR gene cannot be solely responsible for the red hair phenotype, since five of 13 pairs tested had both haplotypes identical by state (with three of the five having both identical by descent)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 841,
                    "offsetInEndSection": 1114,
                    "text": "Mutations in the P gene were responsible for classic phenotype of oculocutaneous albinism type 2 (OCA2) in all eight, and mutations in the MC1R gene were responsible for the red (rather than yellow/blond) hair in the six of eight who continued to have red hair after birth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 988,
                    "offsetInEndSection": 1141,
                    "text": "Rather, it is likely that additional modifier genes exist, making variance in the MSHR gene necessary but not always sufficient, for red hair production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 775,
                    "text": "Sequence variation in the melanocortin-1 receptor (MC1R) gene is associated with red hair in the normal population, but red hair is unusual in OCA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                    "endSection": "abstract",
                    "offsetInBeginSection": 734,
                    "offsetInEndSection": 851,
                    "text": "People with R allele have not only flaming red hairstyle but also very fair skin (often with freckles) and blue eyes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17147521",
                    "endSection": "abstract",
                    "offsetInBeginSection": 128,
                    "offsetInEndSection": 308,
                    "text": "Red hair in man is due to certain loss of function mutations of one of the peptide products of the pro-opiomelanocortin (POMC) gene, the melanocortin-1 receptor (MC1R, MIM 155555)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19482440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 443,
                    "offsetInEndSection": 617,
                    "text": "A causal association between red hair and melanocortin-1 receptor has been shown, and is the only gene that is known to explain physiological variation in human pigmentation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 318,
                    "text": "Variants of the melanocortin 1 receptor (MC1R) gene are common in individuals with red hair and fair skin, but the relative contribution to these pigmentary traits in heterozygotes, homozygotes and compound heterozygotes for variants at this locus from the multiple alleles present in Caucasian populations is unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8783939",
                    "endSection": "abstract",
                    "offsetInBeginSection": 404,
                    "offsetInEndSection": 612,
                    "text": "Recent developments show that homologous genes in humans are responsible not only for rare diseases, such as albinism and piebaldism, but also for common phenotypic variations, such as red hair and fair skin."
                }
            ]
        },
        {
            "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8246264",
                "http://www.ncbi.nlm.nih.gov/pubmed/6254890",
                "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                "http://www.ncbi.nlm.nih.gov/pubmed/3025697",
                "http://www.ncbi.nlm.nih.gov/pubmed/776705",
                "http://www.ncbi.nlm.nih.gov/pubmed/3015739",
                "http://www.ncbi.nlm.nih.gov/pubmed/10573394",
                "http://www.ncbi.nlm.nih.gov/pubmed/486086",
                "http://www.ncbi.nlm.nih.gov/pubmed/6087480",
                "http://www.ncbi.nlm.nih.gov/pubmed/9653552"
            ],
            "id": "5abd5a62fcf4565872000031",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8246264",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 407,
                    "text": "High-level mupirocin resistance in coagulase-negative staphylococci isolated from patients undergoing peritoneal dialysis was investigated by transfer of the resistance determinants, usually in the form of a plasmid, to Staphylococcus aureus strains, cleavage of the plasmid by restriction endonuclease and hybridisation with a probe comprising a 4.05 kb EcoRI fragment of a plasmid from a S. aureus strain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6254890",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 206,
                    "text": "In an Escherichia coli strain of human origin, ampicillin resistance and heat-stable enterotoxin activity were shown by EcoRI restriction endonuclease and genetic analysis to be in an 80-megadalton plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "An endonuclease having EcoRI specificity is produced by bacteria containing the ColE1 plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 95,
                    "offsetInEndSection": 379,
                    "text": "Such bacterial cells fail to express restriction or modification functions in vivo, and phage or plasmid DNA obtained from ColE1-containing cells has unmodified EcoRI sites that are cleaved in vitro by purified EcoRI endonuclease or by enzyme extracted from bacteria that carry ColE1."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Phenotypically cryptic EcoRI endonuclease activity specified by the ColE1 plasmid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 453,
                    "offsetInEndSection": 734,
                    "text": "The finding of phenotypically cryptic ColE1-dependent EcoRI endonuclease activity and the absence of any detectable EcoRI modification system in ColE1-containing cells suggest a control mechanism that appears to prevent functional expression of the ColE1-determined enzyme in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025697",
                    "endSection": "abstract",
                    "offsetInBeginSection": 566,
                    "offsetInEndSection": 872,
                    "text": "Recombination of plasmid RP4 with the plasmid pSA14, carrying EcoRI genes, has been registered in E. coli cells, producing the restriction endonuclease, while plasmid recombination has not been found in the cells harbouring plasmid pSA25, isogenic for all genes, except for EcoRI genes, with plasmid pSA14."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/776705",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "A restriction endonuclease analysis of the bacterial plasmid controlling the ecoRI restriction and modification of DNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3015739",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 610,
                    "text": "The pKGW and pKGS plasmids encode an altered EcoRI endonuclease which, when repressed in a lacIQ host, allows survival in the absence of the methylase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/776705",
                    "endSection": "abstract",
                    "offsetInBeginSection": 368,
                    "offsetInEndSection": 547,
                    "text": "Restriction endonucleases EcoRI and HindIII were used to analyze the structure of the plasmid genome responsible for the EcoRI restriction endonuclease and modification methylase."
                }
            ]
        },
        {
            "body": "Which is the main reason for the increase in the incidence of cryptococcal disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                "http://www.ncbi.nlm.nih.gov/pubmed/19245939",
                "http://www.ncbi.nlm.nih.gov/pubmed/10231771",
                "http://www.ncbi.nlm.nih.gov/pubmed/9827275",
                "http://www.ncbi.nlm.nih.gov/pubmed/16011530",
                "http://www.ncbi.nlm.nih.gov/pubmed/29371581",
                "http://www.ncbi.nlm.nih.gov/pubmed/25960942",
                "http://www.ncbi.nlm.nih.gov/pubmed/12421503",
                "http://www.ncbi.nlm.nih.gov/pubmed/21982529",
                "http://www.ncbi.nlm.nih.gov/pubmed/27187754"
            ],
            "id": "5ace37d50340b9f058000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2975,
                    "offsetInEndSection": 3328,
                    "text": "When the two studies using fluconazole as the intervention were analyzed together (N=518), the incidence of cryptococcal disease was decreased in those taking fluconazole for primary prophylaxis (RR 0.25, 95% CI 0.07, 0.87) compared to those taking placebo; however, there was no significant difference in overall mortality (RR 0.59, 95% CI 0.14, 2.62)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2617,
                    "offsetInEndSection": 2974,
                    "text": "When the three studies using itraconazole as the intervention were analyzed together (N=798), the incidence of cryptococcal disease was decreased in those taking itraconazole for primary prophylaxis (RR 0.12, 95% CI 0.03, 0.51) compared to those taking placebo; however, there was no significant difference in overall mortality (RR 1.12, 95% CI 0.70, 1.80)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19245939",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 445,
                    "text": "The increasing incidence of cryptococcal infection as a result of the AIDS epidemic, the recent emergence of a hypervirulent cryptococcal strain in Canada and the fact that mortality from cryptococcal disease remains high have stimulated intensive research into this organism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3331,
                    "offsetInEndSection": 3522,
                    "text": "AUTHORS' CONCLUSIONS\nAntifungal primary prophylaxis with either itraconazole or fluconazole is effective in reducing the incidence of cryptococcal disease in adults with advanced HIV disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2298,
                    "offsetInEndSection": 2511,
                    "text": "When all five studies are analyzed as a single group (N=1316), the incidence of cryptococcal disease was decreased in those taking primary prophylaxis (RR 0.21, 95% CI 0.09, 0.46) compared to those taking placebo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10231771",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 213,
                    "text": "BACKGROUND\nThe objectives of this study were to analyze the changes in the incidence of cryptococcal disease in the last 10 years (1987-1997) and to assess the factors of poor prognosis in HIV-1 infected patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9827275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "The incidence of acute respiratory failure (ARF) associated with cryptococcal disease in patients with AIDS is underestimated in the literature."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 130,
                    "offsetInEndSection": 249,
                    "text": "Primary prophylaxis with antifungal interventions may decrease cryptococcal disease incidence and associated mortality."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "BACKGROUND\nCryptococcal disease is an opportunistic infection that causes significant morbidity and mortality in adults with HIV."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16011530",
                    "endSection": "abstract",
                    "offsetInBeginSection": 335,
                    "offsetInEndSection": 502,
                    "text": "The study was performed at a metropolitan hospital with a large indigent population and an incidence of seven cases of cryptococcal disease per 1000 persons with AIDS."
                }
            ]
        },
        {
            "body": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                "http://www.ncbi.nlm.nih.gov/pubmed/24513612",
                "http://www.ncbi.nlm.nih.gov/pubmed/23666208",
                "http://www.ncbi.nlm.nih.gov/pubmed/15970466",
                "http://www.ncbi.nlm.nih.gov/pubmed/22068265",
                "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                "http://www.ncbi.nlm.nih.gov/pubmed/26781569",
                "http://www.ncbi.nlm.nih.gov/pubmed/22233893"
            ],
            "id": "5ace20fa0340b9f05800000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "Recent studies have identified genes involved in high-altitude adaptation in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                    "endSection": "abstract",
                    "offsetInBeginSection": 383,
                    "offsetInEndSection": 469,
                    "text": "Recent studies have identified genes involved in high-altitude adaptation in Tibetans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Two functional loci in the promoter of EPAS1 gene involved in high-altitude adaptation of Tibetans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 74,
                    "text": "Metabolic insight into mechanisms of high-altitude adaptation in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 87,
                    "offsetInEndSection": 370,
                    "text": "Genetic variants/haplotypes within regions containing three of these genes (EPAS1, EGLN1, and PPARA) are associated with relatively decreased hemoglobin levels observed in Tibetans at high altitude, providing corroborative evidence for genetic adaptation to this extreme environment."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 58,
                    "text": "Metabolic aspects of high-altitude adaptation in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1042,
                    "offsetInEndSection": 1384,
                    "text": "The CC genotype at rs56721780:G>C and the insertion genotype at -742 indel were found associated with higher EPAS1 and LOX expression levels in amnion, as well as higher birth weight of Tibetan newborns, suggesting that EPAS1 gene might play important roles in the development of amnion, fetus growth and high-altitude adaptation of Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "EPAS1 involves in the hypoxic response and is suggested to be responsible for the genetic adaptation of high-altitude hypoxia in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1277,
                    "offsetInEndSection": 1620,
                    "text": "Measurements of serum metabolites from Tibetans living at high altitude are consistent with this hypothesis; the EPAS1 haplotype is significantly associated with increased lactate levels (suggesting increased anaerobic metabolism), and the PPARA haplotype and serum free fatty acids are positively related (suggesting decreased fat oxidation)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24513612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 325,
                    "text": "Studies of Tibetans revealed candidates for high-altitude adaptations in the EGLN1 and EPAS1 genes, associated with lower haemoglobin concentration."
                }
            ]
        },
        {
            "body": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18938135",
                "http://www.ncbi.nlm.nih.gov/pubmed/24876128",
                "http://www.ncbi.nlm.nih.gov/pubmed/25565202",
                "http://www.ncbi.nlm.nih.gov/pubmed/1763812",
                "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                "http://www.ncbi.nlm.nih.gov/pubmed/28270523",
                "http://www.ncbi.nlm.nih.gov/pubmed/3887525",
                "http://www.ncbi.nlm.nih.gov/pubmed/23839524",
                "http://www.ncbi.nlm.nih.gov/pubmed/23293681",
                "http://www.ncbi.nlm.nih.gov/pubmed/23550082"
            ],
            "id": "5a8980d2fcd1d6a10c00000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18938135",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "We investigated the contribution of fatty acid-binding protein 3 (FABP3) to adaptive thermogenesis in brown adipose tissue (BAT) in rodents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24876128",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 152,
                    "text": "Brown adipose tissue (BAT) plays an essential role in metabolic homeostasis by dissipating energy via thermogenesis through uncoupling protein 1 (UCP1)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25565202",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "Brown adipose tissue (BAT) directly regulates energy homeostasis via uncoupling of mitochondrial ATP production and thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1763812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Brown adipose tissue (BAT) is the main effector of nonshivering thermogenesis and diet-induced thermogenesis in mammals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Brown adipose tissue (BAT) is specialized for energy expenditure, a process called adaptive thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28270523",
                    "endSection": "abstract",
                    "offsetInBeginSection": 79,
                    "offsetInEndSection": 185,
                    "text": "Brown adipose tissue (BAT) is specialized for energy expenditure, a process called adaptive thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3887525",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Brown adipose tissue (BAT) is a site of non-shivering thermogenesis in mammals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23839524",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 239,
                    "text": "Brown adipose tissue (BAT) is the main site of nonshivering thermogenesis in mammals."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18938135",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Induction of fatty acid-binding protein 3 in brown adipose tissue correlates with increased demand for adaptive thermogenesis in rodents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23293681",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Non-shivering thermogenesis in brown adipose tissue (BAT) plays an important role in thermoregulation."
                }
            ]
        },
        {
            "body": "Which method is Proseek based on?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
                "http://www.ncbi.nlm.nih.gov/pubmed/26475405",
                "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                "http://www.ncbi.nlm.nih.gov/pubmed/29026368"
            ],
            "id": "5a9e202bde7cb99d40000002",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "ProSeeK: a web server for MLPA probe design."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
                    "endSection": "abstract",
                    "offsetInBeginSection": 160,
                    "offsetInEndSection": 575,
                    "text": "Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek Multiplex, Olink), enhanced serum levels of Adrenomedullin (ADM, Pcorr= .0004), Growth differentiation factor 15 (GDF15, Pcorr= .003), and soluble Major histocompatibility complex class I-related chain A (sMICA, Pcorr= .023), all prosurvival and chemoprotective factors for myeloma cells, were detected in MM comparing to MGUS."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1548,
                    "offsetInEndSection": 1676,
                    "text": "ProSeeK will become a useful tool for all laboratories that are currently using MLPA in their research projects for CNV studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26475405",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1057,
                    "offsetInEndSection": 1175,
                    "text": "Laboratory analyses were performed by Proximity Extension Assay (Proseek Multiplex CVD I(96 \u00d7 96)), ELISAs and RT-PCR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 654,
                    "text": "Among 92 proteins in the Proseek Multiplex Oncology Iv2 panel, 87 were above the limit of detection (LOD) in liquid plasma and 56 among 92 above LOD in plasma applied to FTA cards."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 929,
                    "text": "In addition to conventional laboratory tests, 92 inflammatory proteins were analysed with a multiplex system (Proseek Multiplex Inflammation I, Olink Bioscience)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1490,
                    "offsetInEndSection": 1618,
                    "text": "Proseek found that expression of Carcinoembryonic Antigen (CEA), IL-8 and prolactin are significantly correlated with CRC stage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 366,
                    "offsetInEndSection": 542,
                    "text": "To simultaneously measure 92 inflammatory biomarkers, we used the proximity extension assay with the Proseek Multiplex Inflammation I panel (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "abstract",
                    "offsetInBeginSection": 331,
                    "offsetInEndSection": 493,
                    "text": "Multiplex Ligation-dependent Probe Amplification (MLPA) is a targeted method to assess copy number differences for up to 40 genomic loci in one single experiment."
                }
            ]
        },
        {
            "body": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16436187",
                "http://www.ncbi.nlm.nih.gov/pubmed/29075213",
                "http://www.ncbi.nlm.nih.gov/pubmed/28119174",
                "http://www.ncbi.nlm.nih.gov/pubmed/18845200",
                "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                "http://www.ncbi.nlm.nih.gov/pubmed/16110245",
                "http://www.ncbi.nlm.nih.gov/pubmed/16360899",
                "http://www.ncbi.nlm.nih.gov/pubmed/16584839",
                "http://www.ncbi.nlm.nih.gov/pubmed/21601990",
                "http://www.ncbi.nlm.nih.gov/pubmed/8771218"
            ],
            "id": "5a99566e1d1251d03b00000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16436187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 377,
                    "text": "By conferring allele-specific transcriptional activity on the monoamine oxidase A (MAOA) gene in humans, length variation of a repetitive sequence [(variable number of tandem repeat (VNTR)] in the MAOA promoter influences a constellation of personality traits related to aggressive and antisocial behavior and increases the risk of neurodevelopmental and psychiatric disorders."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29075213",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Monoamine Oxidase A (MAOA) Gene and Personality Traits from Late Adolescence through Early Adulthood: A Latent Variable Investigation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28119174",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 349,
                    "text": "We investigated monoamine oxidase A (MAOA: rs2064070, rs6323, rs909525) and B\u00a0(MAOB: rs1799836, rs2311013, rs2205655) genetic modulation of personality traits (Temperament and Character Inventory, TCI) as endophenotype for suicidal behaviour."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18845200",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "Association between monoamine oxidase A (MAOA) and personality traits in Japanese individuals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16436187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1232,
                    "offsetInEndSection": 1479,
                    "text": "The extent of variability of the MAOA promoter repeat in both rhesus monkeys and humans supports the notion that there may be a relationship between functional MAOA expression and aggression-related traits in humans and rhesus macaque populations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29075213",
                    "endSection": "abstract",
                    "offsetInBeginSection": 201,
                    "offsetInEndSection": 361,
                    "text": "We examined the role of the monoamine oxidase A gene (MAOA) on extraversion and neuroticism from adolescence to adulthood, using modern latent variable methods."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29075213",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1191,
                    "text": "In males, the MAOA genetic latent variable (AAG) was associated with lower extraversion score at age 16 (\u03b2 = -0.167; CI: -0.289, -0.045; p = 0.007, FDRp = 0.042), as well as greater increase in extraversion score from 16 to 26 years (\u03b2 = 0.197; CI: 0.067, 0.328; p = 0.003, FDRp = 0.036)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28119174",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Maoa and Maob polymorphisms and personality traits in suicide attempters and healthy controls: a preliminary study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 274,
                    "text": "We hypothesised that a functional polymorphism in the 5' untranslated region of the MAOA gene is associated with specific personality traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16110245",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "Monoamine oxidase A (MAOA), a mitochondrial outer membrane enzyme, degrades biogenic amines including norepinephrine, dopamine and serotonin, which have been implicated in the expression of personality traits."
                }
            ]
        },
        {
            "body": "What is the function of HDAC  proteins?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                "http://www.ncbi.nlm.nih.gov/pubmed/19199971",
                "http://www.ncbi.nlm.nih.gov/pubmed/24483782",
                "http://www.ncbi.nlm.nih.gov/pubmed/22728920",
                "http://www.ncbi.nlm.nih.gov/pubmed/26927903",
                "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                "http://www.ncbi.nlm.nih.gov/pubmed/17786239",
                "http://www.ncbi.nlm.nih.gov/pubmed/18437899",
                "http://www.ncbi.nlm.nih.gov/pubmed/19826124",
                "http://www.ncbi.nlm.nih.gov/pubmed/10869435"
            ],
            "id": "5aafc37afcf4565872000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 303,
                    "text": "Efforts to understand how associated proteins modulate the function of HDACs would benefit from new technologies that evaluate HDAC activity in native biological systems."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19199971",
                    "endSection": "abstract",
                    "offsetInBeginSection": 735,
                    "offsetInEndSection": 1080,
                    "text": "The molecular mechanisms mediating the anti-cancer effects of HDAC inhibitors on neuroblastoma cells are incompletely understood and involve targeting of aberrant epigenetic repression of tumor suppressor genes, activation of developmental differentiation pathways, as well as changing the acetylation level and function of non-histone proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483782",
                    "endSection": "abstract",
                    "offsetInBeginSection": 207,
                    "offsetInEndSection": 549,
                    "text": "RECENT ADVANCES\nBesides the classical function of HDACs as HDAC enzymes controlling the transcription, it is becoming increasingly evident that these proteins are involved in the regulation of several other cellular processes by their ability to deacetylate hundreds of proteins with different functions in both the cytoplasm and the nucleus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22728920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 101,
                    "offsetInEndSection": 288,
                    "text": "Some HDAC isoforms can also modulate the function of nonhistone proteins implicated in regulatory processes, and therefore HDACs are recognized as useful targets for therapeutic purposes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26927903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 780,
                    "offsetInEndSection": 896,
                    "text": "Rpd3, the Drosophila HDAC1 homolog, is a class I lysine deacetylase and a member of a large family of HDAC proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                    "endSection": "abstract",
                    "offsetInBeginSection": 559,
                    "offsetInEndSection": 803,
                    "text": "This review provides a comprehensive examination of the transcriptional and post-translational mechanisms by which HDACs alter the expression and function of cancer-associated proteins and examines the general impact of HDAC activity in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17786239",
                    "endSection": "abstract",
                    "offsetInBeginSection": 421,
                    "offsetInEndSection": 564,
                    "text": "Accordingly, pharmacological blockade of proteasome function specifically increases expression of class II HDAC proteins in the soleus in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 891,
                    "offsetInEndSection": 1113,
                    "text": "These data indicate that certain HDAC-associated proteins are directly modified by SAHA-BPyne, placing them in close proximity to HDAC active sites where they would be primed to regulate substrate recognition and activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18437899",
                    "endSection": "abstract",
                    "offsetInBeginSection": 290,
                    "offsetInEndSection": 551,
                    "text": "While histones represent a primary target for the physiological function of HDACs, the antitumor effect of HDAC inhibitors might also be attributed to transcription-independent mechanisms by modulating the acetylation status of a series of non-histone proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17786239",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 420,
                    "text": "We show that class II histone deacetylase (HDAC) proteins, which function as transcriptional repressors of the myocyte enhancer factor 2 (MEF2) transcription factor, fail to accumulate in the soleus, a slow muscle, compared with fast muscles (e.g., white vastus lateralis)."
                }
            ]
        },
        {
            "body": "What is the H4S47C cleavage mapping method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                "http://www.ncbi.nlm.nih.gov/pubmed/25352141",
                "http://www.ncbi.nlm.nih.gov/pubmed/9276688",
                "http://www.ncbi.nlm.nih.gov/pubmed/6316277",
                "http://www.ncbi.nlm.nih.gov/pubmed/177985",
                "http://www.ncbi.nlm.nih.gov/pubmed/26275423",
                "http://www.ncbi.nlm.nih.gov/pubmed/3368463",
                "http://www.ncbi.nlm.nih.gov/pubmed/6208845"
            ],
            "id": "5a885add61bb38fb24000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 170,
                    "offsetInEndSection": 332,
                    "text": "To resolve this controversy, we have applied H4S47C-anchored cleavage mapping, which reveals the precise position of histone H4 in every nucleosome in the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 349,
                    "text": "To identify nucleosomes with alternative structures genome-wide, we used H4S47C-anchored cleavage mapping, which revealed that 5% of budding yeast (Saccharomyces cerevisiae) nucleosome positions have asymmetric histone-DNA interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                    "endSection": "abstract",
                    "offsetInBeginSection": 616,
                    "offsetInEndSection": 766,
                    "text": "The peptide antibody method used, called cleavage mapping, should be a convenient technique for mapping residues and ligand binding sites in proteins."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25352141",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Assessing intermolecular RNA:RNA interactions within a ribonucleoprotein complex using heavy metal cleavage mapping."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 333,
                    "offsetInEndSection": 516,
                    "text": "We find that cleavage patterns at centromeres are unique within the genome and are incompatible with symmetrical structures, including octameric nucleosomes and (Cse4/H4)2 tetrasomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25352141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 245,
                    "text": "Heavy metal cleavage mapping analysis of both assembling and fully mature ribonucleoprotein (RNP) complexes are informative techniques for assessing the intermolecular base pairing between small non-coding RNAs and their interacting target RNAs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 426,
                    "text": "Maps constructed from the cleavage pattern suggest that villin contains six cysteine residues, two located in its amino-terminal peptide of Mr 44,000, and four located in the carboxyl-terminal peptide of Mr 51,000."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9276688",
                    "endSection": "abstract",
                    "offsetInBeginSection": 420,
                    "offsetInEndSection": 582,
                    "text": "Precise RNA cleavage site mapping in this divergent Old World virus, LRV2-1, confirms that cleavage is occurring within a region of homology to the LRV1 isolates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 517,
                    "offsetInEndSection": 759,
                    "text": "Centromere cleavage patterns are compatible with a precisely positioned core structure, one in which each of the 16 yeast centromeres is occupied by oppositely oriented Cse4/H4/H2A/H2B hemisomes in two rotational phases within the population."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25352141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 246,
                    "offsetInEndSection": 493,
                    "text": "Lead cleavage of the RNA in partially or fully assembled RNPs in the absence or presence of the interacting RNA can determine both the accessibility of the base pairing sequence within the RNP itself as well as its interaction with the target RNA."
                }
            ]
        },
        {
            "body": "Which human gene encode for DNA polymerase \u03b8?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                "http://www.ncbi.nlm.nih.gov/pubmed/29079701",
                "http://www.ncbi.nlm.nih.gov/pubmed/25642963",
                "http://www.ncbi.nlm.nih.gov/pubmed/28695890",
                "http://www.ncbi.nlm.nih.gov/pubmed/26514729",
                "http://www.ncbi.nlm.nih.gov/pubmed/10215605",
                "http://www.ncbi.nlm.nih.gov/pubmed/28570559",
                "http://www.ncbi.nlm.nih.gov/pubmed/10978529",
                "http://www.ncbi.nlm.nih.gov/pubmed/27264557"
            ],
            "id": "5aacd487fcf4565872000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "DNA polymerase theta (pol \u03b8) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "The gene encoding DNA polymerase \u03b8 (Pol\u03b8) was discovered over ten years ago as having a role in suppressing genome instability in mammalian cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 885,
                    "offsetInEndSection": 1152,
                    "text": "However, challenges for expression and purification are presented by the large size of pol \u03b8 (2590 residues in humans) and unusual juxtaposition of domains (a helicase-like domain and distinct DNA polymerase, separated by a region predicted to be largely disordered)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Expression and Structural Analyses of Human DNA Polymerase \u03b8 (POLQ)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 677,
                    "offsetInEndSection": 914,
                    "text": "Intriguingly, the POLQ gene also encodes for a conserved superfamily 2 Hel308-type ATP-dependent helicase domain which likely assists in alt-EJ and was reported to suppress homologous recombination (HR) via its anti-recombinase activity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "DNA Polymerase \u03b8: A Unique Multifunctional End-Joining Machine."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29079701",
                    "endSection": "abstract",
                    "offsetInBeginSection": 819,
                    "offsetInEndSection": 1091,
                    "text": "Surprisingly, mutagenic repair by polymerase theta (Pol \u03b8, encoded by the Polq gene) is most prevalent for blunt double-strand breaks (DSBs), while cNHEJ dictates mutagenic repair of DSBs with protruding ends, in which the cNHEJ polymerases lambda and mu play minor roles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25642963",
                    "endSection": "abstract",
                    "offsetInBeginSection": 338,
                    "offsetInEndSection": 582,
                    "text": "Previous studies have implicated the DNA polymerase \u03b8 (Pol\u03b8 also known as POLQ, encoded by POLQ) in a pathway required for the repair of DNA double-strand breaks, referred to as the error-prone microhomology-mediated end-joining (MMEJ) pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 245,
                    "text": "Pol \u03b8 is the defining enzyme for a pathway of DSB repair termed \"alternative end-joining\" (altEJ) or \"theta-mediated end-joining.\""
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28695890",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 633,
                    "text": "Here we show that DNA polymerase \u03b8, despite its minor role in chromosomal DNA repair, substantially contributes to random integration, and that cells lacking both DNA polymerase \u03b8 and DNA ligase IV, which is essential for non-homologous end joining (NHEJ), exhibit 100% efficiency of spontaneous gene targeting by virtue of undetectable levels of random integration."
                }
            ]
        },
        {
            "body": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                "http://www.ncbi.nlm.nih.gov/pubmed/10704448",
                "http://www.ncbi.nlm.nih.gov/pubmed/9149080",
                "http://www.ncbi.nlm.nih.gov/pubmed/7516752",
                "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                "http://www.ncbi.nlm.nih.gov/pubmed/8213828",
                "http://www.ncbi.nlm.nih.gov/pubmed/26449883",
                "http://www.ncbi.nlm.nih.gov/pubmed/28566768",
                "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                "http://www.ncbi.nlm.nih.gov/pubmed/27279388"
            ],
            "id": "5ac0a82d19833b0d7b000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 278,
                    "text": "BACKGROUND\nExon skipping oligonucleotides (ESOs) of 2'O-Methyl (2'OMe) and morpholino chemistry have been shown to restore dystrophin expression in muscle fibers from the mdx mouse, and are currently being tested in phase I clinical trials for Duchenne Muscular Dystrophy (DMD)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "abstract",
                    "offsetInBeginSection": 955,
                    "offsetInEndSection": 1313,
                    "text": "Three weekly intramuscular injections of 5 microg of ESO complexed with PEI2K-PEG550 copolymers resulted in about 500 dystrophin-positive fibers and about 12% of normal levels of dystrophin expression at 3 weeks after the initial injection, which is significantly greater than for injections of ESO alone, which are known to be almost completely ineffective."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "abstract",
                    "offsetInBeginSection": 565,
                    "offsetInEndSection": 741,
                    "text": "RESULTS\nWe examined whether PEG-PEI copolymers can facilitate ESO-mediated dystrophin expression after intramuscular injections into tibialis anterior (TA) muscles of mdx mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10704448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 336,
                    "text": "Obviation of such a blockage is seen in the mdx mouse, where despite a nonsense mutation in exon 23 of the dystrophin gene, occasional so-called revertant muscle fibers are seen to contain near-normal levels of its protein product."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9149080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 249,
                    "text": "The mdx mouse, an animal model used to study Duchenne muscular dystrophy, has a nonsense mutation in exon 23 of the dystrophin gene which should result in a truncated protein that cannot be correctly localized at the sarcolemma of the muscle fibers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7516752",
                    "endSection": "abstract",
                    "offsetInBeginSection": 558,
                    "offsetInEndSection": 722,
                    "text": "In DMD, a very small percentage of muscle fibers show dystrophin staining along the sarcolemma, presumably due to a second in-frame deletion in the dystrophin gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1535,
                    "offsetInEndSection": 1762,
                    "text": "Surprisingly, using the same injection and dosing regimen, we found no significant difference in dystrophin expression by Western blot between the NG-PEI2K-PEG550, CG-PEI2K-PEG5K, and non-functionalized PEI2K-PEG550 copolymers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                    "endSection": "abstract",
                    "offsetInBeginSection": 730,
                    "offsetInEndSection": 848,
                    "text": "administration of the PPMO restored the dystrophin expression in nearly 100% skeletal muscle fibers in all age groups."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1918,
                    "offsetInEndSection": 2124,
                    "text": "Further improvements in dystrophin expression up to 20% of normal levels were found at 6 weeks after 10 twice-weekly injections of the NG-PEI2K-PEG550 copolymer complexed with 5 microg of ESO per injection."
                }
            ]
        },
        {
            "body": "Which miRNA is associated with the circular RNA ciRS-7?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                "http://www.ncbi.nlm.nih.gov/pubmed/28174233",
                "http://www.ncbi.nlm.nih.gov/pubmed/27614453",
                "http://www.ncbi.nlm.nih.gov/pubmed/28296235",
                "http://www.ncbi.nlm.nih.gov/pubmed/26211738",
                "http://www.ncbi.nlm.nih.gov/pubmed/27929395",
                "http://www.ncbi.nlm.nih.gov/pubmed/27796758",
                "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                "http://www.ncbi.nlm.nih.gov/pubmed/26649774"
            ],
            "id": "5ac725250340b9f058000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 484,
                    "text": "Particularly, the recently identified circular RNA, ciRS-7, which acts as a designated miR-7 inhibitor/sponge, has conceptually changed the mechanistic understanding of miRNA networks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 299,
                    "text": "The identification of competing endogenous RNA and circular RNA (circRNA) as important regulators of miRNA activity underscores the increasing complexity of ncRNA-mediated regulatory networks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 852,
                    "text": "Here, we review the current knowledge about the ciRS-7/miR-7 axis in cancer-related pathways and discuss possible models explaining the relevance of coexpressing miR-7 along with a circRNA inhibitor."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 33,
                    "text": "Circular RNA and miR-7 in cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "The emerging landscape of circular RNA ciRS-7 in cancer (Review)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 485,
                    "offsetInEndSection": 652,
                    "text": "As miR-7 modulates the expression of several oncogenes, disclosing the regulation of miR-7 activity will likely advance the understanding of various cancer etiologies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "MicroRNAs (miRNA) play important roles in fine-tuning gene expression and are often deregulated in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28174233",
                    "endSection": "abstract",
                    "offsetInBeginSection": 77,
                    "offsetInEndSection": 161,
                    "text": "Recently, a novel circular RNA, ciRS-7, was proposed to be a potential miR-7 sponge."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27614453",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28296235",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "The circular RNA ciRS-7 promotes APP and BACE1 degradation in an NF-\u03baB-dependent manner."
                }
            ]
        },
        {
            "body": "Which are the two main bacterial phyla in human gut?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25873372",
                "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                "http://www.ncbi.nlm.nih.gov/pubmed/27900395",
                "http://www.ncbi.nlm.nih.gov/pubmed/26061054",
                "http://www.ncbi.nlm.nih.gov/pubmed/21829462",
                "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                "http://www.ncbi.nlm.nih.gov/pubmed/22025614",
                "http://www.ncbi.nlm.nih.gov/pubmed/28967204",
                "http://www.ncbi.nlm.nih.gov/pubmed/18338233",
                "http://www.ncbi.nlm.nih.gov/pubmed/22205877"
            ],
            "id": "5abd2ce0fcf456587200002a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873372",
                    "endSection": "abstract",
                    "offsetInBeginSection": 961,
                    "offsetInEndSection": 1208,
                    "text": "Analyses of sequenced bacterial genomes revealed that the cut cluster is present in many human gut bacteria, is predictive of choline utilization in sequenced isolates, and is widely but discontinuously distributed across multiple bacterial phyla."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1517,
                    "offsetInEndSection": 1764,
                    "text": "This simplified model of the human gut microbiota illustrates niche specialization and functional redundancy within members of its major bacterial phyla, and the importance of host glycans as a nutrient foundation that ensures ecosystem stability."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27900395",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 304,
                    "text": "Out of thousands of bacterial species-level phylotypes inhabiting the human gut, the majority belong to two dominant phyla, the Bacteroidetes and Firmicutes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "The adult human distal gut microbial community is typically dominated by 2 bacterial phyla (divisions), the Firmicutes and the Bacteroidetes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26061054",
                    "endSection": "abstract",
                    "offsetInBeginSection": 237,
                    "offsetInEndSection": 393,
                    "text": "Recent evidence suggests that obesity is influenced by specific bacterial phyla present in the human gut that have increased energy harvesting capabilities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21829462",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 267,
                    "text": "The human gut microbiota is considered one of the most fascinating reservoirs of microbial diversity hosting between 400 to 1000 bacterial species distributed among nine phyla with Firmicutes, Bacteroidetes and Actinobacteria representing around 75% of the diversity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                    "endSection": "abstract",
                    "offsetInBeginSection": 334,
                    "offsetInEndSection": 577,
                    "text": "Here we reconstructed GEMs for three key species, (Bacteroides thetaiotamicron, Eubacterium rectale and Methanobrevibacter smithii) as relevant representatives of three main phyla in the human gut (Bacteroidetes, Firmicutes and Euryarchaeota)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22025614",
                    "endSection": "abstract",
                    "offsetInBeginSection": 801,
                    "offsetInEndSection": 1093,
                    "text": "The alternative spermidine biosynthetic pathway is present in many bacterial phyla and is the dominant spermidine route in the human gut, stomach, and oral microbiomes, and it appears to have supplanted the S-adenosylmethionine decarboxylase/spermidine synthase pathway in the gut microbiota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 656,
                    "offsetInEndSection": 947,
                    "text": "Germ-free mice were then colonized with E. rectale and/or a prominent human gut Bacteroidetes, Bacteroides thetaiotaomicron, followed by whole-genome transcriptional profiling, high-resolution proteomic analysis, and biochemical assays of microbial-microbial and microbial-host interactions."
                }
            ]
        },
        {
            "body": "What are 7 symptoms of yellow fever?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                "http://www.ncbi.nlm.nih.gov/pubmed/19869938",
                "http://www.ncbi.nlm.nih.gov/pubmed/18261201",
                "http://www.ncbi.nlm.nih.gov/pubmed/6268925",
                "http://www.ncbi.nlm.nih.gov/pubmed/28810279",
                "http://www.ncbi.nlm.nih.gov/pubmed/12437192",
                "http://www.ncbi.nlm.nih.gov/pubmed/19870044",
                "http://www.ncbi.nlm.nih.gov/pubmed/11463409",
                "http://www.ncbi.nlm.nih.gov/pubmed/20150888",
                "http://www.ncbi.nlm.nih.gov/pubmed/17253051"
            ],
            "id": "5aac5469fcf4565872000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 220,
                    "offsetInEndSection": 730,
                    "text": "Of 74 guinea pigs inoculated with specimens of blood from 27 cases of yellow fever, 8, representing 6 cases, came down with the symptoms; namely, a marked rise of temperature after a period of incubation averaging 3 to 6 days, with simultaneous suffusion of the capillaries, particularly of the conjunctivaes and soles, then preliminary hyperleucocytosis followed by progressive leucopenia, the early appearance of albumin and casts in the urine, which gradually diminishes in volume as the disease progresses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19869938",
                    "endSection": "abstract",
                    "offsetInBeginSection": 895,
                    "offsetInEndSection": 1083,
                    "text": "If the brain was mildly injured at the time of the intraperitoneal injection, the symptoms of yellow fever encephalitis appeared 6 days later, but the virus was then absent from the blood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "By injecting into guinea pigs the blood of yellow fever cases occurring in Guayaquil a group of symptoms and lesions closely resembling those observed in human yellow fever were induced in a limited number of instances."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1964,
                    "offsetInEndSection": 2124,
                    "text": "The leptospira transmitted from yellow fever cases to guinea pigs was found to induce similar symptoms and lesions upon further passage into normal guinea pigs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19869938",
                    "endSection": "abstract",
                    "offsetInBeginSection": 711,
                    "offsetInEndSection": 894,
                    "text": "When mice were given large intraperitoneal injections of yellow fever virus fixed for mice, the virus could be recovered from the blood for 4 days although encephalitis did not occur."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18261201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1575,
                    "offsetInEndSection": 1905,
                    "text": "Blood specimens were collected from all suspected cases (within 14 days of onset of symptoms) and tested at a central laboratory for yellow fever IgM antibodies; leading to confirmation of yellow fever outbreaks in the health districts of Bafia, M\u00e9ri and Ntui in 2003, Ngaound\u00e9r\u00e9 Rural in 2004, Yoko in 2005 and Messamena in 2006."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1699,
                    "offsetInEndSection": 1963,
                    "text": "In the blood, liver, and kidneys of the guinea pigs experimentally infected with the blood of yellow fever patients a minute organism was demonstrated which closely resembles in morphology the causative agent of infectious jaundice (Leptospira icterohamorrhagiae)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 30,
                    "text": "ETIOLOGY OF YELLOW FEVER : II."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2125,
                    "offsetInEndSection": 2238,
                    "text": "The leptospira obtained from cases of yellow fever has been givern the provisional name of Leptospira icteroides."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18261201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "BACKGROUND\nCameroon is one of 12 African countries that bear most of the global burden of yellow fever."
                }
            ]
        },
        {
            "body": "Which test is used for the definition of colour-blindness?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                "http://www.ncbi.nlm.nih.gov/pubmed/306798",
                "http://www.ncbi.nlm.nih.gov/pubmed/1495767",
                "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                "http://www.ncbi.nlm.nih.gov/pubmed/4049749",
                "http://www.ncbi.nlm.nih.gov/pubmed/16431664",
                "http://www.ncbi.nlm.nih.gov/pubmed/9893853",
                "http://www.ncbi.nlm.nih.gov/pubmed/310055",
                "http://www.ncbi.nlm.nih.gov/pubmed/19493108",
                "http://www.ncbi.nlm.nih.gov/pubmed/11125268"
            ],
            "id": "5ad6e431133db5eb7800000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "title",
                    "offsetInBeginSection": 25,
                    "offsetInEndSection": 84,
                    "text": "Behavioural evidence for colour-blindness in harbour seals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1294,
                    "offsetInEndSection": 1382,
                    "text": "However, the seal responded with \"same\", providing strong evidence for colour-blindness."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 965,
                    "offsetInEndSection": 1096,
                    "text": "To test for colour-blindness, we used a cognitive approach involving a harbour seal trained to use a concept of same and different."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/306798",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "The incidence of colour-blindness among the tribal populations of Andhra Pradesh."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1495767",
                    "endSection": "abstract",
                    "offsetInBeginSection": 547,
                    "offsetInEndSection": 663,
                    "text": "In his first pedigree Horner demonstrates that colour-blindness is transmitted from the grandfather to the grandson."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                    "endSection": "abstract",
                    "offsetInBeginSection": 748,
                    "offsetInEndSection": 1082,
                    "text": "The association of colour-blindness with higher socio-economic status is expected given the history of European conquest in the New World, and suggests that the major cause of varying rates of the defect in Latin American populations is socio-economic heterogeneity and by inference different degrees of European-Amerindian admixture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/306798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 471,
                    "offsetInEndSection": 593,
                    "text": "Post's (1962) hypothesis of relaxation of selection against colour-blindness is also supported by our Andhra Pradesh data."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/306798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 181,
                    "offsetInEndSection": 223,
                    "text": "Samanta males exhibit no colour-blindness."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 29,
                    "text": "Colour-blindness in Colombia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/306798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 180,
                    "text": "Among 126 Valmiki, 128 Bagatha, 129 Konda Dora and 73 Samanta tribals of Andhra Pradesh, the incidence of red-green colour-blindness in the males ranges from zero to 2.27 per cent."
                }
            ]
        },
        {
            "body": "Of what origin is the MCF-7 cell line?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                "http://www.ncbi.nlm.nih.gov/pubmed/849449",
                "http://www.ncbi.nlm.nih.gov/pubmed/10961387",
                "http://www.ncbi.nlm.nih.gov/pubmed/176383",
                "http://www.ncbi.nlm.nih.gov/pubmed/25321415",
                "http://www.ncbi.nlm.nih.gov/pubmed/7604203",
                "http://www.ncbi.nlm.nih.gov/pubmed/26422101",
                "http://www.ncbi.nlm.nih.gov/pubmed/1638514",
                "http://www.ncbi.nlm.nih.gov/pubmed/15183541",
                "http://www.ncbi.nlm.nih.gov/pubmed/2432833"
            ],
            "id": "5ac08fe7d0c506ce46000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 838,
                    "text": "Since the MCF-7/ADR' cell line was definitely derived from parental MCF-7 cells, we were able to directly compare these cell lines together with MCF-7/ADR using immunocytochemical, morphological, and consecutive DNA fingerprinting analyses to determine the true origin of MCF-7/ADR."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1277,
                    "offsetInEndSection": 1352,
                    "text": "MCF-7/ADR and the breast cancer cell line MCF-7 are not of the same origin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 108,
                    "offsetInEndSection": 221,
                    "text": "The origin of MCF-7/ADR has been a matter of debate since MCF-7/ADR cells were re-designated NCI/ADR-RES in 1998."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 390,
                    "text": "Thus, the real origin of MCF-7/ADR cells remains more unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 222,
                    "offsetInEndSection": 327,
                    "text": "Many recent studies still describe MCF-7/ADR cells as originating from the breast cancer cell line MCF-7."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 391,
                    "offsetInEndSection": 555,
                    "text": "In this study, a new adriamycin (ADR)-resistant cell line MCF-7/ADR' was reproduced using the same procedure employed during the initial establishment of MCF-7/ADR."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/849449",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "In a mammary gland cell line (MCF-7) of human origin, insulin stimulated the rates of RNA, DNA and protein biosynthesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10961387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 452,
                    "text": "Genistein, a prominent isoflavone in soy products, produced dose- and time-dependent in vitro growth inhibition at high concentrations (at least 185 microM) with an IC50 of 7.0-274.2 microM after 72 h incubation in four breast cancer cell lines (DD-762, Sm-MT, MCF-7 and MDA-MB-231) and one breast epithelial cell line (HBL- 100) of human and animal origin; it stimulated estrogen-receptor-positive MCF-7 cells at low concentrations (3.7 nM-37 microM)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1189,
                    "offsetInEndSection": 1276,
                    "text": "However, the DNA fingerprints of MCF-7/ADR cells did not relate to MCF-7 or MCF-7/ADR'."
                }
            ]
        },
        {
            "body": "Is lumican a secreted protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                "http://www.ncbi.nlm.nih.gov/pubmed/23480731",
                "http://www.ncbi.nlm.nih.gov/pubmed/18083934",
                "http://www.ncbi.nlm.nih.gov/pubmed/15966909",
                "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                "http://www.ncbi.nlm.nih.gov/pubmed/21421073",
                "http://www.ncbi.nlm.nih.gov/pubmed/12128073",
                "http://www.ncbi.nlm.nih.gov/pubmed/10517185",
                "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                "http://www.ncbi.nlm.nih.gov/pubmed/12381269"
            ],
            "id": "5ad255210340b9f058000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 374,
                    "offsetInEndSection": 449,
                    "text": "Lumican is a secreted proteoglycan that regulates collagen fibril assembly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1531,
                    "offsetInEndSection": 1790,
                    "text": "CONCLUSIONS\nOur results demonstrate that activated pancreatic stellate cells within PDAC secrete lumican under the negative control of TGF-\u03b2; once secreted, the extracellular lumican enhances stellate cell adhesion and mobility in a collagen-rich environment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23480731",
                    "endSection": "abstract",
                    "offsetInBeginSection": 969,
                    "offsetInEndSection": 1130,
                    "text": "In\u00a0vitro, mechanical stretch and the proinflammatory cytokine interleukin-1\u03b2 increased lumican mRNA as well as secreted lumican protein from cardiac fibroblasts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1372,
                    "offsetInEndSection": 1528,
                    "text": "In addition, we found that the ability of HPSCs to produce and secrete extracellular lumican significantly enhances HPSCs adhesion and mobility on collagen."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18083934",
                    "endSection": "abstract",
                    "offsetInBeginSection": 526,
                    "offsetInEndSection": 703,
                    "text": "were included, collagen alpha2 (I), matrix extracellular phosphoglycoprotein, secreted phosphoprotein 24, chondroadherin, lumican, perlecan, thrombospondin 1, nucleobindin, etc."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 798,
                    "offsetInEndSection": 1028,
                    "text": "In vitro studies examined the molecular mechanisms of lumican transcription and secretion from PSCs (HPSCs and HPaSteC), and cell adhesion and migration assays examined the effect of lumican on PSCs in a collagen-rich environment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15966909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "BACKGROUND\nSmall leucine-rich proteoglycans (SLRPs) decorin, biglycan, fibromodulin and lumican are secreted extracellular matrix molecules that associate with fibrillar collagens and regulate collagen fibrillogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1031,
                    "offsetInEndSection": 1155,
                    "text": "RESULTS\nHere we identify PSCs as a significant source of extracellular lumican production through quantitative IHC analysis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Transforming Growth Factor-\u03b2 Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1156,
                    "offsetInEndSection": 1371,
                    "text": "We demonstrate that the cytokine, TGF-\u03b2, negatively regulates lumican gene transcription within HPSCs through its canonical signaling pathway and binding of SMAD4 to novel SBEs identified within the promoter region."
                }
            ]
        },
        {
            "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                "http://www.ncbi.nlm.nih.gov/pubmed/26910068",
                "http://www.ncbi.nlm.nih.gov/pubmed/12051692",
                "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                "http://www.ncbi.nlm.nih.gov/pubmed/11336977",
                "http://www.ncbi.nlm.nih.gov/pubmed/23975654",
                "http://www.ncbi.nlm.nih.gov/pubmed/27490210",
                "http://www.ncbi.nlm.nih.gov/pubmed/19371336",
                "http://www.ncbi.nlm.nih.gov/pubmed/9667078",
                "http://www.ncbi.nlm.nih.gov/pubmed/16308281"
            ],
            "id": "5ab2cc66fcf4565872000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 224,
                    "text": "Induction of the cytochrome P450 (CYP) family of enzymes by coadministered compounds can result in drug-drug interactions, as in the case of the coadministration of rifampicin with many CYP3A substrates, including midazolam."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26910068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 660,
                    "text": "In this investigation, we tested the hypothesis that induction of cytochrome P450 (Cyp)3a11 gene by paclitaxel is downregulated by the inflammatory mediator, lipopolysaccharide (LPS), and that the pro-inflammatory cytokine, tumor necrosis factor (TNF)-\u03b1, attenuates human CYP3A4 gene induction by rifampicin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 804,
                    "offsetInEndSection": 993,
                    "text": "The E(max) and EC(50) values in two separate lots of hepatocytes for CYP3A induction by rifampicin in a 96-well format were similar when discrete probe was compared with the probe cocktail."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26910068",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Application of a substrate cocktail approach in the assessment of cytochrome P450 induction using cultured human hepatocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 332,
                    "offsetInEndSection": 487,
                    "text": "We present a substrate cocktail method that was applied to assess the induction of CYP1A, CYP2B6, CYP2C9, and CYP3A using a 96-well high-throughput format."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12051692",
                    "endSection": "abstract",
                    "offsetInBeginSection": 394,
                    "offsetInEndSection": 513,
                    "text": "Phenobarbital induced CYP2B and rifampicin induced CYP3A, respectively, in addition to NADPH-cytochrome P450 reductase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 994,
                    "offsetInEndSection": 1092,
                    "text": "This system has been demonstrated to be suitable for high-throughput assessments of CYP induction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 225,
                    "offsetInEndSection": 331,
                    "text": "Identification of potential drug-drug interactions due to CYP induction during drug discovery is critical."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12051692",
                    "endSection": "abstract",
                    "offsetInBeginSection": 251,
                    "offsetInEndSection": 393,
                    "text": "Phenytoin induced activity in NADPH-cytochrome P450 reductase, CYP3A, CYP2B, and CYP2C that was 3 to 4 times higher than that of the controls."
                }
            ]
        },
        {
            "body": "Which human chromosome is the product of fusion?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                "http://www.ncbi.nlm.nih.gov/pubmed/28333343",
                "http://www.ncbi.nlm.nih.gov/pubmed/28259884",
                "http://www.ncbi.nlm.nih.gov/pubmed/11435402",
                "http://www.ncbi.nlm.nih.gov/pubmed/10637483",
                "http://www.ncbi.nlm.nih.gov/pubmed/227123",
                "http://www.ncbi.nlm.nih.gov/pubmed/1668321",
                "http://www.ncbi.nlm.nih.gov/pubmed/19332641"
            ],
            "id": "5ace238e0340b9f05800000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Human chromosome 2 is unique to the human lineage in being the product of a head-to-head fusion of two intermediate-sized ancestral chromosomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                    "endSection": "abstract",
                    "offsetInBeginSection": 372,
                    "offsetInEndSection": 592,
                    "text": "The results also demonstrate that the product of the activated met gene is a fusion protein and that the amino terminal end of this fusion protein, which is encoded by human chromosome 1, exhibits homology to laminin B1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28333343",
                    "endSection": "abstract",
                    "offsetInBeginSection": 632,
                    "offsetInEndSection": 961,
                    "text": "We investigate the most recent product of a chromosome fusion event fixed in the human lineage, human chromosome 2, whose stability was acquired by the suppression of one centromere, resulting in a unique difference in chromosome number between humans (46 chromosomes) and our most closely related ape relatives (48 chromosomes)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 842,
                    "offsetInEndSection": 1239,
                    "text": "By doing so, one is able to provide evidence for the presence of both active and degenerate centromeric satellite profiles on chromosome 2 in these archaic genomes, supporting the hypothesis that the chromosomal fusion event took place prior to our last common ancestor with Denisovan and Neandertal hominins and presenting a genomic reference for predicting karyotype in ancient genomic datasets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 339,
                    "offsetInEndSection": 705,
                    "text": "Unlike the site of fusion, which is enriched for sequences that are shared elsewhere in the human genome, the region of the nonfunctioning and degenerate ancestral centromere appears to share limited similarity with other sites in the human genome, thereby providing an opportunity to study this genomic arrangement in short, fragmented ancient DNA genomic datasets."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Chromosome-Specific Centromere Sequences Provide an Estimate of the Ancestral Chromosome 2 Fusion Event in Hominin Genomes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28259884",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "The Dicentric Chromosome dic(20;22) Is a Recurrent Abnormality in Myelodysplastic Syndromes and Is a Product of Telomere Fusion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                    "endSection": "abstract",
                    "offsetInBeginSection": 178,
                    "offsetInEndSection": 371,
                    "text": "These analyses reveal that the met kinase domain (located on human chromosome 7) possesses unique features that distinguish met from other members of the src family of protein tyrosine kinases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 144,
                    "offsetInEndSection": 338,
                    "text": "Genomic signatures of this event are limited to inverted telomeric repeats at the precise site of chromosomal fusion and to the small amount of relic centromeric sequences that remain on 2q21.2."
                }
            ]
        },
        {
            "body": "Where is the EpCam protein mainly located?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25469266",
                "http://www.ncbi.nlm.nih.gov/pubmed/22388758",
                "http://www.ncbi.nlm.nih.gov/pubmed/28360395",
                "http://www.ncbi.nlm.nih.gov/pubmed/20728540",
                "http://www.ncbi.nlm.nih.gov/pubmed/20046825",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                "http://www.ncbi.nlm.nih.gov/pubmed/26356670",
                "http://www.ncbi.nlm.nih.gov/pubmed/29245156",
                "http://www.ncbi.nlm.nih.gov/pubmed/23403823",
                "http://www.ncbi.nlm.nih.gov/pubmed/15102668"
            ],
            "id": "5ac09a7b19833b0d7b000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25469266",
                    "endSection": "abstract",
                    "offsetInBeginSection": 505,
                    "offsetInEndSection": 684,
                    "text": "We utilized immunohistochemical staining to confirm that the EpCAM protein is expressed in a subset of angiosarcomas and leiomyosarcomas and in all the investigated osteosarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25469266",
                    "endSection": "abstract",
                    "offsetInBeginSection": 685,
                    "offsetInEndSection": 890,
                    "text": "Finally, we conducted a statistical analysis of clinical data to demonstrate that EpCAM protein expression is significantly and directly correlated with the degree of cytological atypia in leiomyosarcomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22388758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 559,
                    "offsetInEndSection": 912,
                    "text": "To test this hypothesis and to evaluate whether lack of EPCAM expression can already be detected in Lynch syndrome-associated adenomas, we analyzed four carcinomas and two adenomas from EPCAM germline deletion carriers for EPCAM protein expression and allelic deletion status of the EPCAM gene region by multiplex ligation-dependent probe amplification."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22388758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1335,
                    "offsetInEndSection": 1524,
                    "text": "Moreover, we report lack of EPCAM protein expression in a colorectal adenoma, suggesting that EPCAM immunohistochemistry may detect EPCAM germline deletions already at a precancerous stage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22388758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1037,
                    "offsetInEndSection": 1170,
                    "text": "In contrast, monoallelic retention of the EPCAM gene was observed in the remaining two tumors with retained EPCAM protein expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28360395",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1184,
                    "offsetInEndSection": 1328,
                    "text": "Evaluating EpCAM protein overexpression in a portion of samples depicted the fully concordance rate between Western blot and RT-qPCR techniques."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20728540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 710,
                    "offsetInEndSection": 913,
                    "text": "Protein sequence analysis revealed a transmembrane domain and two epidermal growth factor (EGF)-like repeats in the extracellular region of gcEpCAM which were both conserved in EpCAM from fish to mammal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25469266",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "Epithelial cell adhesion molecule (EpCAM) is a protein involved in cell-to-cell attachment and is considered to be strictly expressed in epithelial tissues and epithelial-derived tumors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20046825",
                    "endSection": "abstract",
                    "offsetInBeginSection": 625,
                    "offsetInEndSection": 763,
                    "text": "Gene trapping resulted in a protein comprised of the N-terminus of EpCAM encoded by 2 exons of the tacstd1 gene fused in frame to betageo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25469266",
                    "endSection": "abstract",
                    "offsetInBeginSection": 280,
                    "offsetInEndSection": 504,
                    "text": "In this study, we performed a genomic meta-analysis of gene expression profiles housed in the Cancer Cell Line Encyclopedia to demonstrate that EpCAM mRNA is expressed at low to moderate levels in certain sarcoma cell lines."
                }
            ]
        },
        {
            "body": "What is the drug target for Eliquis (Apixaban)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26095540",
                "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                "http://www.ncbi.nlm.nih.gov/pubmed/25682082",
                "http://www.ncbi.nlm.nih.gov/pubmed/25485923",
                "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                "http://www.ncbi.nlm.nih.gov/pubmed/27984753",
                "http://www.ncbi.nlm.nih.gov/pubmed/26369819",
                "http://www.ncbi.nlm.nih.gov/pubmed/26731855"
            ],
            "id": "5abbe429fcf456587200001c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26095540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 482,
                    "text": "They include the oral direct thrombin inhibitor dabigatran etexilate (Pradaxa, Boehringer Ingelheim) and the oral direct FXa inhibitors rivaroxaban (Xarelto, Bayer HealthCare), apixaban (Eliquis, Bristol-Myers Squibb), and edoxaban (Lixiana/Savaysa, Daiichi-Sankyo)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 692,
                    "offsetInEndSection": 814,
                    "text": "The drugs were dabigatran etexilate mesylate (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 332,
                    "text": "The new direct oral anticoagulants directly targeting thrombin (factor IIa) or factor-Xa, are currently used for the treatment of deep venous thrombosis and pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic embolism in non-valvular atrial fibrillation (rivaroxaban; dabigatran, Pradaxa; Apixaban, Eliquis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 458,
                    "text": "The new oral anticoagulants (NOAC) include dabigatran etexilate (Pradaxa\u00ae), a direct thrombin inhibitor, and rivaroxaban (Xarelto\u00ae), Apixaban (Eliquis) and Edoxaban (Lixiana\u00ae), which are direct anti-Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                    "endSection": "abstract",
                    "offsetInBeginSection": 772,
                    "offsetInEndSection": 952,
                    "text": "These agents have been approved for several therapeutic indications based on phase III prospective randomised controlled clinical trials using warfarin at a target INR of 2.5 (i.e."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26095540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "In recent years, several direct-acting oral anticoagulants (DOAC) have become available for use in Europe and other regions in indications related to prophylaxis and treatment of venous and arterial thromboembolism."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25682082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 152,
                    "offsetInEndSection": 407,
                    "text": "These are small molecules, designed to directly inhibit specific steps in the coagulation pathway, with dabigatran (Pradaxa), inhibiting thrombin and rivaroxaban (Xarelto), apixiban (Eliquis), edoxaban (Lixiana), and betrixaban being factor Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 815,
                    "offsetInEndSection": 1021,
                    "text": "Management of patients on DOACs in the perioperative period involves an assessment of thromboembolic event risk while off anticoagulation compared to the relative risk of bleeding if such drug is continued."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25485923",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 326,
                    "text": "The direct thrombin inhibitor dabigatran and factor Xa inhibitors rivaroxaban and apixaban are US Food and Drug Administration (FDA)-approved target-specific oral anticoagulants (TSOACs) that have emerged onto the market for use in some indications similar to those for warfarin; in addition, edoxaban is seeking FDA approval."
                }
            ]
        },
        {
            "body": "What in vivo tau tracers are being used?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28314821",
                "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                "http://www.ncbi.nlm.nih.gov/pubmed/28587897",
                "http://www.ncbi.nlm.nih.gov/pubmed/28315409",
                "http://www.ncbi.nlm.nih.gov/pubmed/27683159",
                "http://www.ncbi.nlm.nih.gov/pubmed/27856627",
                "http://www.ncbi.nlm.nih.gov/pubmed/20205671",
                "http://www.ncbi.nlm.nih.gov/pubmed/29375461",
                "http://www.ncbi.nlm.nih.gov/pubmed/27413148",
                "http://www.ncbi.nlm.nih.gov/pubmed/27030397"
            ],
            "id": "5a7d5580faa1ab7d2e00001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28314821",
                    "endSection": "abstract",
                    "offsetInBeginSection": 292,
                    "offsetInEndSection": 472,
                    "text": "With the recent advent of in vivo Tau-PET tracers it is now possible to extend investigations on fcMRI in a sample of cognitively normal elderly humans to regional measures of Tau."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 348,
                    "offsetInEndSection": 496,
                    "text": "Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28587897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 191,
                    "text": "The recent development of tau-specific positron emission tomography (PET) tracers enables in vivo quantification of regional tau pathology, one of the key lesions in Alzheimer's disease (AD)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28315409",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 127,
                    "text": "In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28587897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 682,
                    "offsetInEndSection": 948,
                    "text": "Methods for tau tracer quantification included: (i) in vivo Braak staging, (ii) regional uptake in Braak composite regions, (iii) several whole-brain measures of tracer uptake, (iv) regional uptake in AD-vulnerable voxels, and (v) uptake in a priori defined regions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27683159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 258,
                    "text": "BACKGROUND\nThe recent development of tau-specific positron emission tomography (PET) tracers has allowed in vivo quantification of regional tau deposition and offers the opportunity to monitor the progression of tau pathology along with cognitive impairment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27856627",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "This study compared the in vivo imaging characteristics of tau PET ligands 18F-THK-5351 and 18F-THK-5317 in the context of Alzheimer disease (AD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20205671",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 180,
                    "text": "BACKGROUND\nNew in vivo amyloid PET imaging tracers, such as (11)C-PIB, provide possibilities to deeper understand the underlying pathological processes in Alzheimer's disease (AD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 497,
                    "offsetInEndSection": 692,
                    "text": "For use of tau PET as a biomarker of tau pathology in Alzheimer's disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-\u03b2 and other protein deposits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28315409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 504,
                    "offsetInEndSection": 698,
                    "text": "Recently, it has become possible to assess the regional distribution and severity of tau burden in vivo with the development of novel radiotracers for positron emission tomography (PET) imaging."
                }
            ]
        },
        {
            "body": "What is the Formalin test used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17166125",
                "http://www.ncbi.nlm.nih.gov/pubmed/16860855",
                "http://www.ncbi.nlm.nih.gov/pubmed/15105218",
                "http://www.ncbi.nlm.nih.gov/pubmed/10700330",
                "http://www.ncbi.nlm.nih.gov/pubmed/18656400",
                "http://www.ncbi.nlm.nih.gov/pubmed/2537485",
                "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                "http://www.ncbi.nlm.nih.gov/pubmed/17312233",
                "http://www.ncbi.nlm.nih.gov/pubmed/18799335",
                "http://www.ncbi.nlm.nih.gov/pubmed/12101431"
            ],
            "id": "5abbfd97fcf456587200001d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "This study presents data of several reference drugs in rats and gerbils for both the second phase of the formalin test and the cold allodynia in animals with a constriction injury of the sciatic nerve."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1480,
                    "offsetInEndSection": 1725,
                    "text": "In the present acute test conditions, there is a correlation in the pharmacological activity in rats and gerbils for the tested compounds a correlation between the second phase of the formalin test and the cold allodynia in CCI animals is found."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16860855",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1325,
                    "offsetInEndSection": 1485,
                    "text": "This study demonstrates a good correlation between the second phase of the formalin test and the cold allodynia in the CCI model for, both for rats and gerbils."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125",
                    "endSection": "abstract",
                    "offsetInBeginSection": 296,
                    "offsetInEndSection": 461,
                    "text": "It was evaluated whether the second phase of the formalin test could be used as a pharmacological screening to predict outcome in the cold plate test in CCI animals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125",
                    "endSection": "abstract",
                    "offsetInBeginSection": 202,
                    "offsetInEndSection": 295,
                    "text": "A pharmacological validation of the formalin test and the CCI model in gerbils was performed."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Is the second phase of the formalin test useful to predict activity in chronic constriction injury models?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15105218",
                    "endSection": "abstract",
                    "offsetInBeginSection": 549,
                    "offsetInEndSection": 681,
                    "text": "Intrathecal gabapentin produced a suppression of the phase 2 flinching response, but not the phase 1 response, in the formalin test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10700330",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "The formalin test is a well-established model for assessing nociceptive processes and analgesic drug effects."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16860855",
                    "endSection": "abstract",
                    "offsetInBeginSection": 513,
                    "offsetInEndSection": 749,
                    "text": "In the present study the activity of different pharmacological reference compounds was tested in rats and gerbils on the cold plate for animals that had undergone chronic constriction injury and in the second phase of the formalin test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18656400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 684,
                    "offsetInEndSection": 943,
                    "text": "Local pretreatment with a selective 5-HT2A receptor antagonist, ketanserin, and selective 5-HT2C receptor antagonists, RS102221 and SB242084, inhibited the number of flinches in early part of phase 2 (phase 2A) of the formalin test in a dose-dependent manner."
                }
            ]
        },
        {
            "body": "What drug treatment can cause a spinal epidural hematoma?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23276337",
                "http://www.ncbi.nlm.nih.gov/pubmed/25230268",
                "http://www.ncbi.nlm.nih.gov/pubmed/11493875",
                "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                "http://www.ncbi.nlm.nih.gov/pubmed/19857440",
                "http://www.ncbi.nlm.nih.gov/pubmed/2797370",
                "http://www.ncbi.nlm.nih.gov/pubmed/28377250",
                "http://www.ncbi.nlm.nih.gov/pubmed/8568560",
                "http://www.ncbi.nlm.nih.gov/pubmed/24653587"
            ],
            "id": "5ab90a79fcf456587200001b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23276337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 129,
                    "offsetInEndSection": 292,
                    "text": "Making the diagnosis for spinal epidural hematoma and spinal epidural abscess can be challenging; however, a delay in recognition and treatment can be devastating."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25230268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 198,
                    "text": "OBJECTIVE\nThe aim of this study was to assess the clinical presentation, causes or risk factors, treatment and outcomes of symptomatic acute postoperative cervical spinal epidural hematoma (APCSEH)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11493875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "Spontaneous spinal epidural hematoma is a rare condition that usually requires surgical treatment in emergency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25230268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1296,
                    "offsetInEndSection": 1421,
                    "text": "CONCLUSION\nAcute postoperative cervical spinal epidural hematoma is a rare cause of postoperative neurological deterioration."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Drug interaction as cause of spontaneously resolving epidural spinal hematoma on warfarin therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 187,
                    "offsetInEndSection": 276,
                    "text": "SUMMARY OF BACKGROUND DATA\nThe treatment of spinal epidural hematoma is usually surgical."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23276337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Spinal epidural hematoma and spinal epidural abscess are rare surgical emergencies resulting in significant neurologic deficits."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23276337",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 75,
                    "text": "Medicolegal cases for spinal epidural hematoma and spinal epidural abscess."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23276337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1226,
                    "offsetInEndSection": 1515,
                    "text": "Physicians who are able to identify early clinical features, appropriately image, and treat within a 48 hour time frame have demonstrated a more favorable medicolegal outcome compared with their counterparts in filed lawsuits for spinal epidural hematoma and spinal epidural abscess cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19857440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Spinal epidural hematoma is a rare but potentially devastating complication of spinal manipulation therapy."
                }
            ]
        },
        {
            "body": "List diseases caused by protein glutamine expanded repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11448943",
                "http://www.ncbi.nlm.nih.gov/pubmed/19429504",
                "http://www.ncbi.nlm.nih.gov/pubmed/24497578",
                "http://www.ncbi.nlm.nih.gov/pubmed/18216249",
                "http://www.ncbi.nlm.nih.gov/pubmed/10502825",
                "http://www.ncbi.nlm.nih.gov/pubmed/25320121",
                "http://www.ncbi.nlm.nih.gov/pubmed/22021427",
                "http://www.ncbi.nlm.nih.gov/pubmed/9143016",
                "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                "http://www.ncbi.nlm.nih.gov/pubmed/10098399"
            ],
            "id": "5ac2776195d0062724000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11448943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 281,
                    "offsetInEndSection": 454,
                    "text": "Members of this latter group, also known as triplet repeat diseases, are caused by the expansion of unstable CAG repeats coding for glutamine within the respective proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19429504",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 184,
                    "text": "Huntington's Disease (HD) is a rare neurodegenerative disease caused by mutation of the huntingtin gene that results in a protein with an expanded stretch of glutamine repeats (polyQ)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24497578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "The expansion of homopolymeric glutamine (polyQ) or alanine (polyA) repeats in certain proteins owing to genetic mutations induces protein aggregation and toxicity, causing at least 18 human diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18216249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Polyglutamine diseases are inherited neurodegenerative disorders caused by expansion of CAG repeats encoding a glutamine tract in the disease-causing proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10502825",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Huntington disease (HD) is a genetically dominant condition caused by expanded CAG repeats coding for glutamine in the HD gene product huntingtin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25320121",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 189,
                    "text": "Polyglutamine diseases, including spinocerebellar ataxia type 3 (SCA3), are caused by CAG repeat expansions that encode abnormally long glutamine repeats in the respective disease proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22021427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "Homopolymeric amino acid repeat sequences in proteins are of particular interest due to the discovery that expanded copy numbers of these repeats are the molecular basis for a growing list of human genetic diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9143016",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 321,
                    "text": "The mutant gene is translated into protein whose electrophoretic mobility correlates to the number of expanded CAG trinucleotide repeats, indicating that the protein carries an expanded glutamine repeat."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Eight diseases are now known to be caused by an expansion mutation of the trinucleotide repeat CAG encoding glutamine."
                }
            ]
        },
        {
            "body": "What is the nucleotide composition of the Lamin Associated Domains (LADs)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                "http://www.ncbi.nlm.nih.gov/pubmed/26654219",
                "http://www.ncbi.nlm.nih.gov/pubmed/8216425",
                "http://www.ncbi.nlm.nih.gov/pubmed/28424353",
                "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                "http://www.ncbi.nlm.nih.gov/pubmed/2123469",
                "http://www.ncbi.nlm.nih.gov/pubmed/23934658",
                "http://www.ncbi.nlm.nih.gov/pubmed/15636422",
                "http://www.ncbi.nlm.nih.gov/pubmed/2719959",
                "http://www.ncbi.nlm.nih.gov/pubmed/10580070"
            ],
            "id": "5a86e6fafaa1ab7d2e000036",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 856,
                    "offsetInEndSection": 1006,
                    "text": "De novo formation of adipogenic lamin A/C LADs occurs nonrandomly on GADs, which consist of megabase-size intergenic and repressive chromatin domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 143,
                    "offsetInEndSection": 378,
                    "text": "Here, we provide evidence for prepatterning of differentiation-driven formation of lamin A/C LADs by domains of histone H2B modified on serine 112 by the nutrient sensor O-linked N-acetylglucosamine (H2BS112GlcNAc), which we term GADs."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1378,
                    "offsetInEndSection": 1586,
                    "text": "Our results unveil an epigenetic prepatterning of adipogenic LADs by GADs, suggesting a coupling of developmentally regulated lamin A/C-genome interactions to a metabolically sensitive chromatin modification."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1007,
                    "offsetInEndSection": 1159,
                    "text": "Accordingly, whereas predifferentiation lamin A/C LADs are gene-rich, post-differentiation LADs harbor repressive features reminiscent of lamin B1 LADs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 727,
                    "offsetInEndSection": 855,
                    "text": "Lamin A/C LADs are found both in active and repressive chromatin contexts that can be influenced by cell differentiation status."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Dynamic interactions of nuclear lamins with chromatin through lamin-associated domains (LADs) contribute to spatial arrangement of the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 379,
                    "offsetInEndSection": 726,
                    "text": "We demonstrate a two-step process of lamin A/C LAD formation during in vitro adipogenesis, involving spreading of lamin A/C-chromatin interactions in the transition from progenitor cell proliferation to cell-cycle arrest, and genome-scale redistribution of these interactions through a process of LAD exchange within hours of adipogenic induction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1160,
                    "offsetInEndSection": 1377,
                    "text": "Release of lamin A/C from genes directly involved in glycolysis concurs with their transcriptional up-regulation after adipogenic induction, and with downstream elevations in H2BS112GlcNAc levels and O-GlcNAc cycling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654219",
                    "endSection": "abstract",
                    "offsetInBeginSection": 250,
                    "offsetInEndSection": 424,
                    "text": "We reveal that the autophagy protein LC3/Atg8 directly interacts with the nuclear lamina protein LMNB1 (lamin B1), and binds to LMN/lamin-associated chromatin domains (LADs)."
                }
            ]
        },
        {
            "body": "What is the clathrin triskelia structure?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11460887",
                "http://www.ncbi.nlm.nih.gov/pubmed/11795487",
                "http://www.ncbi.nlm.nih.gov/pubmed/10630373",
                "http://www.ncbi.nlm.nih.gov/pubmed/2573598",
                "http://www.ncbi.nlm.nih.gov/pubmed/27410749",
                "http://www.ncbi.nlm.nih.gov/pubmed/8440257",
                "http://www.ncbi.nlm.nih.gov/pubmed/15858577",
                "http://www.ncbi.nlm.nih.gov/pubmed/1973169",
                "http://www.ncbi.nlm.nih.gov/pubmed/19925798",
                "http://www.ncbi.nlm.nih.gov/pubmed/10220410"
            ],
            "id": "5ad4dd93133db5eb78000008",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11460887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 116,
                    "offsetInEndSection": 235,
                    "text": "Binding of clathrin assembly protein to clathrin triskelia induces their assembly into clathrin-coated vesicles (CCVs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11795487",
                    "endSection": "abstract",
                    "offsetInBeginSection": 283,
                    "offsetInEndSection": 402,
                    "text": "Binding of clathrin assembly protein to clathrin triskelia induces their assembly into clathrin-coated vesicles (CCVs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10630373",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Binding of clathrin assembly protein to clathrin triskelia induces their assembly into clathrin-coated vesicle (CCV) in neurons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11460887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 723,
                    "offsetInEndSection": 896,
                    "text": "We found that CALM was associated with the proteins harboring SH3 domain, promote assembly of clathrin triskelia into clathrin cage and bound to the preformed clathrin cage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11795487",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1086,
                    "offsetInEndSection": 1258,
                    "text": "The purified CALM protein could promote the assembly of clathrin triskelia into clathrin cage, and cleaved CALM proteolysed by caspase 3 and calpain could not promote them."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2573598",
                    "endSection": "abstract",
                    "offsetInBeginSection": 447,
                    "offsetInEndSection": 525,
                    "text": "The beta-polypeptide, however, will not induce assembly of clathrin triskelia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27410749",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "The assembly of clathrin triskelia into polyhedral cages during endocytosis is regulated by adaptor proteins (APs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8440257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Binding of AP180 to clathrin triskelia induces their assembly into 60-70 nm coats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15858577",
                    "endSection": "abstract",
                    "offsetInBeginSection": 726,
                    "offsetInEndSection": 932,
                    "text": "Normal mitosis was rescued by clathrin triskelia but not the N-terminal domain of clathrin heavy chain, indicating that stabilization of kinetochore fibres was dependent on the unique structure of clathrin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1973169",
                    "endSection": "abstract",
                    "offsetInBeginSection": 319,
                    "offsetInEndSection": 436,
                    "text": "The purified protein binds to clathrin triskelia and thereby promotes clathrin assembly into regular 50-100-nm cages."
                }
            ]
        },
        {
            "body": "What is myelin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7683887",
                "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                "http://www.ncbi.nlm.nih.gov/pubmed/27417284",
                "http://www.ncbi.nlm.nih.gov/pubmed/1703219",
                "http://www.ncbi.nlm.nih.gov/pubmed/6204014",
                "http://www.ncbi.nlm.nih.gov/pubmed/7452300",
                "http://www.ncbi.nlm.nih.gov/pubmed/22102008",
                "http://www.ncbi.nlm.nih.gov/pubmed/27173133",
                "http://www.ncbi.nlm.nih.gov/pubmed/12605409",
                "http://www.ncbi.nlm.nih.gov/pubmed/19513756"
            ],
            "id": "5abcf108fcf4565872000025",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7683887",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "The structure and function of central nervous system myelin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "Myelin-associated oligodendrocytic basic protein is a member of the proteins constituting the central nervous system myelin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7683887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Multiple sclerosis (MS) is characterized by the active degradation of central nervous system myelin, a multilamellar membrane system that insulates nerve axons."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27417284",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Novel molecular insights into the critical role of sulfatide in myelin maintenance/function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27417284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 292,
                    "offsetInEndSection": 444,
                    "text": "Although these phenotypes suggest that sulfatide plays a critical role in myelin maintenance/function, the underlying mechanisms remain largely unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27417284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1706,
                    "offsetInEndSection": 1823,
                    "text": "In summary, we unraveled novel molecular insights into the critical role of sulfatide in myelin maintenance/function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7683887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 890,
                    "offsetInEndSection": 1249,
                    "text": "This article focuses on the current understanding of the molecular basis of MS as it may relate to the protein and lipid components of myelin, which dictate myelin morphology on the basis of protein-lipid and lipid-lipid interactions, and the relationship, if any, between the protein/lipid components and the destruction of myelin in pathological situations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10854769",
                    "endSection": "abstract",
                    "offsetInBeginSection": 886,
                    "offsetInEndSection": 1197,
                    "text": "Furthermore, we generated myelin basic protein/myelin-associated oligodendrocytic basic protein-double-deficient mice through mating myelin-associated oligodendrocytic basic protein-deficient mice with shiverer mice, an autosomal recessive mutant characterized by a lack of all isoforms of myelin basic protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7683887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 560,
                    "offsetInEndSection": 889,
                    "text": "Knowledge of the biochemical and physical-chemical properties of myelin proteins, and lipids, particularly their composition, organization, structure, and accessibility with respect to the compacted myelin multilayers, thus becomes central to understanding how and why these antigens become selected during the development of MS."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1703219",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 135,
                    "text": "The endogenous lectin cerebellar soluble lectin and its ligands in central nervous system myelin of myelin-deficient (mld) mutant mice."
                }
            ]
        },
        {
            "body": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18390151",
                "http://www.ncbi.nlm.nih.gov/pubmed/22812618",
                "http://www.ncbi.nlm.nih.gov/pubmed/16368972",
                "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                "http://www.ncbi.nlm.nih.gov/pubmed/24609497",
                "http://www.ncbi.nlm.nih.gov/pubmed/26578650",
                "http://www.ncbi.nlm.nih.gov/pubmed/28167945",
                "http://www.ncbi.nlm.nih.gov/pubmed/17296251",
                "http://www.ncbi.nlm.nih.gov/pubmed/21506829",
                "http://www.ncbi.nlm.nih.gov/pubmed/21829705"
            ],
            "id": "5aa6800ad6d6b54f79000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18390151",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Brucella abortus is a bacterium which causes abortions and infertility in cattle and undulant fever in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22812618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 311,
                    "offsetInEndSection": 468,
                    "text": "It is speculated that brucellosis causes fewer spontaneous abortions in humans than animals due to the absence of Erythritol in the human placenta and fetus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16368972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Brucella abortus is a facultative, intracellular zoonotic pathogen which can cause undulant fever in humans and abortions in cattle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1590,
                    "offsetInEndSection": 1720,
                    "text": "In conclusion, Brucella abortus cannot cause spontaneous abortion by altering the mouse cytokine profile towards Th1 in pregnancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 449,
                    "text": "This study sought to determine if Brucella infection causes spontaneous abortion by causing the circulating cytokine profile be Th1 dominant during pregnancy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 290,
                    "text": "Brucellosis is an intracellular bacterium that elicits the Th1 response and is known to cause spontaneous abortion in mammalian species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24609497",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 194,
                    "text": "Brucella abortus is a gram-negative, facultative intracellular pathogen that causes brucellosis, a chronic zoonotic disease resulting in abortion in pregnant cattle and undulant fever in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578650",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "Brucella abortus is a Gram-negative intracellular bacterial pathogen that causes a zoonosis of worldwide occurrence, leading to undulant fever in humans and abortion in domestic animals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28167945",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "Brucella abortus is a Gram-negative, facultative intracellular bacterium that causes brucellosis, a worldwide zoonotic disease leading to undulant fever in humans and abortion in cattle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17296251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "Brucella abortus, a facultative intracellular pathogen, is of tremendous zoonotic importance because of its ability to induce spontaneous abortion in cattle and other livestock."
                }
            ]
        },
        {
            "body": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21337711",
                "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                "http://www.ncbi.nlm.nih.gov/pubmed/7942855",
                "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                "http://www.ncbi.nlm.nih.gov/pubmed/21445243",
                "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                "http://www.ncbi.nlm.nih.gov/pubmed/18951484",
                "http://www.ncbi.nlm.nih.gov/pubmed/17110569",
                "http://www.ncbi.nlm.nih.gov/pubmed/811073",
                "http://www.ncbi.nlm.nih.gov/pubmed/17146600"
            ],
            "id": "5ace1a590340b9f05800000b",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21337711",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Relationship between cusp size and occlusal wear pattern in Neanderthal and Homo sapiens first maxillary molars."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 85,
                    "offsetInEndSection": 242,
                    "text": "This was a result of a detailed analysis of the internal bone composition in the area of the suprainiac depression on Neanderthal and Homo sapiens specimens."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7942855",
                    "endSection": "abstract",
                    "offsetInBeginSection": 470,
                    "offsetInEndSection": 670,
                    "text": "Although ancient, none of these haplogroups is old enough to be compatible with a Neanderthal origin, suggesting that Homo sapiens sapiens displaced H. s. neanderthaliensis, rather than mixed with it."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 500,
                    "offsetInEndSection": 740,
                    "text": "In this article, the hypothesis that the Homo sapiens non-supranuchal fossa and the Neanderthal suprainiac fossa both formed to maintain the optimal shape of the occipital plane (to minimize strain on the posterior cranial vault) is tested."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "Are Homo sapiens nonsupranuchal fossa and Neanderthal suprainiac fossa convergent traits?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 741,
                    "offsetInEndSection": 1019,
                    "text": "First, the variation in the expression of the fossa above inion in the crania of recent Homo sapiens from European, African, and Australian samples was examined, and the degree of structural similarity between these depressions and the Neanderthal suprainiac fossa was assessed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 146,
                    "offsetInEndSection": 565,
                    "text": "When hybridized with genomic DNA of either human or Neanderthal origin, DNA extracted from two Neanderthal finds-the Os parietale, from Warendorf-Neuwarendorf, Germany, and a clavicula, from Krapina, Croatia-was shown to yield hybridization signals that differ by at least a factor of two compared to the signals obtained with the use of fossil DNA of an early Homo sapiens from the Vogelherd cave (Stetten I), Germany."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21445243",
                    "endSection": "abstract",
                    "offsetInBeginSection": 827,
                    "offsetInEndSection": 974,
                    "text": "Neanderthal and early Homo sapiens maxillary molar macrowear indicates strong eco-geographic dietary variation independent of taxonomic affinities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1290,
                    "offsetInEndSection": 1427,
                    "text": "Based on the results, it is suggested that the Homo sapiens non-supranuchal fossa and Neanderthal suprainiac fossa are convergent traits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 499,
                    "text": "However, while anatomical differences between Neanderthal suprainiac fossa and the depression in the inion region of the occipital bone of fossil and recent Homo sapiens have been discussed in detail, the etiology of these structures has not been resolved."
                }
            ]
        },
        {
            "body": "What is Dupuytren's contracture?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                "http://www.ncbi.nlm.nih.gov/pubmed/3056294",
                "http://www.ncbi.nlm.nih.gov/pubmed/26152183",
                "http://www.ncbi.nlm.nih.gov/pubmed/10409813",
                "http://www.ncbi.nlm.nih.gov/pubmed/1960490",
                "http://www.ncbi.nlm.nih.gov/pubmed/1284015",
                "http://www.ncbi.nlm.nih.gov/pubmed/28444647",
                "http://www.ncbi.nlm.nih.gov/pubmed/26388001",
                "http://www.ncbi.nlm.nih.gov/pubmed/18080603",
                "http://www.ncbi.nlm.nih.gov/pubmed/8501390"
            ],
            "id": "5abcf66afcf4565872000026",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 206,
                    "offsetInEndSection": 290,
                    "text": "In the Netherlands, little is known about the prevalence of Dupuytren's contracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2011,
                    "offsetInEndSection": 2187,
                    "text": "CONCLUSIONS\nThis study is a first exploration of Dupuytren's contracture in the Netherlands based on hospitalizations, showing a prevalence of 0.25% among 60-79 year old males."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3056294",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "A study of the incidence of Dupuytren's contracture in a control group of the Zaragoza population is presented."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "BACKGROUND\nDupuytren's contracture is a condition of the palmar fascia involving contractures of the fascia and skin in the hand."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26152183",
                    "endSection": "abstract",
                    "offsetInBeginSection": 694,
                    "offsetInEndSection": 785,
                    "text": "CONCLUSIONS\nDupuytren's contracture is not a known side effect of BRAF inhibitor treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 461,
                    "text": "In this study we determined the prevalence of patients with a hospitalization for Dupuytren's contracture in the Netherlands and characterized their (re)hospitalizations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10409813",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "It is well known that Dupuytren's contracture is often associated with diabetes mellitus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1960490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "In Dupuytren's contracture there is an increase in the ratio of type III to type I collagen."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2316,
                    "offsetInEndSection": 2438,
                    "text": "In addition, patients not yet treated should be included to be able to estimate the prevalence of Dupuytren's contracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1817,
                    "offsetInEndSection": 1934,
                    "text": "During a median (IQR) follow-up of 2.9 (1.8-4.0) years, 523 patients were rehospitalized for Dupuytren's contracture."
                }
            ]
        },
        {
            "body": "What phenotype is associated with the V60L mutation in the human MC1R gene?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                "http://www.ncbi.nlm.nih.gov/pubmed/26710775",
                "http://www.ncbi.nlm.nih.gov/pubmed/18282187",
                "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                "http://www.ncbi.nlm.nih.gov/pubmed/18366057",
                "http://www.ncbi.nlm.nih.gov/pubmed/19924138",
                "http://www.ncbi.nlm.nih.gov/pubmed/19452503",
                "http://www.ncbi.nlm.nih.gov/pubmed/12006619",
                "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                "http://www.ncbi.nlm.nih.gov/pubmed/18484624"
            ],
            "id": "5ace2d600340b9f05800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 700,
                    "offsetInEndSection": 1019,
                    "text": "In this family-based study, we assessed the associations of the four most frequent MC1R variants (V60L, V92M, R151C, and R160W) and the number of variants (1, \u22652 variants), alone or jointly with the host phenotypes (hair color, propensity to sunburn, and number of nevi), with melanoma risk in CDKN2A mutation carriers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26710775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 351,
                    "text": "In particular, rs1805007, rs1805008, and rs1805009 mutations causing the corresponding R151C, R160W, and D294H changes and associated with the phenotype (\"red-hair mutations\") are connected with melanoma and non-melanoma skin cancer risks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1145,
                    "offsetInEndSection": 1393,
                    "text": "RESULTS\nCarrying any one of the four most frequent MC1R variants (V60L, V92M, R151C, R160W) in CDKN2A mutation carriers was associated with a statistically significantly increased risk for melanoma across all continents (1.24 \u00d7 10(-6) \u2264 P \u2264 .0007)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18282187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 856,
                    "offsetInEndSection": 1012,
                    "text": "Certain allelic variants of this gene, namely R151C, R160W and D294H, are strongly associated with red hair phenotype and increased melanoma susceptibility."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 502,
                    "text": "The R151C, R160W and D294H alleles, designated 'R', are strongly associated with the RHC phenotype and have been proposed to result in loss of function receptors due to impaired G-protein coupling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 134,
                    "offsetInEndSection": 348,
                    "text": "Penetrance of CDKN2A mutations is modified by pigmentation characteristics, nevus phenotypes, and some variants of the melanocortin-1 receptor gene (MC1R), which is known to have a role in the pigmentation process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 349,
                    "offsetInEndSection": 470,
                    "text": "However, investigation of the associations of both MC1R variants and host phenotypes with melanoma risk has been limited."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1774,
                    "offsetInEndSection": 2014,
                    "text": "The joint analysis of MC1R variants and host phenotypes showed statistically significant associations of melanoma risk, together with MC1R variants (.0001 \u2264 P \u2264 .04), hair color (.006 \u2264 P \u2264 .06), and number of nevi (6.9 \u00d7 10(-6) \u2264 P \u2264 .02)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1394,
                    "offsetInEndSection": 1505,
                    "text": "A consistent pattern of increase in melanoma risk was also associated with increase in number of MC1R variants."
                }
            ]
        },
        {
            "body": "List proteins with HEAT repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/10378263",
                "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                "http://www.ncbi.nlm.nih.gov/pubmed/27802131",
                "http://www.ncbi.nlm.nih.gov/pubmed/16567089",
                "http://www.ncbi.nlm.nih.gov/pubmed/25435324",
                "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                "http://www.ncbi.nlm.nih.gov/pubmed/9673349",
                "http://www.ncbi.nlm.nih.gov/pubmed/21708948",
                "http://www.ncbi.nlm.nih.gov/pubmed/22315229",
                "http://www.ncbi.nlm.nih.gov/pubmed/20887736"
            ],
            "id": "5abd44b1fcf4565872000030",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10378263",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "The recently determined crystal structure of the PR65/A subunit of protein phosphatase 2A reveals the architecture of proteins containing HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1266,
                    "offsetInEndSection": 1498,
                    "text": "HEAT repeats also were found in dis1-TOG family and cofactor D family microtubule-associated proteins, which, owing to their roles in microtubule dynamics, perform functions related to mitotic progression and chromosome segregation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1499,
                    "offsetInEndSection": 1645,
                    "text": "Hence, our analysis predicts structural features of these proteins and suggests that HEAT repeats may play important roles in chromosome dynamics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 438,
                    "text": "Using sensitive sequence analysis techniques we detected HEAT repeats in various chromosome-associated proteins, including four families of proteins associated with condensins and cohesins, which are nuclear complexes that contain structural maintenance of chromosome (SMC) proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27802131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 393,
                    "offsetInEndSection": 723,
                    "text": "In this Opinion article, we will focus on HEAT repeats, flexible arrays of amphiphilic helices found in many eukaryotic proteins, such as karyopherins and condensins, and discuss how these uniquely designed helical repeats might underlie dynamic protein-protein interactions and support cellular functions in crowded environments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16567089",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 243,
                    "text": "Recent structural work on nuclear transport factors of the importin-beta superfamily of karyopherins has shown that these proteins are superhelices of HEAT repeats that are able to assume different conformations in different functional states."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1088,
                    "text": "HEAT repeats were also found in the TBP-associated TIP120 protein, a global enhancer of transcription, and in the budding yeast Mot1p protein, which is a member of the SWI2/SNF2 family."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25435324",
                    "endSection": "abstract",
                    "offsetInBeginSection": 385,
                    "offsetInEndSection": 632,
                    "text": "An in vitro transport assay and FRAP analyses demonstrated that not only karyopherin \u03b2 family proteins but also other proteins with HEAT repeats could pass through the NPC by themselves, and serve as transport mediators for their binding partners."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "The Noc proteins involved in ribosome synthesis and export contain divergent HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25435324",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 384,
                    "text": "Karyopherin \u03b2 family proteins mediate the nuclear/cytoplasmic transport of various proteins through the nuclear pore complex (NPC), although they are substantially larger than the size limit of the NPC.To elucidate the molecular mechanism underlying this paradoxical function, we focused on the unique structures called HEAT repeats, which consist of repetitive amphiphilic \u03b1 helices."
                }
            ]
        },
        {
            "body": "What is the aim of  perfoming a \"cycloheximide chase assay\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27987332",
                "http://www.ncbi.nlm.nih.gov/pubmed/25742191",
                "http://www.ncbi.nlm.nih.gov/pubmed/202461",
                "http://www.ncbi.nlm.nih.gov/pubmed/18227081",
                "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                "http://www.ncbi.nlm.nih.gov/pubmed/12952867",
                "http://www.ncbi.nlm.nih.gov/pubmed/15173609",
                "http://www.ncbi.nlm.nih.gov/pubmed/16666455",
                "http://www.ncbi.nlm.nih.gov/pubmed/28669563",
                "http://www.ncbi.nlm.nih.gov/pubmed/26903295"
            ],
            "id": "5ac08478d0c506ce46000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27987332",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 434,
                    "text": "To this end, we investigated the effects of the inhibition of Cullin E3 ligases, by using inhibitors and knockdown techniques in HUVECs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25742191",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 621,
                    "text": "These approaches are not amenable to rapid or large-scale screening for mutations that prevent protein degradation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25742191",
                    "endSection": "abstract",
                    "offsetInBeginSection": 368,
                    "offsetInEndSection": 505,
                    "text": "While these techniques provide sensitive means for observing protein degradation, they are laborious, time-consuming, and low-throughput."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25742191",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1766,
                    "offsetInEndSection": 1858,
                    "text": "These techniques can be adapted to monitor degradation of a variety of short-lived proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/202461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 172,
                    "text": "The transport of cytoplasmically synthesized mitochondrial proteins was investigated in whole cells of Neurospora crassa, using dual labelling and immunological techniques."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27987332",
                    "endSection": "abstract",
                    "offsetInBeginSection": 562,
                    "offsetInEndSection": 681,
                    "text": "The results revealed that NEDD8-conjugated Cullin 3 is required for VE-cadherin-mediated endothelial barrier functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18227081",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1687,
                    "offsetInEndSection": 1843,
                    "text": "At the very least, a review of the current guidance documents for the photosafety evaluation of pharmaceuticals and cosmetics should be undertaken urgently."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 182,
                    "offsetInEndSection": 443,
                    "text": "Many assays reporting on protein abundance (e.g., single-time point western blotting, flow cytometry, fluorescence microscopy, or growth-based reporter assays) do not allow discrimination of the relative effects of translation and proteolysis on protein levels."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27987332",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "Neddylated Cullin 3 is required for vascular endothelial-cadherin-mediated endothelial barrier function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27987332",
                    "endSection": "abstract",
                    "offsetInBeginSection": 682,
                    "offsetInEndSection": 837,
                    "text": "Treatment of HUVECs with MLN4924, a chemical inhibitor of the NEDD8-activating enzyme, led to high vascular permeability due to impaired cell-cell contact."
                }
            ]
        },
        {
            "body": "What is an exosome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                "http://www.ncbi.nlm.nih.gov/pubmed/26601950",
                "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                "http://www.ncbi.nlm.nih.gov/pubmed/27841793",
                "http://www.ncbi.nlm.nih.gov/pubmed/24462375",
                "http://www.ncbi.nlm.nih.gov/pubmed/28850588",
                "http://www.ncbi.nlm.nih.gov/pubmed/25267620",
                "http://www.ncbi.nlm.nih.gov/pubmed/16087368",
                "http://www.ncbi.nlm.nih.gov/pubmed/16046478",
                "http://www.ncbi.nlm.nih.gov/pubmed/28094758"
            ],
            "id": "5ac0a36f19833b0d7b000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "The exosome consists of a core of ten essential proteins that includes the ribonuclease Rrp44p and is present in both the cytoplasm and nucleus of eukaryotic cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26601950",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1210,
                    "text": "Regarding exosome function, fibronectin-mediated binding of exosomes to myeloma cells activated p38 and pERK signaling and expression of downstream target genes DKK1 and MMP-9, two molecules that promote myeloma progression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "The exosome consists of a core often essential proteins that includes the ribonuclease Rrp44p and is present in both the cytoplasm and nucleus of eukaryotic cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 622,
                    "offsetInEndSection": 707,
                    "text": "These cofactors presumably direct the exosome to specific cytoplasmic RNA substrates."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 37,
                    "text": "Functions of the cytoplasmic exosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 619,
                    "offsetInEndSection": 704,
                    "text": "These cofactors presumably direct the exosome to specific cytoplasmic RNA substrates."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21618876",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 37,
                    "text": "Functions of the cytoplasmic exosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26601950",
                    "endSection": "abstract",
                    "offsetInBeginSection": 709,
                    "offsetInEndSection": 840,
                    "text": "Removal of heparan sulfate from the exosome surface releases fibronectin and dramatically inhibits exosome-target cell interaction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27841793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1154,
                    "offsetInEndSection": 1310,
                    "text": "The stimulation of proliferation, migration, and chemokine gene expression by the conditioned medium of PSCs was suppressed by GW4869, an exosome inhibitor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21713679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 377,
                    "text": "The cytoplasmic exosome has been extensively characterized in the budding yeast Saccharomyces cerevisiae and some characterization of its metazoan counterpart indicates that most functional aspects are conserved."
                }
            ]
        },
        {
            "body": "Are human enhancers or promoters evolving faster?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24842994",
                "http://www.ncbi.nlm.nih.gov/pubmed/25635462",
                "http://www.ncbi.nlm.nih.gov/pubmed/28288115",
                "http://www.ncbi.nlm.nih.gov/pubmed/2104960",
                "http://www.ncbi.nlm.nih.gov/pubmed/23479409",
                "http://www.ncbi.nlm.nih.gov/pubmed/7597099",
                "http://www.ncbi.nlm.nih.gov/pubmed/28116828",
                "http://www.ncbi.nlm.nih.gov/pubmed/18062958",
                "http://www.ncbi.nlm.nih.gov/pubmed/23652427",
                "http://www.ncbi.nlm.nih.gov/pubmed/2554495"
            ],
            "id": "5ac3699f0340b9f058000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24842994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 465,
                    "offsetInEndSection": 586,
                    "text": "Tyr1P is predominantly found in antisense orientation at promoters but is also specifically enriched at active enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25635462",
                    "endSection": "abstract",
                    "offsetInBeginSection": 174,
                    "offsetInEndSection": 375,
                    "text": "Here, we track the evolution of promoters and enhancers active in liver across 20 mammalian species from six diverse orders by profiling genomic enrichment of H3K27 acetylation and H3K4 trimethylation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28288115",
                    "endSection": "abstract",
                    "offsetInBeginSection": 826,
                    "offsetInEndSection": 1021,
                    "text": "In addition, we apply LINSIGHT to an atlas of human enhancers and show that the fitness consequences at enhancers depend on cell type, tissue specificity, and constraints at associated promoters."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25635462",
                    "endSection": "abstract",
                    "offsetInBeginSection": 601,
                    "offsetInEndSection": 695,
                    "text": "In contrast, almost all liver promoters are partially or fully conserved across these species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2104960",
                    "endSection": "abstract",
                    "offsetInBeginSection": 135,
                    "offsetInEndSection": 282,
                    "text": "3), for which binding sites are widely distributed in the promoters and enhancers of the globin gene family, and of other erythroid-specific genes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23479409",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "Porcine CD4 promoters and enhancers can direct foreign gene expression in human cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7597099",
                    "endSection": "abstract",
                    "offsetInBeginSection": 486,
                    "offsetInEndSection": 879,
                    "text": "A plasmid-borne luciferase reporter gene fused to various muscle-specific contractile gene promoters was differentially expressed when injected into slow- versus fast-twitch rat muscle: the luciferase gene was preferentially expressed in slow muscle when fused to a slow troponin I promoter, and conversely, was preferentially expressed in fast muscle when fused to a fast troponin C promoter."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23479409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 603,
                    "offsetInEndSection": 734,
                    "text": "The results indicated the porcine CD4 promoters and enhancers could effectively direct expression of a foreign gene in human cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24842994",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Tyrosine phosphorylation of RNA polymerase II CTD is associated with antisense promoter transcription and active enhancers in mammalian cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28116828",
                    "endSection": "abstract",
                    "offsetInBeginSection": 461,
                    "offsetInEndSection": 603,
                    "text": "Promoters and enhancers are functionally similar; both can regulate the transcription of distal promoters and both direct local transcription."
                }
            ]
        },
        {
            "body": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                "http://www.ncbi.nlm.nih.gov/pubmed/27626268",
                "http://www.ncbi.nlm.nih.gov/pubmed/24275169",
                "http://www.ncbi.nlm.nih.gov/pubmed/28198201",
                "http://www.ncbi.nlm.nih.gov/pubmed/24205696",
                "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                "http://www.ncbi.nlm.nih.gov/pubmed/23455714",
                "http://www.ncbi.nlm.nih.gov/pubmed/21838659",
                "http://www.ncbi.nlm.nih.gov/pubmed/27913536",
                "http://www.ncbi.nlm.nih.gov/pubmed/26814780"
            ],
            "id": "5ac0f7b919833b0d7b000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 301,
                    "offsetInEndSection": 576,
                    "text": "Specific antidotes for the reversal of the anticoagulant effect of these drugs, such as monoclonal antibodies against the direct thrombin inhibitor dabigatran or recombinant Xa-analog in the case of factor Xa inhibitors, are still being investigated in early clinical trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27626268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 716,
                    "offsetInEndSection": 949,
                    "text": "This is followed by analysing the present-day results of clinical trials aimed at working out pharmaceutical agents (andexanet alpha, idarucizumab, aripazine) being antidotes to direct thrombin inhibitor and the factor Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 705,
                    "offsetInEndSection": 1059,
                    "text": "Several non-specific prohemostatic agents or coagulation factor concentrates have been suggested as potential candidates for the reversal of NOACs, but the evidence supporting these agents was mainly derived from small animal studies, or is based on partial or complete correction of laboratory parameters in healthy volunteers treated with these agents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1324,
                    "offsetInEndSection": 1527,
                    "text": "In this article, the evidence- or the lack of it - supporting the use of the different prohemostatic agents for the management of bleeding and for reversal of the different classes of NOACs is discussed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1060,
                    "offsetInEndSection": 1253,
                    "text": "Activated prothrombin complex concentrate seems promising for the reversal of dabigatran, while non-activated prothrombin complex concentrates have potential for the reversal of anti-factor Xa."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24275169",
                    "endSection": "abstract",
                    "offsetInBeginSection": 254,
                    "offsetInEndSection": 450,
                    "text": "Major advances have been made in targeting downstream clotting factors in the coagulation cascade, resulting in two major new classes of drugs: direct thrombin inhibitors and factor Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28198201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 215,
                    "offsetInEndSection": 409,
                    "text": "Now, a specific antidote for the direct thrombin inhibitor, dabigatran has been approved for use, and antidotes for factor Xa inhibitors (rivaroxaban, apixaban and edoxaban) are being developed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27626268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 425,
                    "text": "NOACs are classified into two groups: direct thrombin inhibitor (notably dabigatran) and factor Xa inhibitors (including rivaroxaban, apixaban, and edoxaban)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "In the past decade, several new oral anticoagulants (NOACs) have been studied and approved for the prophylaxis and treatment of arterial and venous thromboembolism."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23953907",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 50,
                    "text": "Bleeding and antidotes in new oral anticoagulants."
                }
            ]
        },
        {
            "body": "Which genes are associated with Epidermolysis Bullosa Simplex?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                "http://www.ncbi.nlm.nih.gov/pubmed/25354580",
                "http://www.ncbi.nlm.nih.gov/pubmed/27186702",
                "http://www.ncbi.nlm.nih.gov/pubmed/7561171",
                "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                "http://www.ncbi.nlm.nih.gov/pubmed/19797037",
                "http://www.ncbi.nlm.nih.gov/pubmed/22161089",
                "http://www.ncbi.nlm.nih.gov/pubmed/421361",
                "http://www.ncbi.nlm.nih.gov/pubmed/7539246"
            ],
            "id": "5ace34eb0340b9f058000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 392,
                    "text": "The simplex forms of epidermolysis bullosa are caused by mutations in the genes for the basal epidermal keratins, K5 and K14."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                    "endSection": "abstract",
                    "offsetInBeginSection": 809,
                    "offsetInEndSection": 1075,
                    "text": "Junctional epidermolysis bullosa is caused by mutations in the genes encoding different chains of the novel laminin isoform, nicein/kalinin, also known as laminin 5, which is associated with the anchoring filament-hemidesmosome complex of the basement membrane zone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                    "endSection": "abstract",
                    "offsetInBeginSection": 570,
                    "offsetInEndSection": 670,
                    "text": "In this study we sequenced these genes in a family with epidermolysis bullosa simplex Dowling-Meara."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                    "endSection": "abstract",
                    "offsetInBeginSection": 361,
                    "offsetInEndSection": 569,
                    "text": "The keratin 5 and keratin 14 genes encode proteins that form the primary structural components of the basal epidermal keratinocytes, mutations in either of these genes can cause epidermolysis bullosa simplex."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                    "endSection": "abstract",
                    "offsetInBeginSection": 671,
                    "offsetInEndSection": 808,
                    "text": "Both recessive and dominant forms of dystrophic epidermolysis bullosa result from mutations in an anchoring fibril collagen gene, COL7A1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25354580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 460,
                    "text": "Epidermolysis bullosa is caused by mutations in the genes that code for structural proteins of the cytoskeleton of the basal keratinocytes or of the basement membrane zone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27186702",
                    "endSection": "abstract",
                    "offsetInBeginSection": 538,
                    "offsetInEndSection": 630,
                    "text": "Most of the mutations in JEP-PA are associated with the \u03b16\u03b24 integrin genes (ITGA6, ITGB4,)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7561171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "Mutations in genes encoding the keratin intermediate filaments expressed in basal cells have been identified in some families with epidermolysis bullosa simplex as the proximate cause of the fragility."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "Mutation analysis of the entire keratin 5 and 14 genes in patients with epidermolysis bullosa simplex and identification of novel mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19797037",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "Epidermolysis bullosa simplex is an autosomal dominant inherited skin blistering disorder caused by mutations in the genes KRT5 or KRT14 coding for the basal epidermal keratins 5 and 14, respectively."
                }
            ]
        },
        {
            "body": "What biologic process in the body is associated with Mast cells?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26840764",
                "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                "http://www.ncbi.nlm.nih.gov/pubmed/22815822",
                "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                "http://www.ncbi.nlm.nih.gov/pubmed/3818976",
                "http://www.ncbi.nlm.nih.gov/pubmed/17485116",
                "http://www.ncbi.nlm.nih.gov/pubmed/29363910",
                "http://www.ncbi.nlm.nih.gov/pubmed/10589021"
            ],
            "id": "5aac543bfcf4565872000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26840764",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 277,
                    "text": "Mast cell degranulation is the typical anaphylaxis process of mast cells associated with the release of cytokines, eicosanoids and their secretory granules, which play very important roles in the allergic inflammatory response of the human body upon anaphylactogen stimulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                    "endSection": "abstract",
                    "offsetInBeginSection": 139,
                    "offsetInEndSection": 342,
                    "text": "This may be associated with mast cells, which are found in all body tissues of an organism, secrete a wide range of biologically active substances and are important in the regulation of repair processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22815822",
                    "endSection": "abstract",
                    "offsetInBeginSection": 126,
                    "offsetInEndSection": 215,
                    "text": "A body of evidence indicates that mast cells are associated with various types of tumors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26840764",
                    "endSection": "abstract",
                    "offsetInBeginSection": 925,
                    "offsetInEndSection": 1240,
                    "text": "These results provide the precise morphological information of ionomycin-induced mast cell degranulation at nanoscale, which could benefit our understanding of ionomycin-induced mast cell anaphylaxis model and also validate the applicability of AFM for the detection of allergic inflammatory response in mast cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                    "endSection": "abstract",
                    "offsetInBeginSection": 730,
                    "offsetInEndSection": 865,
                    "text": "Index of degranulation of mast cells in the testes increased immediately after the injury in the absence of their pronounced migration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 454,
                    "text": "Lipid body accumulation in mast cells is associated with enhanced levels of leukotriene-synthesizing enzymes (LTC4S and 5-LO)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1076,
                    "offsetInEndSection": 1299,
                    "text": "Lipid body accumulation in mast cells is mechanistically distinct from the process in adipocytes; for example, it is independent of PPAR\u03b3 up-regulation and does not involve significant accumulation of conjugated glycerides."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 512,
                    "text": "Since mast cells clearly play both physiological and pathophysiological functions in the body, it is important to learn about the components of mast cells that drive these responses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                    "endSection": "abstract",
                    "offsetInBeginSection": 866,
                    "offsetInEndSection": 1159,
                    "text": "Stabilizing membranes of mast cells using the drug ketotifen led to inhibition of the repair of the skin, which was manifested itself in the absence of increasing the thickness of dermis, epidermis, the number of fibroblasts and collagen fibers, and also in slowing down the formation of scar."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "Mast cells are found resident in tissues throughout the body, particularly in association with structures such as blood vessels and nerves, and in proximity to surfaces that interface the external environment."
                }
            ]
        },
        {
            "body": "What are the 3 types of ultraviolet (UV) solar radiation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16897517",
                "http://www.ncbi.nlm.nih.gov/pubmed/11920550",
                "http://www.ncbi.nlm.nih.gov/pubmed/23113025",
                "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                "http://www.ncbi.nlm.nih.gov/pubmed/25685424",
                "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                "http://www.ncbi.nlm.nih.gov/pubmed/22747844",
                "http://www.ncbi.nlm.nih.gov/pubmed/20858922",
                "http://www.ncbi.nlm.nih.gov/pubmed/19360745",
                "http://www.ncbi.nlm.nih.gov/pubmed/21192130"
            ],
            "id": "5aae6a86fcf456587200000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16897517",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "The ultraviolet UV solar radiation flux is monitored over a fixed time interval to study the daily, monthly and annual variations for a nearly one decade in Riyadh."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16897517",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 75,
                    "text": "Distribution of ultraviolet solar radiation at Riyadh region, Saudi Arabia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11920550",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 593,
                    "text": "The purpose of the current study was to determine how many types of cancer are affected by solar radiation and how many premature deaths from cancer occur due to insufficient ultraviolet (UV)-B radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16897517",
                    "endSection": "abstract",
                    "offsetInBeginSection": 275,
                    "offsetInEndSection": 516,
                    "text": "It is believed that the present analysis of UV radiation suggest that the environmental effects led to a better understanding of UV scattering, UV reflection, ozone and clouds layers in Riyadh and other selected areas in the mid-east region."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23113025",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "BACKGROUND\nIn general, measurements of solar ultraviolet (UV) radiation are related to horizontal surfaces."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Terrestrial solar ultraviolet (UV) radiation has significant implications for human health and increasing levels are a key concern regarding the impact of climate change."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25685424",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 621,
                    "text": "We present the ambitions of the SWUSV (Space Weather and Ultraviolet Solar Variability) Microsatellite Mission that encompasses three major scientific objectives: (1) Space Weather including the prediction and detection of major eruptions and coronal mass ejections (Lyman-Alpha and Herzberg continuum imaging); (2) solar forcing on the climate through radiation and their interactions with the local stratosphere (UV spectral irradiance from 180 to 400\u00a0nm by bands of 20\u00a0nm, plus Lyman-Alpha and the CN bandhead); (3) simultaneous radiative budget of the Earth, UV to IR, with an accuracy better than 1% in differential."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 259,
                    "text": "Sunlight, skin cancer and vitamin D: What are the conclusions of recent findings that protection against solar ultraviolet (UV) radiation causes 25-hydroxyvitamin D deficiency in solid organ-transplant recipients, xeroderma pigmentosum, and other risk groups?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22747844",
                    "endSection": "abstract",
                    "offsetInBeginSection": 173,
                    "offsetInEndSection": 325,
                    "text": "Therefore, research into environmental factors that may impact folate status, such as solar ultraviolet (UV) radiation, is of great health significance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20858922",
                    "endSection": "abstract",
                    "offsetInBeginSection": 149,
                    "offsetInEndSection": 383,
                    "text": "The film changes from a clear colour to blue colour when exposed to ultraviolet radiation and results have shown that the colour change is reproducible within \u00b110% at 5 kJ m(-2) UV exposure under various conditions of solar radiation."
                }
            ]
        },
        {
            "body": "Please list 10 conditions which play a role in causing atrial fibrillation.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                "http://www.ncbi.nlm.nih.gov/pubmed/26872434",
                "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                "http://www.ncbi.nlm.nih.gov/pubmed/11978585",
                "http://www.ncbi.nlm.nih.gov/pubmed/16138954",
                "http://www.ncbi.nlm.nih.gov/pubmed/12423819",
                "http://www.ncbi.nlm.nih.gov/pubmed/10646954",
                "http://www.ncbi.nlm.nih.gov/pubmed/12395678",
                "http://www.ncbi.nlm.nih.gov/pubmed/28169950",
                "http://www.ncbi.nlm.nih.gov/pubmed/25032725"
            ],
            "id": "5aaef38dfcf456587200000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 314,
                    "text": "5-Hydroxytryptamine, a recent addition to the list of hormonal triggers for atrial fibrillation (AF), may play a pivotal role in the induction of AF related not only to cardiac surgery but also to acute coronary syndromes, valvular heart disease, cardiomyopathies, alcoholism, aging, and conducting tissue disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26872434",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Cardiac arrhythmias, with, on top of the list, atrial fibrillation, are frequent conditions and any physician might have to get involved at any stage of patient care (from diagnosis to treatment), without always having the opportunity to immediately refer to the cardiologist."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 453,
                    "text": "Of the long list of various cardiac conditions associated with an increased risk of cardioembolic strokes, non-valvular atrial fibrillation is the most common cause."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 963,
                    "offsetInEndSection": 1161,
                    "text": "Apart from atrial fibrillation, there is relatively limited evidence for the role of antithrombotic therapy for other cardiac conditions associated with cardioembolism and how long one should treat."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 619,
                    "offsetInEndSection": 801,
                    "text": "Treatment with vitamin K-antagonists substantially reduces the long-term complications associated with cardioembolism in some high-risk patients, for example, in atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 468,
                    "offsetInEndSection": 600,
                    "text": "It also delves into the potential benefits and limitations of 5-HT4 antagonists in the prevention and management of this arrhythmia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26872434",
                    "endSection": "abstract",
                    "offsetInBeginSection": 277,
                    "offsetInEndSection": 475,
                    "text": "The aim of this review is to present a summary of pathophysiology, clinical and electrocardiographic presentations, as well as diagnostic and therapeutic strategies for the main cardiac arrhythmias."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26872434",
                    "endSection": "abstract",
                    "offsetInBeginSection": 476,
                    "offsetInEndSection": 661,
                    "text": "Supra-ventricular tachycardias (atrial fibrillation and flutter, atrioventricular reciprocating tachycardias) and ventricular tachycardias will be consecutively presented and discussed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11978585",
                    "endSection": "abstract",
                    "offsetInBeginSection": 263,
                    "offsetInEndSection": 498,
                    "text": "The multiple-causes mortality files from 1980 through 1998 were analyzed for decedents, with atrial fibrillation (International Classification of Diseases, Ninth Revision, code 427.3) listed as one of up to 20 conditions causing death."
                }
            ]
        },
        {
            "body": "Is p53 a transcription factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8418500",
                "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                "http://www.ncbi.nlm.nih.gov/pubmed/10446138",
                "http://www.ncbi.nlm.nih.gov/pubmed/21042708",
                "http://www.ncbi.nlm.nih.gov/pubmed/15734577",
                "http://www.ncbi.nlm.nih.gov/pubmed/9215863",
                "http://www.ncbi.nlm.nih.gov/pubmed/9344880",
                "http://www.ncbi.nlm.nih.gov/pubmed/17383232",
                "http://www.ncbi.nlm.nih.gov/pubmed/15361854",
                "http://www.ncbi.nlm.nih.gov/pubmed/7651386"
            ],
            "id": "5ac0817cd0c506ce46000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8418500",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "The tumor suppressor p53 is a nuclear phosphoprotein with characteristics of a transcription factor."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 69,
                    "text": "Regulation of p53 gene expression by a poxviral transcription factor."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10446138",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "The adenovirus oncoprotein E1a stimulates binding of transcription factor ETF to transcriptionally activate the p53 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8418500",
                    "endSection": "abstract",
                    "offsetInBeginSection": 667,
                    "offsetInEndSection": 839,
                    "text": "These results suggest that protein-protein interaction between p53 and specific transcription factors may be an additional mechanism by which p53 regulates gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21042708",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "Tumor suppressor p53 is a transcription factor that induces growth arrest and/or apoptosis in response to cellular stress."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21042708",
                    "endSection": "abstract",
                    "offsetInBeginSection": 283,
                    "offsetInEndSection": 446,
                    "text": "Using microarray analysis, we have identified the transcription factor early growth response 2 (EGR2) as a target of the p53 family, specifically p53, p63 and p73."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15734577",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "The tumor suppressor p53 is a transcription factor and is activated in response to DNA damage or oncogenic transformation through modification of its interaction with regulatory proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "abstract",
                    "offsetInBeginSection": 699,
                    "offsetInEndSection": 750,
                    "text": "The increased p53 mRNA reflected new transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9215863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 332,
                    "offsetInEndSection": 419,
                    "text": "p53 is a transcription factor which is involved in cell cycle regulation and apoptosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9344880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 350,
                    "offsetInEndSection": 437,
                    "text": "p53 is a transcription factor which is involved in cell cycle regulation and apoptosis."
                }
            ]
        },
        {
            "body": "Is Cystatin D a biomarker?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28178353",
                "http://www.ncbi.nlm.nih.gov/pubmed/19623638",
                "http://www.ncbi.nlm.nih.gov/pubmed/28282874",
                "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                "http://www.ncbi.nlm.nih.gov/pubmed/22350134",
                "http://www.ncbi.nlm.nih.gov/pubmed/24266750",
                "http://www.ncbi.nlm.nih.gov/pubmed/26066476",
                "http://www.ncbi.nlm.nih.gov/pubmed/29087712",
                "http://www.ncbi.nlm.nih.gov/pubmed/26724852"
            ],
            "id": "5a9d9ab94e03427e73000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28178353",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "Cystatin F is a biomarker of prion pathogenesis in mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28178353",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1028,
                    "offsetInEndSection": 1251,
                    "text": "Our results validate cystatin F as a useful biomarker of early pathogenesis in experimental models of prion disease, and point to unexpected species-specific differences in the transcriptional responses to prion infections."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19623638",
                    "endSection": "abstract",
                    "offsetInBeginSection": 195,
                    "offsetInEndSection": 356,
                    "text": "Cystatin C, a nonglycosylated protein unaffected by muscle mass, is potentially an ideal biomarker of nephrotoxicity for this population but requires validation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28282874",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Cystatin C (cysC) is an endogenous cysteine peptidase (proteinase) inhibitor that has been intensively investigated as a biomarker of kidney function for many years."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19623638",
                    "endSection": "abstract",
                    "offsetInBeginSection": 934,
                    "offsetInEndSection": 1044,
                    "text": "This study demonstrates the potential value of cystatin C as a biomarker for monitoring renal function in DMD."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 323,
                    "offsetInEndSection": 437,
                    "text": "Cystatin C, a biomarker of kidney functioning that has been linked to poor health outcomes, was measured in blood."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "[Urinary cystatin C as a biomarker of renal tubular injury]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28282874",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1162,
                    "offsetInEndSection": 1307,
                    "text": "Therefore, serum cystatin C may be a novel biomarker that reflects tumor burden in DLBCL but bears no prognostic significance regarding survival."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22350134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1333,
                    "offsetInEndSection": 1522,
                    "text": "Concluding, we could not confirm our hypothesis (supported by the Polish results) that cystatin C level is altered by HNF1A mutations; thus, it cannot be used as a biomarker for HNF1A-MODY."
                }
            ]
        },
        {
            "body": "What causes leishmaniasis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15259461",
                "http://www.ncbi.nlm.nih.gov/pubmed/25228325",
                "http://www.ncbi.nlm.nih.gov/pubmed/17361837",
                "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                "http://www.ncbi.nlm.nih.gov/pubmed/25116660",
                "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                "http://www.ncbi.nlm.nih.gov/pubmed/25404076",
                "http://www.ncbi.nlm.nih.gov/pubmed/24707415",
                "http://www.ncbi.nlm.nih.gov/pubmed/25759741",
                "http://www.ncbi.nlm.nih.gov/pubmed/19300044"
            ],
            "id": "5abcf0b0fcf4565872000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15259461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 339,
                    "text": "Identification of 5 isolates from 4 CL patients by enzyme analysis during 2002 showed that they were all Leishmania donovani zymodeme MON-37, the parasite which also causes visceral leishmaniasis in India and East Africa."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25228325",
                    "endSection": "abstract",
                    "offsetInBeginSection": 491,
                    "offsetInEndSection": 612,
                    "text": "L. (L.)\u00a0donovani usually causes visceral leishmaniasis, but in this case, the patient manifested cutaneous leishmaniasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17361837",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 254,
                    "text": "Disseminated cutaneous leishmaniasis is a rare presentation characterized by hematogenous dissemination of the parasite that causes the appearance of multiple nodules and plaques in the skin of the whole body and even including the nasal mucous membrane."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15259461",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Leishmania donovani in India causes visceral infection (kala-azar) and dermal infection (post-kala-azar dermal leishmaniasis)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25116660",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 506,
                    "text": "Visceral leishmaniasis causes high morbidity and mortality in the developing world."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                    "endSection": "abstract",
                    "offsetInBeginSection": 409,
                    "offsetInEndSection": 520,
                    "text": "However, in Sri Lanka, L. donovani causes mainly cutaneous leishmaniasis, while visceral leishmaniasis is rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25404076",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "We report the first case of visceral leishmaniasis (VL) caused by Leishmania martiniquensis in the Caribbean, which until now, was known only to cause cutaneous leishmaniasis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25228325",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "An imported case of cutaneous leishmaniasis caused by Leishmania (Leishmania) donovani in Japan."
                }
            ]
        },
        {
            "body": "Please list 7 classes of drugs that interact with Warfarin.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                "http://www.ncbi.nlm.nih.gov/pubmed/21359645",
                "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                "http://www.ncbi.nlm.nih.gov/pubmed/9707357",
                "http://www.ncbi.nlm.nih.gov/pubmed/23045839",
                "http://www.ncbi.nlm.nih.gov/pubmed/15585436",
                "http://www.ncbi.nlm.nih.gov/pubmed/12462133",
                "http://www.ncbi.nlm.nih.gov/pubmed/901698",
                "http://www.ncbi.nlm.nih.gov/pubmed/22198820",
                "http://www.ncbi.nlm.nih.gov/pubmed/27416928"
            ],
            "id": "5abce6acfcf4565872000022",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1744,
                    "offsetInEndSection": 2026,
                    "text": "CONCLUSION\nThis assessment of official US product labeling for 50 drugs, biologics, and drug classes known to interact with warfarin, comprising 73 distinct agents, found that 15% failed to mention the interaction, even though the interaction was mentioned in the warfarin labeling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 399,
                    "offsetInEndSection": 754,
                    "text": "METHODS\nWe examined the official labeling information approved by the US Food and Drug Administration for the 50 drugs, biologics, and drug classes that were commonly identified by 3 drug information compendia--Clinical Pharmacology, ePocrates(\u00ae), and Micromedex(\u00ae)--and the warfarin US prescribing information (PI) as having an interaction with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 207,
                    "offsetInEndSection": 396,
                    "text": "OBJECTIVE\nThe aim of this study was to assess the information regarding warfarin interactions that is included in the official labeling of prescription products that interact with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21359645",
                    "endSection": "abstract",
                    "offsetInBeginSection": 982,
                    "offsetInEndSection": 1376,
                    "text": "As the list of drugs and supplements that interact with warfarin is continuously expanding, and the knowledge on drug interactions with the novel oral anticoagulants is still in its infancy, clinicians need to be vigilant when initiating any of these agents or when any changes in the patient's medication profile occur and perform a close screening for potential drug and dietary interactions."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 204,
                    "text": "BACKGROUND\nBecause interactions with warfarin represent a serious risk to patients, drug information sources used by clinicians should contain accurate, timely, and practical drug interaction information."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 611,
                    "offsetInEndSection": 797,
                    "text": "The types of substances listed as interacting with warfarin were entire classes of drugs, individual drugs, and combinations; biologics; dietary supplements; foods; alcohol; and tobacco."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1304,
                    "offsetInEndSection": 1404,
                    "text": "Those failing to mention the warfarin interaction were for older generic drugs or influenza vaccine."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1405,
                    "offsetInEndSection": 1583,
                    "text": "Among the labels listing an interaction with warfarin, the location of the information, the terminology used, and the inclusion of evidence for the interaction was inconsistent ."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 521,
                    "text": "The drug information compendia and warfarin label differed greatly as to the total number of substances that interact with warfarin."
                }
            ]
        },
        {
            "body": "What part of the body is affected by mesotheliomia?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                "http://www.ncbi.nlm.nih.gov/pubmed/22134536",
                "http://www.ncbi.nlm.nih.gov/pubmed/29333361",
                "http://www.ncbi.nlm.nih.gov/pubmed/8216764",
                "http://www.ncbi.nlm.nih.gov/pubmed/24520350",
                "http://www.ncbi.nlm.nih.gov/pubmed/24928524",
                "http://www.ncbi.nlm.nih.gov/pubmed/7673586",
                "http://www.ncbi.nlm.nih.gov/pubmed/1820100",
                "http://www.ncbi.nlm.nih.gov/pubmed/17957509",
                "http://www.ncbi.nlm.nih.gov/pubmed/10833575"
            ],
            "id": "5a74eaa50384be955100000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 764,
                    "text": "Symptoms vary from person to person, and may come and go, depend on what part of the body is affected, can be mild, moderate, or severe."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Systemic lupus erythematosus (SLE) is a chronic, multifaceted autoimmune inflammatory disease that can affect any part of the body."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22134536",
                    "endSection": "abstract",
                    "offsetInBeginSection": 830,
                    "offsetInEndSection": 923,
                    "text": "Both techniques were equally able to define the body part affected and the type of deformity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22134536",
                    "endSection": "abstract",
                    "offsetInBeginSection": 445,
                    "offsetInEndSection": 597,
                    "text": "Both studies were evaluated for amniotic band visualization, body part affected, type of deformity, umbilical cord involvement and vascular abnormality."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29333361",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1291,
                    "offsetInEndSection": 1534,
                    "text": "CONCLUSIONS\nThe SF-36 score 1 year after lumbar spinal fusion was affected by the preoperative factors of age, leg muscle strength, living with other family members, employment status, sex, and orthopedic disorders in another part of the body."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8216764",
                    "endSection": "abstract",
                    "offsetInBeginSection": 978,
                    "offsetInEndSection": 1280,
                    "text": "The findings demonstrate that while child burn fatality seems to have declined, the elderly continue to have high CFR for burns regardless of the body part affected, and that the CFRs for hospitalized burns remained constant between 1981 and 1990 in Maryland despite considerable advances in treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24520350",
                    "endSection": "abstract",
                    "offsetInBeginSection": 220,
                    "offsetInEndSection": 485,
                    "text": "In isolated focal dystonia, whole putaminal binding of dopamine D2-like receptor radioligands is quantitatively decreased, but it has not been known whether selected parts of the putamen are differentially affected depending upon the body part affected by dystonia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24928524",
                    "endSection": "abstract",
                    "offsetInBeginSection": 823,
                    "offsetInEndSection": 915,
                    "text": "MRI was able to detect and characterize the body part affected and associated abnormalities."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8216764",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "Case-fatality rates by body part affected and trends in hospitalized burns in Maryland, 1981-90."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7673586",
                    "endSection": "abstract",
                    "offsetInBeginSection": 188,
                    "offsetInEndSection": 429,
                    "text": "For their survey, they examined clinical screening forms and medical charts of 300 students (160 men and 140 women) to determine the type of injury, the body part affected, loading behavior of tissues involved, and mechanism of the injuries."
                }
            ]
        },
        {
            "body": "What is BORSA?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                "http://www.ncbi.nlm.nih.gov/pubmed/25352679",
                "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                "http://www.ncbi.nlm.nih.gov/pubmed/26064878",
                "http://www.ncbi.nlm.nih.gov/pubmed/21875361",
                "http://www.ncbi.nlm.nih.gov/pubmed/10834971",
                "http://www.ncbi.nlm.nih.gov/pubmed/1563385",
                "http://www.ncbi.nlm.nih.gov/pubmed/17108271",
                "http://www.ncbi.nlm.nih.gov/pubmed/18819540"
            ],
            "id": "5aae6499fcf456587200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1066,
                    "offsetInEndSection": 1175,
                    "text": "This clearly shows that BORSA may be misidentified as MRSA while heteroresistant MRSA may appear to be BORSA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                    "endSection": "abstract",
                    "offsetInBeginSection": 444,
                    "offsetInEndSection": 895,
                    "text": "Further testing revealed three distinct resistance patterns: 61 strains (69%) consistently met BORSA criteria and had average beta-lactamase levels five- to six-fold higher than oxacillin-susceptible controls; 11 strains (13%) were markedly heteroresistant MRSA with delayed appearance of resistant colonies leading to spurious susceptibility to amoxicillin/clavulanic acid; 16 strains (18%) appeared to be oxacillin-susceptible on repetitive testing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                    "endSection": "abstract",
                    "offsetInBeginSection": 896,
                    "offsetInEndSection": 1065,
                    "text": "Under conditions used to elicit intrinsic methicillin resistance in Staphylococcus aureus, a large percentage of BORSA appeared resistant to amoxicillin/clavulanic acid."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 443,
                    "text": "Eighty-eight Staphylococcus aureus clinical isolates meeting criteria for borderline oxacillin resistance (intermediate susceptibility or resistance to oxacillin but susceptibility to amoxicillin/clavulanic acid upon disk diffusion testing) were studied to determine optimal test techniques and conditions for differentiating borderline oxacillin-resistant Staphylococcus aureus (BORSA) from methicillin-resistant Staphylococcus aureus (MRSA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1228,
                    "offsetInEndSection": 1440,
                    "text": "The available evidence suggests that BORSA represent a frequently neglected problem, and their emergence in new environments implies that they need to be monitored and accurately distinguished from MSSA and MRSA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25352679",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1456,
                    "offsetInEndSection": 1572,
                    "text": "The spa t091 and t084 dominated among BORSA from chicken meat, whereas t548 and t002 were found within animal BORSA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 774,
                    "offsetInEndSection": 870,
                    "text": "A case-control study was undertaken to identify possible risk factors for being a BORSA patient."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26064878",
                    "endSection": "abstract",
                    "offsetInBeginSection": 607,
                    "offsetInEndSection": 701,
                    "text": "BORSA phenotype was found in 14% S. aureus isolates from pigs and 10% isolates from pork meat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 586,
                    "offsetInEndSection": 692,
                    "text": "BORSA cannot be classified as either truly methicillin-resistant or truly methicillin-susceptible strains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21875361",
                    "endSection": "abstract",
                    "offsetInBeginSection": 740,
                    "offsetInEndSection": 1002,
                    "text": "Besides decreased susceptibility to oxacillin, all MRSA and BORSA of these two major clonal lineages displayed resistance to gentamicin and kanamycin conferred by the aac(6')-Ie-aph(2')-Ia gene and to trimethoprim conferred by dfr(K) in MRSA and dfr(A) in BORSA."
                }
            ]
        },
        {
            "body": "Which gene is responsible for proper speech development?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                "http://www.ncbi.nlm.nih.gov/pubmed/27148578",
                "http://www.ncbi.nlm.nih.gov/pubmed/16497722",
                "http://www.ncbi.nlm.nih.gov/pubmed/23687080",
                "http://www.ncbi.nlm.nih.gov/pubmed/21108403",
                "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                "http://www.ncbi.nlm.nih.gov/pubmed/17565757",
                "http://www.ncbi.nlm.nih.gov/pubmed/10880297",
                "http://www.ncbi.nlm.nih.gov/pubmed/23949335",
                "http://www.ncbi.nlm.nih.gov/pubmed/25269856"
            ],
            "id": "5ace12be0340b9f058000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "The FOXP2 gene is important for the development of proper speech motor control in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27148578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Forkhead box protein P2 (FOXP2) is a well-studied gene known to play an essential role in normal speech development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16497722",
                    "endSection": "abstract",
                    "offsetInBeginSection": 265,
                    "offsetInEndSection": 423,
                    "text": "We have identified the Xq22 gene SRPX2 as being responsible for rolandic seizures (RSs) associated with oral and speech dyspraxia and mental retardation (MR)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                    "endSection": "abstract",
                    "offsetInBeginSection": 731,
                    "offsetInEndSection": 971,
                    "text": "These results demonstrate that the Foxp2 gene is critical for normal vocal behavior in juvenile and adult mice, and that Foxp2 mutant mice may provide a tractable model system for the study of the gene's role in general vocal motor control."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23687080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 502,
                    "offsetInEndSection": 637,
                    "text": "There were four genes identified in this deletion, of which SYNGAP1 is considered to be responsible for speech impairment and epilepsy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21108403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1131,
                    "offsetInEndSection": 1408,
                    "text": "CNTNAP2 is known to be involved in the cause of language and speech disorders and autism spectrum disorder and is in the same pathway as FOXP2, another important language gene, which makes it a candidate gene for causal studies speech and language disorders such as stuttering."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                    "endSection": "abstract",
                    "offsetInBeginSection": 90,
                    "offsetInEndSection": 191,
                    "text": "However, the role of the gene in general vocal behavior in other mammals, including mice, is unclear."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27148578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 117,
                    "offsetInEndSection": 305,
                    "text": "Deletions in the gene have been shown to result in developmental speech disorders and regulatory disruption of downstream gene targets associated with common forms of language impairments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21108403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 855,
                    "offsetInEndSection": 1130,
                    "text": "We report on a case with a complex set of speech and language difficulties including stuttering who presented with a 10\u2009Mb deletion of chromosome region 7q33-35 causing the deletion of several genes and the disruption of CNTNAP2 by deleting the first three exons of the gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27148578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 306,
                    "offsetInEndSection": 533,
                    "text": "Despite similarities in motor planning and execution between speech development and oral feeding competence, there have been no reports to date linking deletions within the FOXP2 gene to oral feeding impairments in the newborn."
                }
            ]
        },
        {
            "body": "What is PNPPP?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                "http://www.ncbi.nlm.nih.gov/pubmed/21747892"
            ],
            "id": "5a9da59c4e03427e73000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 520,
                    "offsetInEndSection": 722,
                    "text": "CONCLUSION\nPNPPP efficiently controls for non-disease-related variance, allowing both for efficient discovery of novel biomarkers and for covariate-independent linear cut-offs suitable for clinical use."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 196,
                    "text": "OBJECTIVE\nTo study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 919,
                    "offsetInEndSection": 1050,
                    "text": "PdeM is a monomer of 29.3 kDa, which exhibits optimum activity at 25\u00b0C and pH 8.5, but low affinity for bis(pNPP) as well as pNPPP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 531,
                    "text": "In the + MP transgenic plants, as compared with non-transgenic and - MP plants, higher hydrolytic activities were found on the following substrates: bis-(nitrophenyl)-phosphate (BPNPP, phosphodiesterase), p-nitrophenyl-(phenyl)-phosphate (PNPPP, nucleotidephosphodiesterase) and thymidine-3'-monophosphate p-nitrophenyl ester (T3MPP; 3'nucleotide phosphodiesterase.)"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21747892",
                    "endSection": "abstract",
                    "offsetInBeginSection": 654,
                    "offsetInEndSection": 926,
                    "text": "The extract, when tested colorimetrically for its inhibitory activities on phosphordiesterase-5 (PDE-5) in vitro towards p-nitrophenyl phenyl phosphate (PNPPP), was observed to induce significant dose-dependent inhibition of PDE-5, with an ID(50) of 0.161\u2009mg/ml (P < .05)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1225,
                    "offsetInEndSection": 1399,
                    "text": "Overexpression of PdeM in E.coli neither affected catabolite respression nor did the recombinant protein hydrolyzed cAMP in vitro, indicating its inability to hydrolyze cAMP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 532,
                    "offsetInEndSection": 702,
                    "text": "The + MP plant lines, as compared with other transgenic plants, exhibited higher nucleotide-phosphodiesterase activity in the soluble as well as in the membrane fraction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1647,
                    "offsetInEndSection": 1826,
                    "text": "Structural comparison of PdeM with its homologs showed that it lacked critical residues required for dimerization, cAMP hydrolysis, and for the high affinity binding of bis(pNPP)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "Hydrolytic activities of leaf extracts from normal and transgenic plants, with (+ MP) and without (-MP) the movement protein of tobacco mosaic virus, were examined."
                }
            ]
        },
        {
            "body": "What is Mendelian randomization?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17715159",
                "http://www.ncbi.nlm.nih.gov/pubmed/15321841",
                "http://www.ncbi.nlm.nih.gov/pubmed/21414999",
                "http://www.ncbi.nlm.nih.gov/pubmed/28684612",
                "http://www.ncbi.nlm.nih.gov/pubmed/28645627",
                "http://www.ncbi.nlm.nih.gov/pubmed/18767201",
                "http://www.ncbi.nlm.nih.gov/pubmed/25185943",
                "http://www.ncbi.nlm.nih.gov/pubmed/23258625",
                "http://www.ncbi.nlm.nih.gov/pubmed/20978399",
                "http://www.ncbi.nlm.nih.gov/pubmed/16410347"
            ],
            "id": "5a9da37e4e03427e73000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17715159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 276,
                    "offsetInEndSection": 525,
                    "text": "However, if we know of a gene closely linked to the phenotype without direct effect on the disease, it can often be reasonably assumed that the gene is not itself associated with any confounding factors - a phenomenon called Mendelian randomization."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15321841",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15321841",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1299,
                    "offsetInEndSection": 1460,
                    "text": "An integrated meta-analytical approach may increase the precision of this estimate and provide information on the assumptions underlying Mendelian randomization."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17715159",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "Mendelian randomization as an instrumental variable approach to causal inference."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15321841",
                    "endSection": "abstract",
                    "offsetInBeginSection": 130,
                    "offsetInEndSection": 433,
                    "text": "By combining information from genotype-disease and genotype-phenotype studies, it is possible to use this Mendelian randomization to derive an estimate of the association between phenotype (risk factor) and disease that is free of the confounding and reverse causation typical of classical epidemiology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21414999",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 184,
                    "text": "BACKGROUND\nMendelian randomization is used to test and estimate the magnitude of a causal effect of a phenotype on an outcome by using genetic variants as instrumental variables (IVs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15321841",
                    "endSection": "abstract",
                    "offsetInBeginSection": 674,
                    "offsetInEndSection": 866,
                    "text": "Plotting the log odds ratio of genotype-disease against the mean genotype-phenotype difference may help investigators detect departures from the assumptions underlying Mendelian randomization."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28684612",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study-Brief Report."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28645627",
                    "endSection": "title",
                    "offsetInBeginSection": 47,
                    "offsetInEndSection": 86,
                    "text": "Evidence using Mendelian randomization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18767201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 171,
                    "text": "In Mendelian randomization a carefully selected gene is used as an instrumental variable in the estimation of the association between a biological phenotype and a disease."
                }
            ]
        }
    ]
}